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CpG islands (CGIs) are short GC rich sequences with a high frequency of CpGs that are 
associated with the active chromatin mark H3K4me3. Most occur at gene promoters and are 
often free of cytosine methylation. Recent work has begun to clarify the functional 
significance of CGIs with respect to chromatin structure and transcription. In particular, 
proteins associated with histone-modifying activities, such as Cfp1 and Kdm2a, bind 
specifically to non-methylated CGIs via their CxxC domains. For example, artificial 
promoterless CpG-rich sequences integrated at the 3’ UTR of genes recruit Cfp1 and 
generate novel peaks of H3K4me3 in mouse ES cells without apparent RNA polymerase 
recruitment. There is also evidence that G+C-rich DNA recruits H3K27me3, a gene 
silencing mark.  
 
In this thesis I am exploring the constraints on DNA sequence and genomic location that are 
required to impose both H3K4me3 and H3K27me3 at CGI sequences. Showing that the 
generation of novel peaks of H3K4me3 and H3K27me3 over a promoter-less CpG rich 
sequence in a gene desert region is independent of it’s location in the genome extends earlier 
findings. These findings suggest that shared features of the primary DNA sequence at CGIs 
directly influence chromatin modification. Thus CGIs are not passive footprints of other 
cellular mechanisms, but play an active role in setting up local chromatin structure.  
 
However, the relative contribution of CpG frequency versus G+C content remains unclear. 
Therefore a sequence was generated that contains low levels of CpGs, comparable to the 
bulk genome, but has a G+C content similar to that of CGIs (Low CpG / High G+C). When 
this sequence was inserted into a gene desert neither marks of H3K4me3 or H3K27me3 were 
formed, indicating the importance of CpGs. Surprisingly, the reverse sequence with a high 
CpG frequency similar to that of CGIs and a low G+C content similar to that of the bulk 
genome (High CpG / Low G+C) did not establish H3K4me3 or H3K27me3 either. However, 
it was found that this sequence becomes heavily methylated in contrast to CGI-like 
sequences that remained unmethylated when introduced into a gene desert. This finding 
suggests that a high G+C content is important for keeping CGI-like sequences methylation 
free. Upon insertion of this High CpG / Low G+C sequence into mouse ES cells that were 
devoid of the de-novo DNA methyltransferases 3a and 3b (Dnmt3a/3b -/-) both H3K4me3 
and H3K27me3 marks were established at the inserted sequence. This discovery confirms 
the importance of CpGs for setting up local chromatin structure.  
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Lay summary 
In mammalian cells DNA needs to be tightly packed in order to fit into the nucleus. The way 
this is achieved is by winding the double helix around proteins called histones forming a 
highly ordered structure, called chromatin. Histones can be chemically modified so that the 
chromatin becomes either less tightly or more tightly packed. This change in chromatin 
structure is important for essential cell functions. Some genes need to be accessible in a 
given cell type whereas others need to be silenced, ensuring the right set of genes are 
expressed at the right time in the right cell type. Chromatin and modified histone proteins 
play an important role in this process by attracting different proteins, which are responsible 
for silencing or activating genes. However, it remains unclear how exactly some of these 
histone modifications are established in the first place.  
 
When looking at the structure of mammalian genes it becomes apparent that many 
promoters, the start region of genes, contain DNA sequences with a special base 
composition. These sequences are called CpG islands because they consist of an unusually 
high frequency of the combination CG, have an overall high content of Gs and Cs and are 
mostly unmethylated, unlike the rest of the genome which is heavily methylated. It is 
interesting that right at the start site of genes there are special sequences that aren’t found in 
other regions of the genome. But it is not clear if these CpG islands have an active function 
by itself or if they are just passive footprints in the genome, remainders of past events. 
Recent studies in our laboratory suggest that CpG islands are important regulatory structures 
that influence local chromatin establishment through their special sequence composition. It 
was shown that special proteins, for example Cfp1, could specifically bind to non-
methylated CpGs thereby attracting histone-modifying enzymes.  
 
In this thesis I am testing the influence of CpG island like sequences on chromatin structure 
by inserting them into gene desert regions, regions in the genome where there are no other 
genes present. In this way the effect of base composition can be studied in isolation, without 
having to take into account other influences such as transcription. We found that by 
introducing an artificial CpG rich and G+C rich sequence into the gene desert the local 
chromatin structure changed to a more “opened” form indicating that CpG islands can 
actively influence their chromatin environment. It was not clear what feature of CpG islands, 
the high CpG frequency or the overall G+C content, is important for their function. 
Therefore, I modified the sequence by having one construct that had only a few CpGs but as 
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many G and Cs as in CpG islands. Interestingly, this construct was not able to change 
chromatin structure supporting the fact that CpG density is the important feature. By 
changing the sequence to contain as many CpGs as a CpG islands but an overall G+C 
content like the rest genome I could show that having a high G+C content is important for 
keeping CpG islands free from DNA methylation, another essential feature of CpG islands. 
In summary this thesis provides evidence for the importance of CpGs in attracting histone-
modifying enzymes and of GC content to protect against DNA methylation.  
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ChIP     Chromatin immunopreciptitation 
COMPASS     Complex Proteins Associated with Set1 
CpG     CG dinucleotide 
CTD      C-terminal domain of RNA polymerase II 
DKO     Dnmt3a/3b double knock out ES cells 
dpc      days postcoitum 
DSBH     Double-stranded β-helix 
ES cells     Embryonic stem cells 
FBS      Foetal bovine serum 
Flp      Flippase 
Frt      Flippase recognition target 
G418     Geneticin 
Gsk3     glycogen synthase kinase-3 
H3K27me1/2/3    Histone H3 lysine 27 mono-/di-/tri- methylation  
H3K36me1/2/3    Histone H3 lysine 36 mono-/di-/tri- methylation 
H3K4me1/2/3    Histone H3 lysine 4 mono-/di-/tri- methylation 
H3K9me1/2/3    Histone H3 lysine 9 mono-/di-/tri- methylation 
HAT      Histone acetyl transferase 
HDAC     Histone deacetylases 
HMTs     Histone methyltransferases 
HOTTIP    HOXA transcript at the distal tip 
HP1     Heterochromatin proteins 1 
Hprt     Hypoxanthine-guanine phosphoribosyltransferase 
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IAA     Isoamyl alcohol  
IAP     Intracisternal A-particle 
ICF Immunodeficiency, cetromeric instability and facial 
anomaly 
ICR     Imprinting control regions 
iPSCs     Induced pluripotent stem cells 
JmjC     Jumonji C 
Kb     Kilo base 
KDM2A    Lysine demethylase 2a 
LIF      Leukemia inhibitory factor 
lnc RNA     Long non coding RNA 
LTR     Long terminal repeats 
MBD     Methyl binding domain 
MBP     Methyl binding proteins 
MDR      Methylation determining regions 
Mecp2     Methyl-CpG binding protein 
MEF      Mouse embryonic fibroblast 
Mek     Mitogen-activated protein kinase kinase 
MLL     Mixed-lineage leukemia 
MLL1/2     Mixed-lineage leukaemia 1/2 
nc RNA     Non coding RNA 
NDR     Nucleosome depleted region 
NLS     Nuclear localization signal 
NURD     Nucleosome remodeling factor  
NuRD      Nucleosomal remodeling & deacetylase complex 
o/e      Observed over expected 
o/n      Over night 
ORIs     Origin of replication 
PAF1     Polymerase associated factor 1 
PcG      Polycomb group  
PCL     Polycomb-like  
PCNA      Proliferating- cell nuclear antigen 
PGC     Primordial germ cell 
PHD      Plant homeodomain 
PRC1     Polycomb repressor complex 1 
PRC2     Polycomb repressor complex 2 
PRE      Polycomb response elements 
qPCR     Quantitative polymerase chain reaction 
RA     Retinoic acid 
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RFTS     Replication foci targeting sequence 
RMCE     Recombination mediated cassette exchange 
RNAi     RNA interference 
RNA pol II    RNA polymerase II 
RT     Room temperature 
SET     Su(var)3-9/Enhancer of zeste/trithorax 
shRNA     short hairpin RNA 
SID     Set1 interaction domain 
siRNAs     short interfering RNAs 
SUZ12     Su(z)12 Suppressor of Zeste-12 
SWI/SNF     Switch/sucrose non-fermentable 
TET     Ten-eleven translocation 
TRX     Trithorax 
TSS      Transcription start site 
UV     Ultraviolet 
Wt      Wild type 






1.1. DNA methylation 
DNA can be chemically modified by addition of a methyl-group to the carbon-5 position of 
the pyrimidine ring of cytosines (see Figure 1.1.1-1). This modification is well conserved in 
many plant, animal and fungi models and can be maintained through cell division. DNA 
methylation in mammals occurs preferentially in the context of CpG dinucleotides and is 
essential for normal development (Li et al, 1992; Okano et al, 1999). Three conserved 
enzymes, the DNA methyltransferases (DNMTS) DNMT1, DNMT3A and DNMT3B are 
responsible for its establishment and maintenance. Functionally, it has been implicated in 
genomic imprinting, X-chromosome inactivation, maintenance of genome stability, genome 
defence and transcriptional repression.  
 
1.1.1. DNA methylation across the kingdoms 
The prevalence and distribution of DNA methylation in different kingdoms of life is diverse. 
While vertebrates display a global DNA methylation distribution, invertebrates frequently 
show a mosaic methylation pattern, characterized by domains of heavily methylated DNA 
interspersed with stretches devoid of methylation (Suzuki et al, 2007; Tweedie et al, 1997). 
Some of the most frequently studied model organisms such as the yeast Saccharomyces 
cerevisiae and the nematode worm Caenorhabditis elegans do not have detectable Dnmt-like 
genes and do not show DNA methylation (Gutierrez, 2004; Proffitt et al, 1984), whereas 
DNA methylation is detected at very low levels during early Drosophila melanogaster 
embryogenesis (Lyko et al, 2000). Some fungi like Neurospora crassa possess DNA 
methylation, but only repetitive elements are targeted for methylation. Plants are generally 
heavily methylated but display diverse methylation patterns (Montero et al, 1992). While 
Arabidopsis thaliana displays mosaic methylation similar to that of invertebrates with 
methylated gene bodies and transposable elements, maize, which contains a much larger 
genome and high levels of transposons, shows a global DNA methylation distribution where 
genes tend to be unmethylated (Zhang et al, 2006).  
 
The transition from mosaic to global CpG methylation occurs at the invertebrate-vertebrate 
boundary as Ciona intestinalis, a sea squirt that is the most vertebrate-like among 
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invertebrates, displays mosaic DNA methylation pattern (Suzuki et al, 2007). In contrast, 
jawless fish, the most primitive of vertebrates, already show global CpG methylation 
(Tweedie et al, 1997). Whilst invertebrate methylation is mostly restricted to housekeeping 
genes without preference for repetitive elements, vertebrate methylation occurs at all DNA 
elements such as genes, indiscriminately of their activity state, transposons and intergenic 
regions. This ubiquitous DNA methylation makes it difficult to establish if certain DNA 
sequences are specifically targeted or if all sequences are methylated by default. For example 
it is unclear if genome defence through specific methylation of transposable elements is a 
major feature of vertebrate DNA methylation or if these elements are passively methylated 
as almost the entire genome is methylated (Suzuki & Bird, 2008). It is interesting to 
speculate that this transition from mosaic to global DNA methylation arose as a consequence 
of the need to facilitate gene regulation and dampen transcriptional noise in an increasingly 
complex genome (Bird, 1995).  
 
1.1.1. In mammals DNA is primarily methylated at CpG dinucleotides  
As discussed above, the mammalian genome falls into the category of global DNA 
methylation, which shows a bimodal methylation pattern. The majority, around 70% of all 
CpGs, are methylated (Ehrlich et al, 1982) while a small fraction of the genome (less than 
2%) stays unmethylated. These stretches of DNA that co-localize with the majority of 
promoters are called CpG islands (CGIs) and will be discussed in more detail in section 1.2 
(Bird et al, 1985).  
 
In mammals, DNA methylation occurs primarily in the context of CpGs, which is a 
symmetric mark and therefore ensures that both DNA strands are methylated (Ehrlich & 
Wang, 1981). This provides a mechanism how DNA methylation can be maintained 
throughout cell division, making it an epigenetic heritable mark that does not alter the coding 
potential of its underlying DNA sequence. However, a consequence of DNA methylation at 
CpGs is its mutagenic character. Both, cytosine and 5-methylcytosine are prone to hydrolytic 
deamination, resulting in the presence of uracil and thymine, respectively (Figure 1.1.1-1). 
As uracil is a base not found in DNA it is recognized efficiently by DNA glycosylases and 
reverted to cytosine. In contrast, thymine is a normal DNA base that after deamination is 
incorrectly base-paired. This mismatch is only inefficiently repaired by the cell’s repair 
system, for example by the glycosylase MBD4 (Hendrich & Bird, 1998). As a result of this 
mutability CpGs have been lost from the genome over the course of evolution and the 
observed over expected ratio of CpGs is only 0.21 (Bird, 1980). DNA methylation in other 
 20 
contexts than CpG have been observed, mainly in embryonic stem cells (ES cells). Non-CpG 
methylation predominantly occurs at CpA dinucleotides but has also been found at CpTs 
(Ramsahoye et al, 2000). As this type of methylation lacks the symmetry needed for a 
replication-based maintenance it might have to be continuously established by de-novo 
methyltransferases. Methylation in non-CG contexts show enrichment in gene bodies and 
depletion in protein binding sites and enhancers (Lister et al, 2009).  
 
 
Figure 1.1.1-1 Cytosine methylation  
Cytosine can be methylated at the carbon-5 position to form 5-methylcytosine, which can 
deaminate  to thymine.  
 
 
1.1.2. DNA methyltransferases methylate CpGs 
Specific enzymes, so called DNA methyltransferases (DNMTs) are responsible for 
methylating DNA. All DNMTs use S-adenosyl-methionine (SAM) as the source of the 
methyl group to be transferred to the DNA bases. Mammalian DNMTs use two different 
mechanisms to establish DNA methylation with respect to template specificity. One relies on 
the de novo addition of methyl groups to previously unmethylated DNA. The other 
mechanism re-establishes the DNA methylation pattern after DNA replication to that of the 
original strand (reviewed in (Hermann et al, 2004)). DNMT1, the sole maintenance 
methyltransferase belongs to the latter class, whereas DNMT3A and DNMT3B are de novo 
methyltransferases. All three DNMTs possess a conserved catalytic domain comprised of 10 
highly conserved peptide motives located at the carboxy terminal domain (Figure 1.1.2-1). 
The observed functional differences between the DNMTs are due to the variable amino-






DNMT1 is a large modular protein composed of a replication foci-targeting sequence 
(RFTS), a ZF-CxxC domain, a pair of bromo-adjacent homology (BAH) domains and a C-
terminal catalytic domain. DNMT1 associates with proliferating-cell nuclear antigen 
(PCNA) at replication forks via its RFTS, ensuring that the methylation pattern of the 
parental strand is faithfully transferred to the newly replicated strand after DNA replication 
(Iida et al, 2002; Chuang et al, 1997). It associates with the replication machinery and 
preferentially methylates hemimethylated DNA. This preference for hemimethylated DNA 
lies in the N-terminal domain as cleavage of this domain abolishes this preference and 
increases de novo methyltransferase activity (Bestor, 1992; Yoder et al, 1997). The CxxC 
domain is probably required to restrict proper targeting of DNMT1 (see also Chapter 1.2.5). 
Consistent with its function to maintain DNA methylation through replication, it is expressed 
at high levels in all replicating somatic cells. DNMT1 deficiency in mouse is embryonic 
lethal, shortly after gastrulation, and is coincident with a 70% reduction in DNA methylation 
levels. DNMT1-deficient ES cells however can be maintained, leading to the notion that 
DNA methylation is crucial for development (Li et al, 1992). As it was shown that Dnmt1 
knock-out (KO) ES cells are still capable of de novo methylating retroviral DNA (Lei et al, 
1996) it became apparent that there must be a yet unidentified enzyme with DNA 
methylation ability. Initially it was thought that DNMT2 could fulfil that role but although it 
possesses all the conserved motives shared by DNMTs, inactivation of DNMT2 does not 
perturb de novo or maintenance methylation (Okano et al, 1998a). 
 
DNMT3A/3B 
It turned out that DNMT3A and 3B are the long sought after de novo methyltransferases that 
are responsible for establishing DNA methylation patterns de novo after global 
demethylation during embryogenesis and gametogenesis. This is reflected by their 
expression pattern. Both enzymes are highly expressed in undifferentiated ES cells, are 
downregulated during differentiation and expressed at low levels in adult somatic cells 
(Okano et al, 1998b). The PWWP domain, a conserved Prolin-Tryptophan-Tryptophan-
Prolin motif, of DNMT3A/3B specifically binds histone H3 with trimethylated lysine 36 
(H3K36me3), which increases the ability of DNMT3A to methylate nucleosomal DNA 
(Dhayalan et al, 2010). The ADD domain contains many cysteine residues providing 
interaction with other proteins such as transcription factors, histone deacetylases (HDACs), 
heterochromatin protein HP1 or histone methyltransferases such as SUV39H1, SETDB1 and 
EZH2 (Jurkowska et al, 2011). Additionally, the ADD has been shown to interact 
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specifically with the N-terminal part of histone H3 when its lysine 4 residue is not modified 
(Ooi et al, 2007; Zhang et al, 2010b). Sequence analysis and domain structure of DNMT3A 
and DNMT3B suggest overlapping function and indeed double knock-out mice have a more 
severe phenotype than either single knock-out, suggesting a synergistic effect. Inactivation 
of both genes blocks de novo methylation in ES cells and early embryos, but it has no effect 
on the maintenance of imprinted DNA methylation patterns. DNMT3A and 3B are essential 
for normal development as mice deficient for both enzymes die at approximately embryonic 
day 11.5 (E11.5), however ES cell lines can be successfully maintained (Okano et al, 1999). 
Despite their overlapping function, they also exhibit specific functionality. DNMT3B in 
particular is known to be required for de novo methylation of specific genomic regions, as 
mice or human patients with DNMT3B mutations are deficient in methylation of 
pericentromeric repetitive DNA sequences and at CGIs on the inactive X chromosome 
(Hansen et al, 2000). DNMT3A is required for methylation of the major satellite repeats and 
for establishing maternal imprints through interaction with the third member of the Dnmt3 
family, DNMT3L (Kaneda et al, 2004). 
 
DnmtL shows clear homology to Dnmt3a and 3b but lacks essential motives rendering it 
catalytically inactive. DNTM3A and DNMT3B interact with DNMT3L and this interaction 
enhances their enzymatic activity (Gowher et al, 2005). DNMT3L specifically interacts with 
the N-terminus of histone H3 and this interaction is strongly inhibited by methylation at 
lysine 4 of histone H3 but is insensitive to modifications at other positions (Ooi et al, 2007). 
This suggests that DNMT3L might be important in inducing de novo methylation by 





Figure 1.1.2-1 Structure of mammalian DNMTs 
The carboxy terminal domain contains the conserved catalytic motifs (roman numerals; dark 
blue bars) whilst the variable amino terminal region contains various domains required for 
intracellular delivery and allosteric regulation of the catalytic C-terminus. Adapted from 
(Ryazanova, 2012).  
 
 
1.1.3. Dynamics of DNA demethylation 
Global changes in DNA methylation occur during normal development, especially during 
primordial germ cell (PGC) specification and just after fertilization, but also during cell 
differentiation. During gametogenesis global DNA demethylation occurs over the course of 
approximately 1 day from E10.5 to E11.5, encompassing the whole genome with the 
exception of IAP elements and a few LTRs that are only partially demethylated 
(Seisenberger et al, 2012; Popp et al, 2010). In the paternal genome methylated cytosine 
(5mC) is converted to hydroxymethylcytosine (5hmC) at fertilisation, followed by passive 
loss that reaches a minimum at blastocyst stage (Smith et al, 2012) and reviewed in (Smith 
& Meissner, 2013). Additionally, many tissue specific genes are methylated in almost all 
tissues but unmethylated in the tissue these genes are expressed in (Illingworth et al, 2008; 
Schilling & Rehli, 2007). From these examples it becomes clear that a demethylation 
mechanism must exist that either demethylates 5mC globally or specifically at target genes.  
 
For many decades the mechanism of demethylation was unknown and much disputed. 
Recent work has shown that a direct conversion of 5mC to unmethylated cytosine (C) is 
unlikely but that this process involves intermediate states, DNA repair and base excision 
(Guo et al, 2011b). 5mC can be modified by the ten-eleven translocation (TET) family of 
dioxygenases that catalyse the oxidation of 5mC to 5hmC (Ito et al, 2010; Tahiliani et al, 
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2009; Koh et al, 2011). It has been suggested that deamination may be involved in the 
process of converting 5hmc to unmodified C, and this is supported by evidence showing that 
Aid or APOBEC may be necessary for demethylation in the brain (Guo et al, 2011a). It is 
also possible that 5hmC could be deaminated to 5hmU, a good substrate for several known 
glycosylases (Rusmintratip & Sowers, 2000) but it is still not clear whether 5hmC can 
actually serve as a substrate for deamination in vitro or in vivo (Nabel et al, 2012). 
Alternatively, 5hmC can be further oxidized to 5-formylcytosine (5fC) or 5-carboxylcytosine 
(5caC) (Ito et al, 2010; He et al, 2011) which can be removed by glycosylation enzymes. 
Otherwise, 5hmC, which is not recognized by DNMT1, could become diluted out during 
replication. Passive DNA demethylation might be especially relevant in rapidly dividing 
cells such as ES cells. The discovery that 5hmC levels are particularly high in brain cells that 
do not divide supports this model (Kriaucionis & Heintz, 2009). It is also conceivable that 
5hmC might function by altering the local chromatin environment through recruitment or 
displacement of proteins as most 5mC binding proteins do not recognize 5hmC (Valinluck & 
Sowers, 2007; Jin et al, 2010).  
 
The TET protein family consist of TET1, TET2 and TET3, with TET1 being highly 
expressed in ES cells whereas TET2 and TET3 are more ubiquitously expressed (see also 
Section 1.2.5). TET1 is a candidate for mediating DNA demethylation during PGC 
development as it is expressed in PGCs and enriched at germ line specific genes and 
imprinting control regions which are demethylated at this stage. Global 5hmC levels in 
PGCs seem to be dependent on TET1 activity (Hackett et al, 2013). However, TET1 
deficient mice are viable and loss of TET1 does not seem to inhibit germ line competence or 
embryonic development (Dawlaty et al, 2011). Recently, double TET1 and TET2 KO mice 
were generated and while some embryos show perinatal lethality, also viable mice can be 
obtained suggesting a compensatory role of TET3 (Dawlaty et al, 2013). Adult mutant males 
have normal gonads and are fertile but double-mutant females display smaller ovaries, 
reduced numbers of mature follicles, and reduced fertility, which is more pronounced than 
previously observed in TET1 single-knockout mice. TET3 is expressed at high levels in 
oocytes and zygotes but is downregulated rapidly from the 2-cell stage onwards. 
Furthermore, it is enriched in the paternal pronucleus in zygotes and might be the 
responsible enzyme for demethylation after fertilization, as downregulation of TET3 in the 
zygote impedes 5mC to 5hmC conversion in the paternal pronucleus (Wossidlo et al, 2011; 
Gu et al, 2011). In summary, the recent advances made in deciphering demethylation of 
DNA highlight the dynamic nature of epigenetic modifications of DNA. 
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1.1.4. Targeting de novo DNA methylation 
After erasure of DNA methylation in the early embryo a new pattern of DNA methylation 
needs to be established. How exactly de novo DNMTs are targeted to ensure global 
methylation with the exception of CGIs has been studied intensively. More and more 
evidence is emerging that the basic DNA methylation profile during early development is 
established through interaction with histones. The pattern of H3K4 methylation is probably 
established before the global wave of de novo methylation, possibly through sequence-
directed binding of RNA polymerase II (RNA pol II), which then recruits specific H3K4 
methyltransferases (Guenther et al, 2007). At CGIs, H3K4me3 is established while the rest 
of the genome is densely packed into nucleosomes that contain unmethylated H3K4. 
DNMT3L recruits DNMTs to DNA by binding to unmethylated histones. However, 
interaction of DNMT3L with histones is inhibited by H3K4 methylation. This would provide 
a mechanism through which the majority of CpGs become methylated while CGIs remain 
methylation free (Ooi et al, 2007; Jia et al, 2007). 
 
Once the basic bimodal pattern of DNA methylation has been created, specifically targeted 
methylation and demethylation events occur throughout development. How this precise 
targeting occurs is less clear as there is little evidence for sequence specificity for any of the 
main DNMTs except the central CpG site. If it is not sequence specificity what kind of 
mechanism does target DNMTs? One proposition is that they are targeted by histone 
modifying enzymes, especially by histone methyltransferases (HMTs) that are recruited by 
local regulatory factors (reviewed in (Cedar & Bergman, 2009)). An example for locus-
specific gain of DNA methylation is represented by the promoter region of Oct3/4 (also 
known as Pou5f1), a pluripotency factor, which needs to be shut down for successful 
development. In ES cell models, it has been shown that this inactivation occurs in a stepwise 
manner. Initially, transcription is turned off through interaction of repressor molecules with 
the Oct3/4 promoter. Subsequently, a complex that contains the HMT G9A and enzymes 
with histone deacetylase (HDAC) activity are recruited. This leads to deacetylation, which 
then allows H3K9 methylation (Feldman et al, 2006). Finally, the G9A containing complex 
recruits DNMT3A and DNMT3B to the Oct3/4 promoter, resulting in de novo DNA 
methylation. Recently it has been shown that the same can be achieved ectopically by 
artificial targeting of HP1, which instructs H3K9 methylation followed by DNA methylation 
(Hathaway et al, 2012). There is evidence that this mechanism plays a role in the 
inactivation of other genes such as Nanog (Epsztejn-Litman et al, 2008).  
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Targeting of DNMTs to pericentromeric regions is achieved via the H3K9 HMTs 
SUV39H1/H2. The establishment of H3K9me3 recruits DNMT3B which is responsible for 
DNA methylation of pericentromeric repeats (Lehnertz et al, 2003). Methylation of these 
repeats is essential as pericentromeric elements contain the potential to initiate transcription. 
The fact that patients suffering from the heritable, autosomal recessive immunodeficiency, 
centromeric instability and facial anomaly (ICF) syndrome, display a missense mutation in 
DNMT3B suggests how the silencing of pericentromeric repeats is essential for normal 
development (Xu et al, 1999).  
 
Alternatively, DNMTs can be recruited to target genes via Polycomb Repressive Complex 2 
(PRC2), which is a member of the other major silencing system in cells, the Polycomb 
system (see section 1.3.3). It has been reported that DNMTs are able to interact with EZH2, 
the HMT in the PRC2 complex that establishes H3K27me3 (Viré et al, 2006). In this study it 
was suggested that EZH2 is required for DNA methylation of EZH2-target promoters, 
indicating that EZH2 could act as a recruiting platform. However, it must be noted that 
usually PRC2 target genes have unmethylated CGI promoters and therefore remain 
unmethylated throughout development, as H3K27me and DNA methylation seem to be 
mutually exclusive (Bartke et al, 2010). Nonetheless, in certain cases some of these genes 
become targets of de novo methylation, for example during differentiation of ES cells to 
neuronal precursors (Mohn et al, 2008; Meissner et al, 2008). 
 
An alternative mechanism of recruiting DNMTs to their targets could involve non-coding 
RNAs. However, it is likely that targeting of DNMTs via an RNA mediated pathway is not 
happening directly but again via histone methylating enzymes (Zhao et al, 2008; Nagano et 
al, 2008). 
 
The above examples illustrated how histone-modifying enzymes might be important for 
establishing DNA methylation patterns. Inversely, there is evidence that DNA methylation is 
needed in order to help to maintain histone modification profiles through cell division. It is 
probable that histone modification patterns are disrupted during replication and need to be 
re-established in the daughter cells. As DNA methylation profiles are retained through the 
activity of DNMT1 on hemimethylated DNA, it might offer a platform used for 
reconstructing the epigenetic state of the genome following cell division. It is possible that 
the presence of DNA methylation recruits G9A via its interaction with DNMT1 (Estève et 
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al, 2006). Additionally, it has been shown that DNA methylation inhibits H3K4me3 (Lande-
Diner et al, 2007).  
 
Another way how DNA methylation leads to a repressive chromatin state involves the 
recruitment of repressive complexes by methyl binding proteins (MBPs). This family of 
proteins possesses a methyl binding domain that specifically recognizes and binds to 
methylated CpGs (Hendrich & Bird, 1998). There are several models, how MBPs repress 
transcription. The interaction of MBPs with methylated CpGs could either result in steric 
hindrance of binding of transcription factors or other proteins of the transcriptional 
machinery. It could occlude transcription factor binding sites or it could recruit histone-
modifying enzymes that establish a heterochromatic environment. The MBD proteins consist 
of MeCP2, MBD1, MBD2, MBD3 and MBD4. For instance, MeCP2 interacts with the 
SIN3A/HDAC and NCoR/SMRT complexes. MeCP2 is particularly abundant in the brain, 
specifically in neurons, and mutations in MeCP2 are responsible for the neurological 
disorder Rett syndrome (Amir et al, 1999). Interestingly, some Rett syndrome-causing 
mutations in MeCP2 abolish the interaction with the NCoR/SMRT co-repressor complexes, 
which contains HDAC3 (Lyst et al, 2013). MBD1 associates with the H3K9 HMTs SETDB1 
and SUV39H1 and the heterochromatin binding protein HP1 (Fujita et al, 2003), while 
MBD2 associates with the NuRD co-repressor complex (Zhang et al, 1999). MBD3 does not 
posses a methyl-specific binding domain although it acts as a transcriptional repressor (Saito, 
2002). MBD4, which contains a thymine glycosylase domain, is involved in DNA repair. It 
preferentially repairs T:G mismatches (Hendrich et al, 1999). In addition, an unrelated 
family of Kaiso-like proteins also have binding specificity for methylated DNA (Filion et al, 
2006). Given the severity of symptoms displayed by DNMT knock-out (KO) mice it might 
be surprising to find that none of the MBD proteins is essential as shown by the relatively 
mild phenotypes of MBD KO mice, which could suggest functional redundancy between 
MBD proteins. Alternatively, this might indicate that DNA methylation exerts its effects not 
only via MBD proteins but also via alternative pathways (reviewed in (Sasai & Defossez, 
2009)).  
 
These examples support the notion of bidirectional cross talk of histone modifications and 
DNA methylation to ensure the establishment and maintenance of a transcriptionally inert 
chromatin environment.  
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1.1.5. Role of DNA methylation 
In order to understand the function of DNA methylation it is important to realize that its role 
varies with context and that its repressive influence on transcription might be more 
complicated and nuanced than initially thought.  
 
Promoter DNA methylation 
How promoter DNA methylation leads to transcriptional repression has been extensively 
studied. Early studies describe how expression of genes is extinguished upon artificially 
methylation of their promoters (Stein et al, 1982; Vardimon et al, 1982). Later, genome-
wide studies confirmed these results by correlating methylated promoters with 
transcriptional inactivity (Mohn et al, 2008; Weber et al, 2007). However, these examples do 
not show that DNA methylation is the initial silencing signal. Indeed, it is probably true that 
DNA methylation maintains an already silenced state rather than initiating it. One striking 
example is the establishment of X-inactivation where DNA methylation occurs only after 
transcriptional silencing is completed (Lock et al, 1987). Another example where silencing 
precedes DNA methylation is the mechanism by which Oct3/4 is shut down during 
differentiation where first transcription is shut down and a heterochromatic environment 
created and only then DNA becomes methylated (Epsztejn-Litman et al, 2008). Genome-
wide studies in cancer cells have shown that CGI promoters that are already marked by 
Polycomb are more likely to become DNA-methylated (Schlesinger et al, 2006).  
The majority of mammalian genes possess CGI-containing promoters that remain widely 
unmethylated. However, in situations that are linked with long-term silencing such as X-
inactivation and genomic imprinting, certain promoter CGIs do become methylated 
(discussed in section 1.2). It is not clear how DNA methylation affects non-CGI promoters 
despite the fact that this category comprises around 45% of all promoters and contains some 
well-studied genes such as Nanog and Oct3/4. A number of non-CGI promoters displays 
tissue-specific methylation patterns, suggesting that DNA methylation might play a role in 
the establishment and maintenance of tissue-specific expression profiles. Some studies have 
shown an inverse correlation between DNA methylation and gene expression, as it is the 
case for CGI promoters (Eckhardt et al, 2006; Han et al, 2011). Others have reported that 
CpG-poor promoters can still be expressed when they are methylated (Weber et al, 2007). It 
has been proposed that promoter strength could play a role in allowing expression from 
sparsely methylated genes (Boyes & Bird, 1992). Strong promoters are thought to be able to 
disrupt MECP2 binding to methylated, CpG poor promoters, which prevents transcription 
(Boyes & Bird, 1992).   
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Gene body methylation 
Although historically most focus was given to promoter methylation, the majority of CpGs 
lies outside of promoters. From early studies it has become clear that gene body methylation 
occurs at active genes and is not associated with repression (Zhang et al, 2006; Suzuki et al, 
2007). A study that examined the methylation pattern between the active X-chromosome and 
the inactive one found a positive correlation between gene body methylation and 
transcription on the active X-chromosome (Hellman & Chess, 2007). A number of reports in 
human have shown a more general correlation between DNA methylation in gene bodies and 
gene expression, with highly expressed genes tending to have more intragenic methylation 
(Ball et al, 2009; Rauch et al, 2009). However, other studies suggest that gene body 
methylation does inhibit transcriptional elongation (Lorincz et al, 2004).  
 
It has been suggested that the function of gene body methylation is to repress spurious 
transcriptional initiation outside of promoter regions. Furthermore, many genes contain 
several transcriptional start sites and it is conceivable that DNA methylation could regulate 
alternative promoter usage (Maunakea et al, 2010). The finding that there is more DNA 
methylation in exons than in introns and that the change in DNA methylation density occurs 
at the exon-intron border led to the suggestion that gene body methylation could play a role 
in splicing (Laurent et al, 2010). Fitting to this theory is the fact that exons seem to have 
more nucleosomes that are preferential sites for DNA methylation, than introns 
(Chodavarapu et al, 2010; Schwartz et al, 2009). Also some factors influencing the rate of 
transcription through RNA pol II pausing, an important feature of the kinetics of splicing, are 
regulated by DNA methylation (Shukla et al, 2011).  
 
DNA methylation in intergenic regions 
It has been suggested that DNA methylation in the bulk genome, which mostly consists of 
repetitive elements derived from transposable elements, plays a role in genome defence to 
prevent unconstrained transposition (Yoder et al, 1997). Indeed, DNMT-deficient mice show 
increased expression levels of IAP elements (Walsh et al, 1998) and human LINE and SINE 
elements are also de-repressed when DNMTs are lacking (Woodcock et al, 1997). However, 
so far no elevated transposition activity could be detected in DNA methylation depleted cells 
(Wilson et al, 2007), raising the possibility that DNA methylation serves to suppress 
spurious transcription from cryptic promoter elements (Bird, 1995).  
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DNA methylation is also implicated in maintaining genome integrity. As discussed above, 
mutation in DNMT3B can lead to ICF, a syndrome that is characterized by chromosomal 
segregation defects which are associated with hypomethylated pericentric satellite repeat 
sequences (Ehrlich, 2003). It is well documented that cancer cells show abnormal DNA 
methylation patterns, with many non-CGI regions being hypomethylated while some CGI 
containing promoters become aberrantly methylated, which is associated with genome 
instability and chromosomal abnormalities (Jones & Baylin, 2007).  
 
1.2. CpG islands 
Unlike the bulk genome, which comprises around 99% of the genome and is heavily 
methylated, CpG islands (CGIs) cover less than 2% of the genome and are usually not 
methylated. CGIs are characterised by an elevated G+C content and a high density of 
unmethylated CpGs. They tend to localize to gene promoters and associate with permissive 
chromatin.  
 
Figure 1.1.5-1 The genomic distribution of CGIs 
CGIs can be located at annotated TSSs, within gene bodies (intragenic), or between 
annotated genes (intergenic). Intragenic and intergenic CGIs of unknown function are 
classed as “orphan” CGIs. Empty circles: Unmethylated CpG residues. Filled circles: 
Methylated CpG residues. Adapted from (Deaton & Bird, 2011). 
 
1.2.1. Identification and characterization of CpG islands 
CGIs were discovered in the 1980s and initially termed HpaII Tiny Fragments (HTFs) due to 
their characteristic of being cut by the methylation-sensitive restriction enzyme HpaII, which 
recognizes a CCGG sequence (Cooper et al, 1983; Bird et al, 1985). The majority of mouse 
genomic liver DNA was resistant to being cut by HpaII whereas a small portion, around 1%, 
was digested by HpaII indicating that these sequences were unmethylated. It was suggested 
that the high content of unmethylated CpGs is a combination of an unusually high G+C 
content and lack of CpG deficiency due to absence of the mutagenic potential of methylated 
CpGs. The number of these CpG-rich sequences was initially estimated to be around 30 000 




Originally, these sequences were defined as at least 200bp in length and with a G+C content 
of 50% and an observed/expected (o/e) CpG frequency of 0.6 (Larsen et al, 1992a; Gardiner-
Garden & Frommer, 1987). The values suggested by Gardiner-Garden and Frommer are 
routinely used by genome browsers to predict CGIs. However, these values are somewhat 
arbitrary and as they are rather relaxed, many false positives are obtained due to the 
inclusion of repetitive elements. One report suggested the use of more stringent criteria in 
order to minimize contaminating Alu sequences, which have a similar base composition as 
CGIs and occur in thousands of copies (Takai & Jones, 2002). This increased stringency 
reduced the number of erroneously included Alu elements but also decreased the number of 
genuine CGIs. Preliminary computational analysis of the human genome sequence identified 
around 50 000 CGIs (Lander et al, 2001), of which only 28 890 were unique when removing 
multi-copy sequences by screening against known classes of repeats using repeat masking 
databases. Varying the stringency of parameters greatly changes the number of identified 
CGIs and any given parameters will always contain an arbitrary element. In order to 
overcome these limitations in determining the correct number of CGIs, a method was 
developed in our laboratory that relies on the identification of unmethylated CGIs using a 
cysteine-rich CxxC3 domain from mouse MBD1 that has a high affinity for nonmethylated 
CpG sites. This technique is called CxxC affinity purification (CAP) and allows the 
biological identification of CGIs (Illingworth et al, 2008). Using this approach around 17000 
CGIs were identified in human blood samples. Using CAP, a comprehensive set of mouse 
and human CGIs was established in a variety of tissues. Contrary to previous estimates that 
suggested one third less CGIs in mouse than in human (Mouse Genome Sequencing 
Consortium et al, 2002), the CGI number in mouse and human were found to be very 
similar, with 25 495 CGIs in humans and 23 021 in mice (Illingworth et al, 2010). The 
reason for this initial discrepancy was found to be the slightly lower overall CpG content of 
mouse CGIs in comparison to human CGIs. This finding strengthened the notion that CGIs 
are functionally important sequences as the apparent lack of conservation between mouse 
and human CGIs initially called their regulatory importance into question. 
 
Traditionally, CGIs were characterized as being associated with gene promoters (Lander et 
al, 2001; Bird et al, 1985; Saxonov et al, 2006; Weber et al, 2007). Approximately 60% of 
human genes have a CGI promoter including all housekeeping genes as well as 
approximately 40% of genes with tissue-specific expression patterns (Larsen et al, 1992b). 
CGI promoters often lack TATA boxes and can initiate transcription from multiple positions 
within the island (Zhu et al, 2008). On a genome-wide scale this correlation between 
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transcription initiation over a few hundred base pairs and presence of CGIs has been 
confirmed (Carninci et al, 2006). Interestingly, half of the CGIs identified in both human and 
mouse samples do not localize to annotated transcription start sites (TSSs) but are found 
within genes (intragenic CGIs) and in between genes (intergenic CGIs) (see Figure 1.1.5-1) 
(Illingworth et al, 2008; 2010). It was proposed that all CGIs, independent of their position, 
act as promoters at some stage in development, as many of these so called “orphan CGIs” 
show evidence for promoter function (Maunakea et al, 2010; Illingworth et al, 2010; 
Macleod et al, 1998). Because only a few tissues have been investigated so far for the 
presence of promoter activity of orphan CGIs and many orphan CGIs are active in a very 
tissue-specific manner, it is possible that all orphan CGIs are associated with novel 
transcripts. Some orphan CGIs might be promoters of hitherto uncharacterized protein-
coding genes, others may act as alternative promoters of nearby protein-coding genes, while 
yet others might give rise to noncoding RNAs. Not only the number of CGIs is conserved 
between mouse and human but also the relative distribution of CGIs to TSSs and inter- and 
intragenic loci proved to be similar between the two species. The genomic position of many 
orphan CGIs appears to have been maintained since the divergence of humans and mice, 
further implying functional importance (Illingworth et al, 2010). 
 
1.2.2. Origin and maintenance of CpG islands 
As the majority of CGIs stays unmethylated throughout development, the question how 
CGIs maintain this state of hypomethylation during the global wave of de novo methylation 
is an intriguing one. An abundance of recent findings contributed to our understanding of 
how this might be achieved. One initial suggestion of how CGIs are kept methylation-free 
and therefore retain their high density of CpGs was that CGIs might be intrinsically 
refractory to DNMT-binding due to their DNA sequence. However, given the fact that CpGs 
seem to be the preferred substrate of DNMTs and that in some cases CGIs do become 
methylated, i.e. during X-inactivation, this seems unlikely.  
 
Other studies argued that interaction of different protein factors with CGIs might exclude 
DNMTs and prevent them from targeting CGIs for de novo methylation. Evidence for such a 
mechanism is provided by the fact that mutating a binding site for the ubiquitous 
transcription factor SP1 in the CGI of the hamster and mouse Aprt gene lead to de novo 
methylation (Brandeis et al, 1994; Macleod et al, 1994). Generally, CGIs show a higher 
enrichment in transcription factor binding sites compared to the rest of the genome due to 
their elevated C+G content (Stadler et al, 2011).  
 33 
 
Gaining more insight into the characteristics of CGIs it became apparent that their role as 
promoters is tightly linked to their hypomethylated state. If promoter function and 
transcription were responsible for keeping CGIs free of methylation, this would require all 
CGIs to be active during the wave of de novo methylation in the early blastocyst and during 
germ cell development (see 1.1.3) (reviewed in (Smith & Meissner, 2013)). Data from early 
studies show that this indeed might be the case (Daniels et al, 1997). For example the tissue-
specific α-globin gene that possesses a CGI promoter is transcribed in the embryo, whereas 
the related β-globin gene that lacks a CGI is silent. In this and other reports highly tissue 
specific CGIs were demonstrated to be active in early development (Daniels et al, 1995; 
1997). Recent large-scale findings strengthen this hypothesis by showing that 90% of genes 
with CGI promoters are expressed in the early embryo or testis (Sequeira-Mendes et al, 
2009). Another report described that global transcription is a hallmark of embryonic stem 
cells and that the transcriptionally hyperactive ES cell genome undergoes large-scale 
silencing as the cells differentiate (Efroni et al, 2008).  
 
Interestingly, CGI promoters seem to attract RNA pol II regardless of their transcriptional 
activity status. Also it has been shown that RNA pol II at CGI promoters engages in short 
bidirectional abortive transcripts, even at otherwise inactive genes (Core et al, 2008; 
Kanhere et al, 2010). These non-productive transcripts might play an important role in 
keeping CGIs free of methylation. One possible mechanism might be that RNA pol II is 
involved in the recruitment of H3K4 HMTs, which methylate lysine 4 on histone 3 
(Guenther et al, 2007; Lee & Skalnik, 2008). H3K4me3 prevents chromatin binding of 
DNMT3L, a partner of DNMT3A and 3B and therefore interferes with DNA methylation. 
(Ooi et al, 2007). Additionally it has been shown that the ADD domain of the two de novo 
DNMTs fails to interact with H3K4me3 and that chromatin substrates with unmodified H3 
tail are methylated more efficiently by DNTM3A and DNMT3A/3L complexes than 
chromatin trimethylated at H3K4 (Zhang et al, 2010b). Alternatively, H3K4me3 can be 
established at CGIs by Cfp1 in the absence of transcription (Thomson et al, 2010) (see 1.2.4 
and 1.2.5). In addition, binding of the H3K4 HMTs of the MLL family may protect 
promoters of developmental genes from DNA methylation, and this is also likely to be 
instructed through their CxxC domains (Erfurth et al, 2008).  
The histone variant H2A.Z, which is preferentially found at TSSs, is another potential 
candidate for preventing DNA methylation at CGIs. It has been shown that H2A.Z is 
strongly anti-correlated with DNA methylation in Arabidopsis thaliana (Zilberman et al, 
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2008), and that H2A.Z and DNA methylation are mutually exclusive at TSSs in mouse B-
cells (Conerly et al, 2010). Although these observations are just correlative it seems 
plausible that the histone variant H2A.Z plays a role in inhibiting DNMTs.  
 
The observation that many CGIs co-localize with origins of replication (ORIs) led to the 
speculation that replication might lead to the local exclusion of DNMTs (Delgado et al, 
1998; Antequera & Bird, 1999). In ES cells more than 80% of CGIs co-localize with ORIs 
but a causal relationship between ORI function and CGIs has not been established (Mouse 
Genome Sequencing Consortium et al, 2002). 
 
The majority of unmethylated CGI promoters in the human genome show significant strand 
asymmetry in the distribution of guanine and cytosines in the immediate vicinity of TSSs, 
whereas GC content and CpG frequency are evenly distributed. This asymmetric distribution 
of Gs and Cs, also known as “GC skew”, allows the formation of R-loop structures, which 
occur when the newly transcribed G-rich RNA strand re-anneals back to its template C-rich 
DNA strand. The non-template G-rich DNA strand is then forced into an unpaired single-
strand conformation. It has been proposed that the R-loop formation might inhibit de novo 
DNMT recruitment, thereby contributing to the hypomethylated state at CGIs (Ginno et al, 
2012). How this inhibition of DNMTs is mechanistically happening is not fully understood, 
but it has been suggested that R-loops present inappropriate substrates for DNMT3B or that 
they may contribute to the recruitment of H3K4 HMTs by the single stranded DNA (Ginno 
et al, 2012). Interestingly, the results presented in this paper indicate that transcription might 
not be enough to protect a CGI from de novo methylation, since a construct orientated in a 
way that did not allow R-loop formation became methylated.  
 
It has long been proposed that an alternative way of protecting CGIs from DNA methylation 
is the active removal of DNA methylation by demethylases. However, this hypothesis could 
not be proven due to the difficulties in deciphering DNA demethylation pathways. The 
recent discovery that the three members of the TET protein family, which also possess a 
CxxC domain, can convert 5mC into 5hmC has provided a potential mechanism leading to 
DNA demethylation (Tahiliani et al, 2009; Ito et al, 2010). TET1 preferentially locates to 
CGIs in mouse ES cells (Ficz et al, 2011; Wu et al, 2011a) and its depletion results in 
increased CpG methylation at CGIs (Wu et al, 2011b). This led to the hypothesis that one 
function of TET1 might be to erase methylation marks that are sporadically put at CGIs, 
thereby contributing to their hypomethylated state.  
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The above section discussed how CGIs might be protected from de novo methylation during 
early development. Since it has been shown that CGIs can become methylated at later stages, 
after early embryogenesis (Mohn et al, 2008; Meissner et al, 2008) the question remains how 
the majority of CGIs escape this methylation at stages when ubiquitous transcription is shut 
down and more restrictive expression patterns are established. As described in the section 
“targeting de novo DNA methylation” (see 1.1.4), DNMTs may be specifically recruited to 
their target genes after the initial wave of global de novo methylation. This would mean that 
CGIs are not targets of DNA methylation by default but can become methylated in certain 
situations that require concerted action of DNMTs and other histone-modifying enzymes 
(see 1.2.3).  
 
1.2.3. CpG island methylation 
Although the majority of CGIs are hypomethylated, a small subset (~ 2‐5%) of promoter-
associated CGIs shows a high level of DNA methylation (Eckhardt et al, 2006; Weber et al, 
2007), which is associated with stable promoter silencing (Bird, 2002). Contrary to earlier 
assumptions that CGI methylation only occurs during specialized situations like X-
inactivation and genomic imprinting, recent studies highlight the fact that CGIs can become 
methylated during normal development, often in a tissue-specific manner (Illingworth et al, 
2008), and that aberrant DNA methylation is a hallmark of many cancers (Baylin & Herman, 
2000).  
 
In mammals, the expression level of genes from the X-chromosome in females, which 
possess two X-chromosomes, and males that have only one X-chromosome, needs to be 
equalised. This is accomplished by a process called X-chromosome inactivation whereby 
one female X-chromosome is randomly inactivated (reviewed in (Augui et al, 2011)). The 
non-coding RNA (ncRNA) Xist plays a pivotal role in this process by coating the X-
chromosome that is to become silenced (Penny et al, 1996). Furthermore, Xist is regulated, at 
least in part, by differential DNA methylation of its promoter region, which is 
hypomethylated on the inactive X (Xi) and hypermethylated on the active X (Xa) 
respectively in somatic cells (Norris et al, 1994). Xist coating is followed by the 
establishment of a repressive chromatin state involving H3K9me3 (Heard et al, 2001), 
Polycomb recruitment and subsequent H3K27me3 of the X-chromosome (Silva et al, 2003). 
DNA methylation of CGIs on the Xi is essential for maintaining the silent stage of genes but 
is not the initiating event in gene silencing. This is supported by the observation that Xi 
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genes are already repressed prior to the acquisition of DNA methylation at these sites (Payer 
& Lee, 2008).  
 
CGI methylation also has a well-characterized role in genomic imprinting where a subset of 
mammalian genes is expressed from only one of the two sister chromosomes depending on 
whether they are the maternally or paternally inherited copy. More than 80 genes are 
controlled by genomic imprinting, the majority of which are found in clusters. These clusters 
contain several imprinted genes and ncRNAs that are controlled by differential DNA 
methylation of imprinting control regions (ICR). For example, the ncRNA Airn is paternally 
expressed from the differentially methylated intragenic CGI of murine Igf2r, and represses 
transcription of several genes in cis, thus restricting their expression to the maternal allele 
(Wutz et al, 1997; Sleutels et al, 2002).  
 
Also cases of tissue-specific differential methylation were described at a small but 
significant number of CGIs, which could play a role in controlling tissue-specific 
transcription (Schilling & Rehli, 2007; Illingworth et al, 2008; Eckhardt et al, 2006). 
Methylated CGIs have been characterized that associate with the promoter regions of germ 
line specific genes which are silenced in somatic tissues. Genes of the MAGE (Melanoma 
Antigen Encoding Genes) family are silenced during embryogenesis primarily through the 
methylation of CpG-rich promoter sequences (De Smet et al, 1999). During differentiation 
from ES cells into neurons a number of CGIs acquire methylation, the majority of which are 
already silenced in ES cells, providing further evidence that silencing precedes methylation 
(Mohn et al, 2008). Additionally, differential CGI methylation can occur within different	  
somatic cell types,	   although these are relatively rare compared with differences between 
germline and somatic CGIs (Meissner et al, 2008). Genes involved in developmental 
processes such as members of the Pax6 or Hox family have been found to exhibit cell type 
specific DNA methylation at CGIs (Illingworth et al, 2008). It has been shown that 
promoters with a low CpG content are more likely to become hypermethylated than CpG-
rich promoters (Weber et al, 2007; Illingworth et al, 2010). Whereas promoter CGI 
methylation is a relatively rare event (~3%), orphan CGIs are methylated much more 
frequently (~15%). Especially intragenic CGIs are prone to gain methylation (20-30%) 
(Maunakea et al, 2010; Deaton et al, 2011; Illingworth et al, 2010). Alternative promoter 
usage or expression of ncRNAs might be regulated by intragenic DNA methylation (Dinger 
et al, 2008). It is also conceivable that regulation of splicing is influenced by intragenic CGI 
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methylation (Kornblihtt, 2006). More work will be needed to decipher the exact role of non-
promoter CGI DNA methylation.  
 
Many human cancers are connected with the aberrant hypermethylation of promoter CGIs. 
Epigenetic silencing of tumor suppressor genes is associated with improper promoter 
methylation (reviewed in (Baylin & Jones, 2012)). Initially it was thought that aberrant DNA 
methylation in cancers happens randomly, but by using genome-wide approaches it became 
apparent that certain CGIs become specifically targeted for de novo DNA methylation 
(Keshet et al, 2006). It is interesting to note that many of these de novo targets are CGIs 
marked by the repressive Polycomb complex (Ohm et al, 2007; Schlesinger et al, 2006). As 
with normal DNA methylation, it is possible that a HMT, in this case EZH2, is responsible 
for recruiting DNMTs to loci of erroneous DNA methylation (Viré et al, 2006; O'Hagan et 
al, 2011). Additionally, human cancers are often characterized by genome-wide DNA 
demethylation resulting in genome instability, aneuploidy or chromosomal rearrangements 
(Rodriguez et al, 2006).  
 
1.2.4. CpG islands and chromatin 
One function of CpG islands seems to be to allow the formation of a permissive chromatin 
environment that facilitates transcription factor binding and consequently transcription. Early 
studies have suggested that CGIs are made of non-nucleosomal DNA that is absent from 
bulk genomic fractions and that CGIs are depleted of the linker histone H1, which is 
considered repressive to transcription (Tazi & Bird, 1990). More recent work found that, 
unlike other promoters, CGI-containing promoters do not require ATP-dependent chromatin 
remodelling complexes to be activated but are intrinsically accessible (Ramirez-Carrozzi et 
al, 2009). Consistently, CGIs in macrophages showed a reduced density of histone 3 even in 
the un-induced state and in vitro chromatin assembly assays showed that CGIs are more 
reluctant to form nucleosomes than other genomic regions (Ramirez-Carrozzi et al, 2009). 
Another recent study analysed the influence of GC-content on nucleosome positioning and 
depletion and showed that CpG-content and CGI-width correlate with nucleosome depletion 
both in vivo and in vitro (Fenouil et al, 2012). As discussed in 1.2.2, a feature of CGI 
promoters is that they generally display paused RNA pol II (Core et al, 2008). It has been 
debated whether paused promoter transcription represents a cause or a consequence of open 
chromatin structures (Seila et al, 2009). Fenouil and colleagues argue that RNA pol II is not 
responsible for the formation of nucleosome depleted regions (NDR), but rather plays a role 
in the precise nucleosome positioning and in the enlargement of the NDR (Fenouil et al, 
 38 
2012). The notion that unstable nucleosomes are an intrinsic feature of CGIs and not 
transcription dependent is strengthened by the discovery that CxxC domain containing 
proteins, many of which possess histone-modifying activities, specifically recognize 
unmethylated CpGs, thereby contributing to the creation of CGI chromatin architecture (see 
1.2.5). These CxxC proteins are recruited by the underlying unmethylated CpG content and 
not by the transcriptional state of the associated gene (Blackledge et al, 2010; Thomson et al, 
2010). The CxxC domain containing protein Cfp1 is thought to recruit the H3K4 HMT 
complex SET1A/1B to CGIs (Thomson et al, 2010). The resulting H3K4me3 mark is a 
general feature of CGIs and can act as a binding platform, via PHD or chromodomains, for 
proteins that support transcription initiation, such as TFIID, for the nucleosome remodeling 
factor NURF30 or histone acetyltransferase (HAT) complexes (Vermeulen et al, 2007; 
Wysocka et al, 2006; Saksouk et al, 2009). In contrast, the histone lysine demethylases 
KDM2A/2B that also possess a CxxC domain are demethylating H3K36me2 at CGIs 
(Blackledge et al, 2010). Experiments in yeast suggest that H3K36me2 is inhibitory to 
transcriptional initiation by acting as a binding site for a histone deacetylase (HDAC) 
complex via a chromodomain (Li et al, 2009). Together all these features seem to create a 
chromatin environment that is permissive to transcription initiation but that require 
additional transcription factors to engage in productive transcription. Apart from this 
permissive chromatin state, CGIs can also adopt a more repressive form. A subset of CGIs is 
marked by the repressive chromatin mark H3K27me3 that is established by the PRC2 
complex (Bernstein et al, 2006). This class of promoters is referred to as “bivalent CGIs” as 
they retain the active chromatin mark H3K4me3 in addition to the repressive mark 
H3K27me3. Bivalency will be further discussed in section 1.3.4. In contrast, a small number 
of CGIs acquire DNA methylation during cell differentiation and this is associated with a 
constitutively repressed state (see 1.2.3).  
 
1.2.5. CxxC containing proteins 
The finding that MBD proteins specifically bind to methylated CpGs sparked the attempt to 
identify proteins that recognize unmethylated CpGs. Skalnik and colleagues identified a non-
methylated CGBP (CpG binding protein) using a phage based ligand screen (Voo et al, 
2000). CGBP was later re-named Cfp1 (CxxC finger protein 1 or CxxC1). Within this 
protein there is a cysteine-rich domain, the so-called Zinc finger CxxC domain (ZF-CxxC) 
that contains eight conserved cysteine residues and coordinates two Zn2+ ions. It was found 
that this ZF-CxxC domain binds specifically to a single nonmethylated CpG (Lee et al, 
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2001). This domain is present in a small group of proteins termed CxxC domain containing 
proteins that contain several histone-modifying enzymes (see Figure 1.2.5-1).  
 
 
Figure 1.2.5-1 CxxC domain containing proteins. 
An illustration of the domain architecture of mouse ZF-CxxC domain-containing proteins. 
The proteins are drawn to scale with the number of amino acids in the protein indicated on 
the left. The proteins are shown with the N-terminus on the left and all proteins are centered 
at the ZF-CxxC domain. In the case of KDM2A and KDM2B, alternative downstream 
promoters give rise to short forms of each protein (SF). Adapted from (Long et al, 2013). 
 
ZF-CxxC domain containing proteins can be split into three subtypes depending on their 
sequence similarity. Whereas the eight cysteine residues are conserved in all three classes, 
only class 1 possesses an extended linker region that is located between the two cysteine-rich 
motifs and contains a highly conserved KFGG (Lysine-Phenylalaninie-Glycine-Glycine) 
motif. A KQ or RQ DNA-binding motif, which binds specifically to the CpG dinucleotide, is 
present in type 1 ZF-CxxC domains, is lost in class 2 proteins and contains an HQ motif in 
class 3 (see Figure 1.2.5-2 A). How this domain recognizes only unmethylated CpGs and not 
the methylated form, which only differs by the presence of a single methyl group, has only 
recently begun to emerge with the availability of exact structural models in both unbound 
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and DNA-associated states (Xu et al, 2012; 2011a; Allen et al, 2006; Song et al, 2010). 
When bound to DNA, the ZF-CxxC domain lies perpendicular to the DNA axis and interacts 
with the major groove via a DNA-binding loop. Regions flanking the ZF-CxxC domain 
interact with the minor groove. While the KFGG motif is not required for sequence specific 
DNA interaction, the KQ or RQ motifs form hydrogen bonds with the cytosines from both 
DNA strands and a guanine from one of the two strands, so that this DNA-binding loop 
penetrates the major groove (see Figure 1.2.5-2 B). This means that the ZF-CxxC domain 
clamps around the DNA, requiring access to both the major and the minor groove. When 
DNA is tightly wound around histone octamers access to both grooves is inhibited. 
Therefore the ZF-CxxC domain must bind to linker DNA between nucleosomes in vivo 
(Zhou et al, 2011). When a CpG dinucleotide becomes methylated, these hydrogen bonds 
cannot form any longer and DNA binding of the CxxC domain containing protein is 
inhibited (reviewed in (Long et al, 2013)). This indicates that the CxxC domain-mediated 
recognition of CGIs requires both the presence of non-methylated CpGs and accessible 
nucleosome depleted DNA. Two studies demonstrated recently on a genome-wide scale that 
CxxC domain containing proteins also function in vivo as CGI targeting molecules that 
contribute to the special chromatin structure found at CGIs (discussed in 1.2.4) (Blackledge 
et al, 2010; Thomson et al, 2010).  
 
KDM2A/2B 
KDM2A is a Jumonji C (JmjC) domain containing histone demethylase that was shown to 
preferentially catalyze the demethylation of H3K36me3 (Tsukada et al, 2006). It has been 
demonstrated that KDM2A recognizes unmethylated CpGs through its ZF-CxxC domain and 
that this binding is abrogated in a CxxC mutant protein or when methylated CpGs are 
present. Moreover, genome-wide ChIP-Seq data shows that KDM2A localizes to CGIs in 
mouse ES cells independently of the transcription status of the associated gene, indicating 
that KDM2A is recruited by unmethylated CpGs rather than by the transcriptional machinery 
(Blackledge et al, 2010). Additionally, KDM2A bound CGIs are depleted of H3K36me2, a 
histone mark that has been implicated in inhibiting transcription initiation in yeast, 
suggesting that KDM2A plays an active role in removing this mark from CGIs (Carrozza et 
al, 2005). The exact role of H3K36me2 in higher eukaryotes is still not fully understood, but 
it is possible that targeting of KDM2A to CGIs via its CxxC domain provides a mechanism 
of how a chromatin state at CGIs can be achieved that is permissive for transcription. 
KDM2B possesses a similar protein structure to KDM2A, displays H3K36me2 demethylase 
activity and localizes to CGIs (Farcas et al, 2012; Wu et al, 2013; He et al, 2013). Although 
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both KDM2A and KDM2B associate with CGIs, there is a specific subset of CGIs that is 
only bound by KDM2B. Upon further analysis of this subset it became apparent that many of 
those genes are Polycomb protein targets, suggesting that KDM2B might play a role in 
Polycomb-mediated transcriptional repression (Farcas et al, 2012). It was subsequently 
shown that KDM2B is a member of a variant PRC1 complex and hypothesized that KDM2B 
could recruit PRC1 to Polycomb targets in a PRC2-independent manner (discussed further in 
1.3.3). The discrepancy that KDM2B is present at virtually all CGIs whereas PRC1 is only 
found at a small subset of CGIs was resolved by showing that the majority of CGIs is also 
occupied by PRC1, albeit to very low levels (Farcas et al, 2012).  
 
FBXL19  
F-box and leucine-rich repeat protein 19 (FBXL19) also possesses a ZF-CxxC domain but is 
devoid of the JmjC domain. Both, the KDM2A and KDM2B genes also have alternative 
transcription start sites giving rise to short forms of these proteins that are similar to 
FBXL19 (see Figure 1.2.5-1). The role of FBXL19 and the short forms of KDM2A and 
KDM2B remain poorly understood, but the presence of a presumably functional ZF-CxxC 
domain suggests that they might recognize CGIs.  
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Figure 1.2.5-2 Sequence variation in ZF-CxxC domains & its interaction with DNA 
(A) Sequence alignment of ZF-CxxC domains from mouse. ZF-CxxC domains can be split 
into three types depending on their sequence similarity, labeled as type-1, -2 and -3 on the 
right of the alignment. Conserved cysteins are highlighted in yellow. (B) A schematic of the 
ZF-CxxC domain highlighting the crescent structure and interaction with both the major and 
minor groove of DNA. Zn2+ ions (red) coordinate the eight cysteine residues (yellow). DNA 
is viewed down the double helix with bases shown as rods. Adapted from (Long et al, 2013). 
 
Cfp1 
Cfp1 (also CxxC1 or CGBP) is a ZF-CxxC domain containing protein that specifically binds 
to unmethylated CpGs. Mutation of either of two conserved cysteine residues in the CxxC 
domain to alanine results in ablation of DNA binding, suggesting that an intact CxxC 
domain is required for Cfp1 DNA binding activity (Voo et al, 2000; Lee et al, 2001). It also 
possesses a PHD domain and a SET1 interaction domain (SID), which is required for the 
interaction with the SET1A and SET1B H3K4 methyltransferase complexes (Lee & Skalnik, 
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2005; Lee et al, 2007a). Moreover, Cfp1 was found to interact with the maintenance DNA 
methyltransferase DNMT1 (Butler et al, 2008). 
 
Cfp1 homologues have been identified in Drosophila, C. elegans, and both S. cerevisiae and 
S. pombe (Miller et al, 2001). SPP1 is the Cfp1 homologue in yeast and is a component of 
the SET1/COMPASS histone H3K4 methyltransferase complex, the analogue of the 
mammalian H3K4 HMT complex. Interestingly, SPP1 lacks the CxxC domain in an 
organism that does not display CpG methylation. The SET1/COMPASS complex is the only 
H3K4 HMT in yeast (Briggs et al, 2001). In contrast, several mammalian H3K4 HMTs exist, 
each containing a component with a unique SET domain (see chapter 1.3.2). 
 
Cfp1 null mice are not viable and die during early embryonic development, between day 3.5 
and 6.5 dpc (days postcoitum). However, Cfp1 does not seem to be required for cell viability 
per se as Cfp1 null blastocysts are viable and capable of inner cell mass and trophectoderm 
formation. Therefore, it is possible that Cfp1 is required for peri-implantation development, 
the developmental stage associated with global remodeling of chromatin structure and 
cytosine methylation patterns (Carlone & Skalnik, 2001). To further characterize Cfp1 
function murine embryonic stem cells lacking Cfp1 were created. Cfp1‐/‐ ES cells are viable 
but display an extended doubling time due to apoptosis and are not able to differentiate in 
vitro, consistent with the inability of Cfp1 null embryos to gastrulate. They also display a 60-
80% reduction in global cytosine methylation, including single copy genes, imprinted genes 
and repetitive elements, due to reduced activity of the maintenance DNA methyltransferase. 
In contrast, de novo methyltransferase activity remains normal in Cfp1‐/‐ cells (Carlone et al, 
2005). These deficiencies alone cannot account for the severe phenotype observed in Cfp1 
null embryos, as mouse embryos lacking DNMT1 die around 9 dpc whereas embryos 
lacking Cfp1 die much earlier. However, it is currently not clear how the lack of Cfp1 
influences reduced DNMT1 activity.  
 
Analysis of genome wide distribution of Cfp1 revealed that 80% of CGIs are associated with 
Cfp1 and this association does not depend on the activity state of the corresponding gene. 
Chromatin immunopreciptitation followed by genome-wide sequencing with antibodies 
against H3K4me3 showed that 90% of Cfp1-associated CGIs also possess H3K4me3 
(Thomson et al, 2010). This result suggests that Cfp1 might be responsible for targeting the 
SET1 histone methyltransferase complex to CGIs via its CxxC domain. Consistently, knock 
down of Cfp1 in NIH3T3 fibroblasts lead to a prominent reduction of H3K4me3 at CGIs 
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(Thomson et al, 2010). In support of this idea, insertion of promoter-less CpG-rich DNA can 
mediate de novo accumulation of H3K4me3 in ES cells (Thomson et al, 2010; Mendenhall 
et al, 2010). Genome-wide H3K4me3 ChIP-Seq data of Cfp1-/- mouse ES cells indicated 
that the around 50% of genes displayed a loss of H3K4me3; in line with the model that Cfp1 
is important for targeting the SET1 complex to CGIs (Clouaire et al, 2012). The observed 
effect was greatest at promoters of active genes without an obvious effect on gene 
expression, implying that Cfp1 is not required in setting up basal H3K4me3 levels but is 
important for transcription-coupled deposition of this mark. Somewhat surprisingly, a 
substitution experiment with a mutated Cfp1 lacking a functional CxxC domain restored 
normal levels of H3K4me3 at affected genes. This result indicates that there must be an 
alternative mechanism that targets SET1 to basal H3K4me3 levels. Cfp1 contains redundant 
functional domains as introduction of either the amino-terminal half of Cfp1 that contains 
the CxxC domain or the carboxyl-terminal half that contains the SID domain is sufficient to 
correct the defects observed in the Cfp1-/- ES cells (Tate et al, 2009). However, no rescue 
was achieved with a full-length construct that contained point mutations in both the CxxC 
and SID domain, suggesting that either the DNA binding domain or the SET1 interaction 
domain is required for Cfp1 function (Tate et al, 2009). Cfp1 also possesses a PHD domain, 
which might be a possible candidate for targeting the SET1 complex to basal levels of 
H3K4me3, as it was recently shown that PHD domains are able to bind to H3K4me3 (Eberl 
et al, 2013). Different H3K4 methyltransferases such as MLL1 or MLL2, which also possess 
a ZF-CxxC domain, could be responsible for establishing these basal H3K4me3 levels. 
 
In addition to reduced H3K4me3 levels at active genes, loss of Cfp1 results in the 
appearance of ectopic H3K4me3 peaks that localize to regulatory elements (Clouaire et al, 
2012). Unlike H3K4me3 deficiency at promoters, ectopic peaks of H3K4me3 were not 
abolished by expression of the DNA-binding mutant of Cfp1, suggesting that the DNA 
binding activity conveyed by the CxxC domain is required to restrict the activity of the SET 
complex to bona fide targets and prevent mislocalization to other genomic regions. This is 
consistent with earlier findings that observed a global increase of H3K4me3 levels in Cfp1-/- 
ES cells, concomitant with reduced levels of heterochromatin, which suggested that Cfp1 
restricts H3K4 methyltransferase activity to euchromatin (Tate et al, 2010).  
 
MLL1/MLL2 
The mixed lineage leukemia (MLL) H3K4 methyltransferase family comprises four large 
proteins, MLL1–MLL4, that form complexes that share a set of interaction partners with the 
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SETD1 complexes, including ASH2L, WDR5, RbBP5 and DPY-30 (see chapter 1.3.2.). 
MLL1 and MLL2 are closely related proteins that also contain a ZF-CxxC domain (see 
Figure 1.2.5-1), whereas MLL3 and MLL4 lack this domain. It has been shown that MLL1 
and MLL2 bind to nonmethylated DNA in vitro via their CxxC domain (Birke et al, 2002; 
Bach et al, 2009), but it is not clear if that domain plays a similar role like Cfp1 and 
KDM2A/2B in vivo.  
 
MLL1 is essential for normal development as it maintains the activity of developmentally 
important genes such as the Hox clusters.  MLL1 knock out mice are embryonically lethal 
and show impaired segmental identity (Yu et al, 1995). MLL1 mostly localizes to gene 
promoters, which is reminiscent to the localization of Cfp1 and KDM2A/2B. However, 
unlike these proteins, which are present at CGIs regardless of the transcriptional state of the 
associated gene, MLL1 is restricted to a subset of CGIs that are found at active genes, 
suggesting that other mechanisms independent of ZF-CxxC-mediated targeting might play a 
role in MLL1 localization (Milne et al, 2005; Guenther et al, 2005). Chromosomal 
translocations that couple the N-terminus of MLL1, including the CxxC domain and an AT-
hook, to the C-terminal domain of fusion partners have been implicated in driving aggressive 
adult and childhood leukemia (Meyer et al, 2009). Many of these fusion proteins are targeted 
aberrantly, leading to the erroneous expression of MLL1 target genes. MLL-fusion proteins 
with a mutant ZF-CxxC domain exhibit reduced transforming potential suggesting that the 
ZF-CxxC domain plays a crucial role in directing fusion proteins to genomic targets (Ayton 
et al, 2004; Milne et al, 2010). 
 
Although MLL2 displays a very similar protein structure to MLL1 they have non-
overlapping functions. Interestingly, MLL2 fusion proteins have not been implicated in 
promoting leukemia (Bach et al, 2009). It was shown that MLL2 is responsible for setting up 
H3K4me3 at bivalent gene promoters in mouse ES cells (Hu et al, 2013).  
 
DNMT1 
DNMT1 is the only maintenance DNA methyltransferase in mammals and it functions by 
associating with proliferating cell nuclear antigen (PCNA) at replication forks via its 
replication foci targeting sequence (RFTS). There, it copies the pre-existing DNA 
methylation pattern from the parental DNA strand to the newly replicated one. Consistent 
with its role to re-establish the symmetric methylation pattern after replication, it has been 
shown that its preferred substrate is hemimethylated DNA (see also chapter 1.1.2). Therefore 
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it might seem surprising that DNMT1 possesses a type 1 ZF-CxxC domain, which 
specifically recognizes unmethylated CpGs. A recent study shed light on this apparent 
discrepancy by demonstrating that this domain is required to restrict DNMT1 to its proper 
targets. This is achieved by an auto-inhibitory mechanism that prevents the catalytic domain 
from methylating DNA when the CxxC domain is bound to unmethylated CpGs (Song et al, 
2010). When DNMT1 encounters a hemimethylated CpG, the CxxC domain cannot bind 
thus rendering the catalytic domain accessible. However, this structural study was based on a 
truncated version of DNMT1 that did not include the N-terminal RFTS. Full-length DNMT1 
with mutations in the CxxC domain, which strongly impair DNA binding of the isolated 
CxxC domain, did not reduce the specificity of the enzyme, suggesting that the auto-
inhibition model does not apply to full-length DNMT1 (Bashtrykov et al, 2012). It was also 
suggested that the RFTS domain can insert into the DNMT1 DNA-binding pocket and play 
an inhibitory role (Syeda et al, 2011) indicating that several mechanisms, dependent and 
independent of the CxxC domain, might play a role in restricting the catalytic activity of 
DNMT1 to hemimethylated CpGs.  
 
MBD1 
MBD1 is a transcriptional repressor protein that contains an MBD domain, with which it is 
able to specifically bind to methylated CpGs. Additionally, this protein possesses three CxxC 
domains, only one of which is functional and capable of binding to unmethylated CpGs in 
vitro (Clouaire et al, 2010). The presence of both, ZF-CxxC and MBDs, in MBD1 makes it 
possible that it could potentially read unmethylated and methylated CpG dinucleotides 
individually or in combination (Jørgensen et al, 2004). However, point mutations in the 
CxxC-3 domain which disrupt DNA binding in vitro did not affect the recruitment of MBD1, 
suggesting that functional MBD1 targeting can be achieved in the absence of the ZF-CxxC 
domain and that MBD1 is primarily a methylated CpG binding protein (Clouaire et al, 
2010).  
 
TET1 and TET3  
TET1 and TET3 are members of the TET family of proteins that also comprises TET2. Apart 
from the catalytic double-stranded β-helix (DSBH) domain, they contain a type 3 ZF-CxxC 
domain. While TET2 does not possess a CxxC domain, its neighboring gene IDAX (CxxC4) 
has a ZF-CxxC domain that is very similar to TET1 and TET3. TET proteins have been 
implicated in the conversion of 5mC to 5hmC, and are thought to be part of the mammalian 
DNA demethylation system (see chapter 1.1.3) (Ito et al, 2010; Tahiliani et al, 2009). The 
 47 
type 3 ZF-CxxC domain permits a more flexible way of DNA binding, allowing the binding 
of unmethylated Cs in any sequence context. This flexibility is achieved by a shortened 
linker region and a divergent DNA-binding loop, making the DNA-binding interface of the 
TET3 ZF-CxxC domain not as rigid as those found in type 1 CxxC domains (Xu et al, 2012). 
In contrast, it has been suggested that TET1 binds to methylated and unmethylated CpGs 
(Xu et al, 2011b; Zhang et al, 2010a) or that is does not show sequence specific DNA 
binding (Frauer et al, 2011). Despite these contradicting reports TET1 seems to localize to 
CGIs in vivo and shows a positive correlation with CpG density (Williams et al, 2011; Wu et 
al, 2011b). 5hmC seems to be least abundant at CpG-rich promoters with high levels of 
TET1. This initially surprising result might indicate that it is the function of TET1 to convert 
sporadic aberrant DNA methylation at CpG-rich promoters to 5hmC, which could be further 
processed to an unmethylated C. This hypothesis is supported by the fact that knock down of 
TET1 results in the accumulation of DNA methylation at specific CGIs (Xu et al, 2011b). 
Alternatively, it has been proposed that TET1 has a repressive role, additionally to its 
function of converting 5mC to 5hmC, that involves the direct recruitment of the SIN3A co-




In eukaryotic cells DNA is tightly packed into a nucleoprotein structure called chromatin. 
The basic unit of chromatin is the nucleosome that consists of 147bp of DNA wrapped 
around an octamer of 4 conserved histone proteins (2 copies of H3, H4, H2A and H2B) 
(Luger et al, 1997). The histone protein H1 interacts with the linker DNA separating two 
nucleosomes, thereby stabilizing the nucleosome structure and locking it in place (Happel & 
Doenecke, 2009). Strings of nucleosomes can be tightly packed and further condensed to 
form chromosomes. Chromatin can be modified in a variety of ways, enhancing or 
restricting accessibility of transcription factors and the transcription machinery. This can 
either be achieved by covalent modifications of histone tails, repositioning of nucleosomes 
by chromatin remodelling complexes or replacement of canonical histones with special 
histone variants. Chromatin modifications occur in a highly combinatorial and, sometimes, 





Figure 1.2.5-1 Chromatin organisation in the cell 
The core particle of the nucleosomes is composed of 147bp of genomic DNA (2nm in 
diameter) wrapped around a histone octamer that consists of two copies of the major types 
of histones (H2A, H2B, H3 and H4). The yellow rod shape symbolizes the linker histone 
protein H1, which binds to DNA and histones, locking nucleosome in its place. Strings of 
nucleosomes can be tightly packed and further organized to form chromosomes. Adapted 
from (Tonna et al, 2010).  
 
  
1.3.1. Histone modifications 
Histones are globular proteins with a largely unstructured N-terminal tail that can be 
covalently modified in a number of ways. These modifications include methylation (me), 
phosphorylation (ph), acetylation (ac), ADP ribosylation (ar), ubiquitination (ub) and 
sumoylation (su), some of which correlate with active chromatin while others are associated 
with a repressed state (Kouzarides, 2007; Bernstein et al, 2007). Different chromatin states 
Figure 2 Organizational network of chromatin in the cell
Tonna, S. et al. (2010) Metabolic memory and diabetic nephropathy: potential role for epigenetic
mechanisms
Nat. Rev. Nephrol. doi:10.1038/nrneph.2010.55
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are defined by combinatorial patterns of these histone modifications and each histone 
modification can induce or inhibit subsequent modifications. Histone modifications can have 
an effect on DNA-protein, protein-protein and nucleosome-nucleosome interactions by 
changing the charge of residues or providing binding platforms for a variety of proteins 
(Kouzarides, 2007). Initially the existence of a strict histone code was proposed that is 
recognized by transcription factors and dictates a transcriptional outcome (Strahl & Allis, 
2000). However, an abundance of studies showed that the patterns of histone modifications 
are more complex than initially anticipated, revealing a multifaceted cross talk between 
histone modifications and context depending effects (Lee et al, 2010). To add to this 
complexity, the chromatin structure is also influenced by effector or “reader” proteins that 
recognize single or multiple histone modifications. The majority of histone modifications are 
reversible, the most prominent ones being histone deacetylases and histone demethylases, 
adding to the dynamics of chromatin.  
 
Histone modifications such as, among many others, H3K4me2, H3K4me3 and H3/H4ac 
occur at gene promoters and are associated with transcriptional activity. H3K36me3 is found 
predominantly at gene bodies and correlates with transcriptional elongation. H3K9me2, 
H3K9me3 and H3K27me3, as well as hypoacetylation of H3 and H4, are implicated in 
transcriptional silencing. Acetylation has a positive influence on transcription by neutralising 
the positive charge of the histone tails, thereby destabilising DNA-histone interactions and 
facilitating chromatin decondensation (Luger et al, 1997). Methylation can have a positive or 
negative effect on transcription. Depending on the position of the methylation mark different 
proteins associate with histone lysine methylation. For example, H3K4me3 attracts proteins 
of the basal transcription machinery while inhibiting DNMTs (Vermeulen et al, 2007; Ooi et 
al, 2007). On the contrary, H3K9me3 is bound by HP1, promoting heterochromatin 
formation (Bannister et al, 2001), while H3K27me3 attracts Polycomb proteins 
(Schuettengruber et al, 2007). Genome-wide mapping of histone modifications led to the 
classification of distinct chromatin states depending on the combinatorial pattern of different 
histone modifications. In Drosophila, 5 or 9 different chromatin states have been predicted, 
respectively (Filion et al, 2010; Kharchenko et al, 2011). Another study suggested the 
existence of 15 different chromatin states in human cells, corresponding to repressed, poised 
and active promoters, strong and weak enhancers, putative insulators, transcribed regions, 
and large-scale repressed and inactive domains (Ernst et al, 2011).  
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Apart from histone modifications, nucleosome positioning can influence transcriptional 
outcome as DNA sequences necessary for transcriptional activation can be occluded by 
nucleosomes (Saha et al, 2006). In the ‘ground state’, nucleosome positioning is largely 
dictated by DNA sequence composition, which provides thermodynamically favorable 
localization sites (Ioshikhes et al, 2006). There are several families of chromatin remodeling 
complexes that physically disrupt nucleosome interactions through the use of ATP 
hydrolysis such as the SWI/SNF (Switch/Sucrose non-fermentable), CHD (chromodomain 
and helicase domain), ISWI (imitation SWI) and INO80 complexes (Ho & Crabtree, 2010). 
These complexes recognize specific histone modifications and are important for 
development and differentiation.  
 
Additionally, the exchange of canonical histones with different variants is a way of 
modulating chromatin in response to cellular triggers such as DNA replication or DNA 
damage (Kamakaka & Biggins, 2005). The canonical histone H3.1 is replaced by the histone 
variant H3.3 in active chromatin in a replication-independent way and is thought to 
positively influence transcription through the expelling of H3K9me3 histones (Ahmad & 
Henikoff, 2002). Another H3 isoform, CENPA, is a component of centromere-specific 
nucleosomes and responsible for the formation of centromeric heterochromatin (Smith, 
2002). The H2A variant H2A.Z is localized to the promoter proximal regions of active 
genes, and has been proposed to have a role in destabilizing chromatin to facilitate 
transcription (Schones et al, 2008). H2AX localizes throughout the genome and becomes 
rapidly phosphorylated in response to double strand breaks (Redon et al, 2002). 
 
  
1.3.2. The Trithorax system 
The activating Trithorax and the repressive Polycomb (see 1.3.3) system represent two 
classes of antagonistic factors that are highly conserved in metazoans. This system is 
essential for the maintenance of the expression pattern of developmentally important Hox 
genes and plays a role in stem cell identity, lineage specification, genomic imprinting and X-
chromosome inactivation (Schuettengruber et al, 2007). It exerts its function by regulating 
and memorizing transcriptional activity and by maintaining a specific gene expression 
pattern, even when the initial cues are diminished, through histone modifications and 
remodelling. H3K4 methyltransferases together with SWI/SNF and NURF chromatin 
remodeling complexes are part of the activating Trithorax system. 
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The first H3K4 methyltransferase identified was Set1, from the yeast Saccharomyces 
cerevisiae, within a complex named COMPASS (Complex Proteins Associated with Set1) 
(Miller et al, 2001). Set1 is the only H3K4 methyltransferase in yeast and capable of mono-, 
di- and trimethylating H3K4 (Krogan et al, 2002). In mammals, on the contrary, at least 10 
known or predicted H3K4 methyltransferases exist. H3K4 methyltransferases contain a 
Su(var)3-9/Enhancer of zeste/trithorax (SET) domain, which is responsible for catalyzing the 
addition of methyl groups to specific lysine residues. The SET domains in these proteins are 
either related to yeast Set1 as in the case of SET1A/B or to the Drosophila trithorax gene 
(Trx), as is in the case of the mixed lineage leukemia (MLL) family (MLL1-4). There are 
additional predicted H3K4 methyltransferases in mammals that are unrelated to yeast genes, 
such as ASH1, SMYD3, SET7/9 or MEISETZ (Ruthenburg et al, 2007). Why mammals 
have the need for several H3K4 methyltransferases when yeast only needs one is not entirely 
understood. However, evidence suggests that they are functionally non-redundant as they 
display a differential expression pattern and associate with different targets. Moreover, 
deletion of either H3K4 methyltransferase gives rise to distinct phenotypes in mice 
(Vastenhouw & Schier, 2012).  
 
H3K4me3 is associated with active chromatin permissive to transcription. While H3K4me3 
is solely enriched at active genes in yeast (Santos-Rosa et al, 2002; Ng et al, 2003), in 
mammals it is a feature of active and inactive genes at levels dependent on gene activity 
(Barski et al, 2007; Guenther et al, 2007). Several interactors of methylated H3K4, which 
bind to H3K4me3 via different domains such as WD40, Tudor or PHD, have been identified 
(Ruthenburg et al, 2007). For example it was shown that H3K4me3 recruits the basal 
transcription factor TFIID via the PHD finger of the TAF3 subunit (Vermeulen et al, 2007). 
Additionally, H3K4me3 could recruit nucleosome remodeling or histone acetyltransferase 
complexes that harbor subunits with PHD motifs (Wysocka et al, 2006). It has been 
suggested that H3K4me3 may modulate the kinetics of RNA pol II elongation to facilitate 
transcript processing (Terzi et al, 2011) or affect antisense transcription of regulatory RNAs 
(van Dijk et al, 2011). However, the exact relationship between H3K4me3 and gene 
transcription remains elusive. The MLL complexes can function as transcriptional activators, 
as loss of MLL leads to loss of H3K4 methylation and activation of transcription at Hox and 
other loci (Wang et al, 2009). Other studies have questioned initial views, that H3K4me3 is 
required for transcription. For example, depletion of DPY30, a component of mammalian 
H3K4 methyltransferases, leads to clear reduction of H3K4me3 in ES cells, yet had only 
minimal effects on transcription levels (Jiang et al, 2011). Another work examined the 
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effects of depletion of Cfp1, a unique component of the SET1A/B H3K4 methyltransferase 
complex, on H3K4me3 and gene expressions. Although a drastic loss of H3K4me3 at 
expressed CGI-associated genes was observed, this had only minimal consequences for 
transcription (Clouaire et al, 2012). Reduction of SET1A occupancy and histone H3K4me3 
following WDR82 depletion, the other unique SET1A/B subunit, had no effect on RNA pol 
II occupancy or steady-state transcript levels for the examined housekeeping target genes 
(Lee & Skalnik, 2008). In yeast, deletion of the only H3K4 methyltransferase Set1 abolishes 
global H3K4 methylation levels but mutants are viable and do not display global 
transcriptome alterations (Briggs et al, 2001; Miller et al, 2001). The lack of effect on 
transcription might indicate that low levels of H3K4me3 might be enough to mediate its role 
in transcription, as a complete erasure of this mark is rarely reached.  
 
 
Figure 1.3.2-1 Mammalian H3K4 methyltransferases 
Subunit composition of mammalian SET1A/B and MLL1-4 complexes. Each complex is 
capable of methylating histone H3 on its fourth lysine (H3K4). The known common subunits 
shared between yeast and mammalian complexes are shown in blue. WDR82 and CxxC, 
are found only in SET1A/B complexes. These subunits are shown in brown. MENIN, which is 
a subunit shared only in the MLL1/2 complexes is shown in lavender. MLL3/4 specific 
components are shown in gold. Adapted from (Eissenberg & Shilatifard, 2010).  
 
Mammalian SET1A and SET1B, MLL1, MLL2, MLL3, and MLL4 form different 
complexes that contain unique subunits but also the common structural subunits WDR5, 
RBBP5 and ASH2 and DPY30 (see Figure 1.3.2-1) (Eissenberg & Shilatifard, 2010). The 
WDR5/RBBP5/ASH2 subcomplex associates with the MLL1 SET domain but can exist 
independently of the catalytic subunit, providing a structural platform that can associate with 
the SET domains of different MLL-family members (Dou et al, 2006). Structural studies of 
WDR5 reveal that it binds the H3 N-terminal tail in such a way that the K4 residue is fully 
exposed, a conformation that is ideal for further methylation (Ruthenburg et al, 2006).While 
ASH2 is not required for the stability of the MLL complex, it can regulate its catalytic 






activity toward H3K4 trimethylation (Steward et al, 2006). Normal levels of DPY30 and 
RBBP5 are required for efficient ES cell differentiation (Jiang et al, 2011).  
 
SET1A/1B 
Human SET1A/1B functions most similarly to yeast COMPASS and mediates the bulk of 
H3K4me3 in mammalian cell extracts (Wu et al, 2008). Additionally to the core subunits 
ASH2, DPY30, WDR5 and RBBP5, SET1A and SET1B H3K4 methyltransferases contain 
two additional subunits, namely WDR82 and Cfp1 (CxxC1) (Wu et al, 2008; Lee & Skalnik, 
2008; Lee et al, 2007a). WDR82 is required for the targeting of SET1A-mediated H3K4me3 
near transcription start sites via tethering to RNA pol II (Lee & Skalnik, 2008). Additionally, 
WDR82 has a role in mediating the crosstalk between histone H2B ubiquitination and H3K4 
methylation. In yeast, COMPASS can be recruited to actively transcribed genes through its 
interaction with the Paf1 complex and RNA pol II, which is sufficient for H3K4 
monomethylation (Krogan et al, 2003). The Paf1 complex may also be involved in recruiting 
Rad6-Bre1 leading to ubiquitinated H2B (Wood et al, 2003). Cps35/WDR82 interacts with 
COMPASS in a histone H2B monoubiquitination-dependent manner, and this interaction on 
chromatin converts COMPASS to a trimethylation-competent complex (Lee et al, 2007b). 
Cfp1, the other unique subunit of SET1A/1B H3K4 methyltransferase complexes, possesses 
a CxxC domain that specifically recognizes unmethylated CpGs and might play a role in 
targeting the SET1 complex to CpG islands or restricting its activity to proper target genes 
(see 1.2.5 for more on Cfp1 and CxxC-domain containing proteins) (Tate et al, 2010; 
Thomson et al, 2010; Clouaire et al, 2012).  
 
MLL1/2 
MLL1 was originally discovered as the gene inducing human leukemia caused by chromo- 
some band 11q23 translocations (Tkachuk et al, 1992). Both MLL1 and MLL2 include the 
unique subunit MENIN (Figure 1.3.2-1), which can act as a tumor suppressor and is required 
for localization of the complex to chromatin (Yang & Hua, 2007). MLL1 was found to be 
responsible for H3K4me3 of only a small subset of promoters in mouse embryonic 
fibroblasts (MEFs). Consistently, the loss of MLL1 does not alter bulk H3K4me3 but is 
required for the H3K4 methylation of developmental regulators such as Hox genes. In 
MLL1-/- MEFs these genes show decreased levels of RNA pol II and decreased gene 
expression (Wu et al, 2008; Wang et al, 2009). Recently, MLL2 was identified as the 
enzyme catalysing H3K4 trimethylation at bivalently marked promoters in embryonic stem 
cells (Hu et al, 2013).  
 54 
MLL3/4 
The MLL3 and MLL4 complexes are additionally associated with PTIP/PA1, NCOA6 and 
UTX, an H3K27 demethylase (Eissenberg & Shilatifard, 2010). They were recently 
identified as enhancer monomethylases (Herz et al, 2012). In this study the authors propose a 
model in which the transition from inactive/poised active enhancers is controlled by the 
combination of the H3K4 monomethylation activity of MLL3/MLL4 with the removal of 
H3K27me3 by UTX. As H3K27me3 is detrimental to H3K27ac, a hallmark of active 
enhancers, the removal of the H3K27me3 is a prerequisite for H3K27ac by CBP/p300 (Calo 
& Wysocka, 2013).  
 
Recruitment of H3K4 methyltransferases 
In flies, TrxG complexes bind to DNA elements called TrxG response elements (TREs), 
which often coincide with PcG response elements (PREs) (Schuettengruber et al, 2011). In 
mammals, no corresponding elements have been identified yet. It is likely that a combination 
of different recruiting mechanisms is responsible for the correct targeting of H3K4 
methyltransferases. For example, MLL1 and MLL2 possess a CxxC domain via which they 
can be recruited to CGIs. CGIs also attract Cfp1, a subunit of the SET1A/1B complexes. 
Sequence-specific transcription factor binding plays an important role in H3K4me3 
establishment. For example, the binding of transcription factors such as nuclear factor Y 
(NF-Y) and E2 to ASH2 induces its recruitment and mediates H3K4me3 at target promoters 
(Fossati et al, 2011). Therefore ASH2 has an important role in linking transcription factors to 
histone H3K4 methylation. Furthermore, ASH2 itself binds CG-rich DNA motifs, 
reinforcing the tethering of MLL complexes to their target chromatin (Sarvan et al, 2011). 
Additionally, H3K4 methyltransferases can be targeted by interaction with the polymerase 
associated factor 1 (PAF1) elongating complex, which directly interacts with sequences 
flanking the CxxC domain of MLL proteins (Muntean et al, 2010). A recent report provides 
evidence that long non-coding RNAs (lncRNAs) might function to activate transcription by 
recruiting H3K4 methyltransferases to chromatin. HOXA transcript at the distal tip 
(HOTTIP), a lncRNA from the 5′ end of the HOXA locus, was shown to interact with 
WDR5, targeting WDR5–MLL complexes across HOXA to induce H3K4me3 and gene 
activation (Wang et al, 2011). Alternatively, methyltransferases can be recruited by pre-
existing chromatin marks. For example, MLL directly binds to di- and tri-methylated H3K4 
via its PHD domain, which is necessary for its recruitment to target genes such as HOXA9 
(Milne et al, 2010). The NURF complex can also read H3K4me3 via the PHD finger of one 
of its subunits, thereby linking H3K4me3-mediated gene activation with nucleosome 
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remodelling (Wysocka et al, 2006). Cross talk between different histone proteins also plays a 
role in chromatin establishment. For example, the human PAF complex recruits BRE1–
RAD6, which ubiquitylates the H2B tail; this modification enhances H3K4 di- and tri-
methylation by inducing the catalytic activity of SET1A/1B complexes (Kim & Buratowski, 
2009).  
 
In summary, different H3K4 methyltransferases show different functions and are required 
for H3K4me3. However, which role this histone mark plays with regard to transcription is 
less clear. H3K4me3 establishment could also provide a mechanism to control and balance 
H3K27me3, a mark written by Polycomb proteins (Smith & Shilatifard, 2010).  
 
1.3.3. The Polycomb system 
PcG proteins were originally identified in Drosophila as key mediators of heritable gene 
silencing, constituting a memory system for stable propagation of gene silencing through 
multiple cell generations (Simon & Kingston, 2009). In mammals, Polycomb repressive 
complexes (PRCs) represent one cellular mechanism to silence key developmental 
regulators. The Polycomb system consist of two main complexes, PRC2 that trimethylates 
H3K27 and PRC1-type complexes that ubiquitylate histone H2A and compact nucleosomes 
(see Figure 1.3.3-1) (Margueron & Reinberg, 2011; Simon & Kingston, 2009). 
 
 





Upper panel: Core subunits of PRC2 are in lavender, and arrows depict association of 
optional subunits. Dashed lines indicate alternative subunits derived from multiple gene 
copies or protein variants from a single gene. Lower Panel: Mammalian canonical PRC1 (c-
PRC1) with four core subunits including CBX (a PC homolog). Non-canonical PRC1 (nc-
PRC1) variants that contain KDM2 and/or RYBP subunits. In human PRC1 complexes, 
assembly of RYBP and CBX subunits are mutually exclusive. Adapted from (Simon & 
Kingston, 2013).  
 
PRC2 complex 
The core PRC2 complex, which is conserved from Drosophila to mammals, consist of 4 
subunits: EZH1/2, EED, SUZ12 and RbAp46/48 (see Figure 1.3.3-1). EZH2 is the catalytic 
subunit that possesses a SET domain, which is responsible for di- and trimethylating H3K27 
(Müller et al, 2002; Kuzmichev et al, 2002). However, EZH2 is catalytically inactive on its 
own and needs to be assembled with EED and SUZ12 to be active (Pasini et al, 2004; Cao & 
Zhang, 2004). Additionally to EZH2, which is the main H3K27 methyltransferase and only 
expressed in actively dividing cells, EZH1 is expressed in both dividing and differentiating 
cells but shows low methyltransferase activity. It is thought that while EZH2 is responsible 
for the majority of H3K27me2/3, EZH1 replaces H3K27me3 marks that were lost through 
histone exchange or demethylase action (Margueron et al, 2008). SUZ12 directly binds to 
EZH2, which promotes PRC2 assembly and plays a role in controlling PRC2 enzyme 
activity (Ketel et al, 2005). There is also evidence that SUZ12 mediates interactions with 
PRC2 cofactors such as JARID2 (Peng et al, 2009). Moreover, SUZ12 is the PRC2 subunit 
with the strongest affinity for a set of short ncRNAs emanating from the 5' ends of repressed 
target genes (Kanhere et al, 2010). EED adopts a donut-like β-propeller structure with a 
conserved aromatic cage in the donut hole that preferentially binds to H3K27me3 
(Margueron et al, 2009). Thus, pre-existing H3K27me3 stimulates the activity of PRC2 and 
this positive feedback might maintain H3K27me3 levels in local chromatin during cell-cycle 
progression (Hansen et al, 2008). Polycomb-like (PCL) proteins comprise a major class of 
co-factors that influence PRC2 function. In mammals there are 3 types, PCL1-3, that 
function in skewing the catalytic activity of EZH2 towards the H3K27 trimethylation state 
(Sarma et al, 2008). PCLs also contribute to PRC2 recruitment in ES cells (Walker et al, 
2010; Hunkapiller et al, 2012). JARID2, a histone demethylase of the Jumonji family, is 
another prominent PRC2-associated protein. (Pasini et al, 2010; Shen et al, 2009; Peng et al, 
2009). However, its Jumonji domain lacks key catalytic residues, which seems to impede 
demethylase activity (Li et al, 2010). JARID2 impacts PRC2 recruitment, as knock out/down 
experiments show loss of PRC2 binding. In contrast, effects, stimulatory or inhibitory on 




PRC1 complexes are more dynamic than PRC2, as multiple different complexes with a 
variety of subunits exist in mammals (see Figure 1.3.3-1). PRC1 complexes contain a central 
core consisting of RING1 and PCGF proteins that are responsible for catalysing the 
monoubiquitination of histone H2A at lysine 119 (H2AK119ub1) (Cao et al, 2005). Another 
non-enzymatic function of PRC1 is the compaction of chromatin (Francis et al, 2004). The 
canonical PRC1 complex additionally possesses CBX proteins, which recognize and bind to 
H3K27me3. This mechanism of hierarchical recruitment of PRC1 by H3K27me3 established 
by PRC2 was long thought to be the main recruiting mechanism of PRC1 (Simon & 
Kingston, 2009). However, recent studies have challenged this view by describing 
alternative PRC1 variants that lack CBX proteins and that do not require PRC2 activity to 
mediate H2AK119ub1 (Tavares et al, 2012; Morey et al, 2012b). These non-canonical PRC1 
variants are characterised by the presences of RYBP or YAF2 instead of CBX and PHC 
proteins. Indeed, it has been shown that RYBP occupancy on chromatin is unchanged in 
EED null ES cells (Tavares et al, 2012). In contrast, CBX7 of the canonical PRC1 is 
completely absent from its target genes in those cells, consistent with the hierarchical model 
of recruitment (Morey et al, 2012b). Interestingly, RING1B, a component of both the 
canonical and non-canonical PRC1 complexes, is only partially lost from target genes in 
EED null ES cells (Tavares et al, 2012). This diversity among PRC1 complexes in ES cells 
poses the question whether they possess distinct or overlapping roles in gene repression. A 
recent report examined the genome-wide localization of the canonical and non-canonical 
PRC1 complexes in mouse ES cells and showed that both complexes co-occupy many of the 
same target genes, but also regulate genes independently of each other (Morey et al, 2012a).  
 
Targeting Polycomb complexes 
PcG proteins can occupy large genomic regions like the four Hox clusters, where Polycomb 
proteins are present for more than 100 kilo bases (kb). In contrast, other PcG target genes are 
isolated loci such as the Ink4A/Arf gene (Simon & Kingston, 2013). At least 10% of genes in 
mouse ES cells are targeted by Polycomb complexes (Mohn et al, 2008). How the PRC 
complexes are delivered to their genomic targets is well understood in Drosophila, where the 
recruitment of PcG complexes is mediated by specific DNA elements called Polycomb 
response elements (PREs). Sequence specific DNA binding proteins, such as PHO, 
recognize PREs and recruit Polycomb proteins (Ringrose & Paro, 2007). In mammals, 
however, the exact mechanism of recruitment remains elusive, partially due to 
heterogeneous complex composition, the fact that they are present at large genomic regions 
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and because many proteins, which mediate Polycomb recruitment in fly do not exist in 
mammals. Somme reports suggested the existence of a mammalian PRE and implied a role 
for YY1, the mammalian orthologue of the Drosophila protein PHO, in Polycomb 
recruitment (Lo et al, 2012; Sing et al, 2009). Yet genome-wide analysis in mammals did not 
show a clear overlap between YY1 and PcG target genes (Xi et al, 2007).  
 
CGIs are thought to play a widespread role in PRC recruitment in mammals (see Figure 
1.3.3-2). For example, genome-wide analysis correlated H3K27me3 presence with CpG-rich 
DNA and it was found that more than 97% of EZH2-bound sites in mouse ES cells 
correspond to CGIs (Ku et al, 2008). This finding was supported by showing that a bacterial 
artificial chromosome (BAC) construct containing a CpG island, or even bacterial DNA with 
similar characteristics, can recruit PRC2 components following their integration into mouse 
genomic sites (Mendenhall et al, 2010). Despite the striking overlap between CGIs and 
H3K27me3 presence, only a small subset of CGIs is marked by Polycomb proteins. It has 
been suggested that only those CGIs, which are devoid of any activating features recruit the 
PRC2 complex to establish the H3K27me3 mark. However, how exactly the PRC2 complex 
is recruited to CGIs remains unclear. No PRC2 associated CxxC containing proteins, which 
could mediate binding to unmethylated CpGs, have been identified. Other proteins, such as 
JARID2, that show binding preferences towards G+C rich DNA have been implicated in 
PRC2 recruitment (Li et al, 2010). Another study suggested that PCL3, a cofactor of PRC2, 
affects binding to CpG islands but no direct CpG binding has been shown (Hunkapiller et al, 
2012). It is also possible that DNA methylation plays a role in regulating PRC2 as around 
95% of PRC2 target genes are also bound by TET1, which is able to bind CGIs via its CxxC 
domain and is involved in the demethylation of methylated CpGs (see 1.1.3 and 1.2.5) (Wu 
et al, 2011b). TET1 activity is needed for full PRC2 recruitment in mouse ES cells, as knock 
down of TET1 leads to an impairment of EZH2 binding at a large fraction (around 70%) of 
PRC2 binding sites (Wu et al, 2011b). However, no direct interaction between TET1 and 
members of the PRC2 complex have been reported. As it has been shown that DNA 
methylation inhibits recruitment of Polycomb proteins (Wu et al, 2010a), TET1 could have a 
function in keeping CGIs methylation-free and therefore accessible to PRC2 proteins. CGIs 
are also involved in the recruitment of non-canonical PRC1 variants. The histone 
demethylase KDM2B/FBXL10 that is present in a complex called BCOR, is associated with 
non-canonical PRC1 complexes (Gao et al, 2012) and was found to bind to unmethylated 
CpGs via its CxxC domain (Farcas et al, 2012; Wu et al, 2013; He et al, 2013). Knockdown 
studies showed that KDM2B is required to target RING1B and H2AK119ub1 to specific loci 
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containing CGIs in mouse ES cells and that KDM2B is needed for full H2A ubiquitination 
activity in mammalian cells (Farcas et al, 2012; Wu et al, 2013; He et al, 2013).  
 
Additional complexity to Polycomb targeting is added by the fact that several non-coding 
RNAs have been implicated in recruiting PRC complexes. As discussed in 1.2.3, the non-
coding RNA (ncRNA) Xist plays a pivotal role in X-inactivation by coating the X-
chromosome that is to become silenced (Penny et al, 1996). Coating with Xist RNA leads to 
heterochromatinization and the inactive X-chromosome becomes methylated at H3K27 in an 
Xist-dependent manner (Plath et al, 2003). The Xist RNA forms two long stem–loop 
structures, which interact with PRC2 in vitro (Zhao et al, 2008). A recent study that used a 
method to capture PRC2-bound transcripts in mouse ES cells found thousands of RNAs, 
among which was Xist, that associate specifically with PRC2, probably via EZH2 (Zhao et 
al, 2010). Besides Xist, other lncRNAs have been reported to bind to either PRC1 or PRC2. 
For example, the lncRNA HOTAIR, which is transcribed from the human HOXC gene 
cluster, was shown to regulate HOXD genes in trans by the recruitment of PRC2, followed 
by the H3K27me3 (Rinn et al, 2007; Tsai et al, 2010). The importance of HOTAIR in PcG 
function was called into question because deleting the Hotair gene in mice shows little effect 
on gene expression or H3K27me3 levels of Hoxd genes. Also, HOTAIR was found to show 
poor sequence-conservation between mouse and human (Schorderet & Duboule, 2011). 
Another study proposed that short ncRNAs play a role in Polycomb recruitment. The authors 
showed that short ncRNAs, which form a stem-loop structure and interact with PRC2 
through SUZ12, are transcribed from Polycomb target gene in ES cells (Kanhere et al, 
2010). Additionally, PRC1 was shown to interact with the locally encoded ANRIL lncRNA 
to regulate the INK4A/ARF locus (Yap et al, 2010). In summary, the sum of relatively weak 
interaction that are established by each subunit of the PRC2 complex could lead to 




Figure 1.3.3-2 PRC2 and PRC1 recruitment to chromatin 
Recruitment of PRC2 likely relies on interactions with DNA, histones, histone modifications, 
auxiliary proteins, and ncRNAs. It is proposed that it is the sum of weak interactions together 
with the absence of repelling factors that ultimately recruits PRC2. PRC1 can be targeted by 
the binding of subunit CBX to H3K27me3. PRC2-independent targeting of PRC1 is mediated 
by the recognition of unmethylated CGIs through the CxxC proteins KDM2B and through 
interaction with TFs. Adapted from (Voigt et al, 2013). 
 
 
Effects of PRC2 and PRC1 on gene silencing 
Despite many years of research, it is still not clear what the functional consequences of 
H3K27me3 are. It is still controversial if H3K27me3 plays an active role in gene silencing or 
if it is a secondary by-product of gene silencing rather than a cause (Henikoff & Shilatifard, 
2011). Although it has been shown that inhibition of PRC2 does trigger gene re-activation 
(McCabe et al, 2012), a recent time course study implies that H3K27me3 accumulation 
occurs after the onset of silencing (Yuan et al, 2012). The initial view that H3K27me3 
functions by targeting the PRC1 complex has been challenged as new finding reveal 
alternative recruitment mechanism for PRC1 (Tavares et al, 2012; Farcas et al, 2012; Wu et 
al, 2013). H3K27me3 could affect chromatin in many ways. For example, through the 
recruitment of other silencing factors, through antagonising activating H3K27Ac, impacts on 
nucleosome dynamics or by creating barriers for activating factors (Simon & Kingston, 
2013). The effects of H2AK119ub1 on gene silencing have been investigated and it was 
found that two groups of genes exist, those that critically require H2AK119ub1 for silencing 
and those that display significant silencing without H2AK119ub1 (Eskeland et al, 2010; 
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Endoh et al, 2012). This indicates that, although H2AK119ub1 is important for gene 
silencing, alternative mechanism, likely chromatin compaction, play an additional role. It is 
not known how H2AK119ub1 influences gene silencing at a molecular level, but it might be 
that it effects chromatin structure or impedes transcription initiation or elongation (Simon & 
Kingston, 2013). Compaction of chromatin is the second well-studied function of the PRC1 
complex, which works independently of H2AK119ub1, as it is unchanged when mouse 
RING1B is made catalytically inactive (Eskeland et al, 2010). The CBX subunit of PRC1 
has been implicated in producing chromatin compaction (Grau et al, 2011). Interestingly, 
CBX proteins bind to H3K27me3 and promote PRC1 recruitment, while H3K27me3 is 
promoted by densely packed chromatin (Yuan et al, 2012). This provides a positive feed 
back loop between compacted chromatin and the chromatin mark that binds the PRC1 
subunit responsible for compaction.  
 
1.3.4. Bivalent genes 
Genome-wide ChIP Seq studies of histone modifications in ES cells have generated location 
maps of H3K4me3 and H3K27me3. From these maps it became apparent that many gene 
promoters are associated with both H3K4me3 and H3K27me3 marks, which are referred to 
as “bivalent” genes (Mikkelsen et al, 2007; Bernstein et al, 2006; Ku et al, 2008; Pan et al, 
2007). Interestingly, these bivalent chromatin domains are often found at developmentally 
important genes where they might contribute to the precise unfolding of gene expression 
programs during pluripotency and differentiation (Azuara et al, 2006; Mikkelsen et al, 
2007). Despite the presence of the activating mark H3K4me3, bivalent genes are expressed 
only at very low levels (Bernstein et al, 2006). It has been suggested that the presence of 
H3K27me3 might contribute to the repression of lineage specific genes in ES cells, while the 
H3K4me3 mark serves to keep them poised for rapid activation upon differentiation 
(Bernstein et al, 2006; Ku et al, 2008). After differentiation into a specific cell type, 
continued association with H3K27me3 might maintain the repression of the majority of 
developmental control genes while only a specific subset of regulators is activated in a given 
lineage. Further studies confirmed the existence of bivalent genes in cell types other than 
mouse and human ES cells. Bivalent domains have been detected in haematopoietic stem 
cells, mouse embryonic fibroblasts (MEFs), neural progenitors and terminally differentiated 
neurons as well as in induced pluripotent stem cells (iPSCs) (Mohn et al, 2008; Mikkelsen et 
al, 2007; Cui et al, 2009; Guenther et al, 2010). These studies also revealed that, although 
the majority of bivalent domains are lost in differentiated cells, new bivalent domains are 
formed during differentiation (Mohn et al, 2008). H3K4me3 might also protect genes from 
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permanent silencing, for example by repelling transcriptional repressors or blocking DNA 
methylation (Fouse et al, 2008)(discussed in 1.3.2). The proposition that bivalent domains 
convey temporal and spatial control to the expression of lineage specific genes has proved to 
be popular and gained widespread attention.  
 
Bivalent domains were initially predominantly observed in ES cells but it is less clear to 
which extent bivalent genes exist in the embryo and which role bivalency plays during 
development. Recent advances in ChIP technology that enables the analysis of chromatin 
states using low cell numbers led to the possibility of analyzing chromatin states in early 
embryos (Rugg-Gunn et al, 2010; Sachs et al, 2013). A study of mouse epiblast cells has 
also found putative bivalent domains but did not assess the simultaneous association of both 
chromatin marks in the same cell (Rugg-Gunn et al, 2010). Bivalent domains were further 
detected in the pluripotent inner cell mass of preimplantation murine embryos (Alder et al, 
2010). Additional support for bivalent domains in developing embryos comes from studies 
in zebrafish, where bivalent domains were detectable by sequential ChIP at inactive genes, 
including the Hox clusters and other developmental transcription factors (Vastenhouw et al, 
2010). Genome-wide analysis of mouse primordial germ cells (PGCs) revealed bivalent 
domains highly enriched at developmental regulatory genes (Sachs et al, 2013). While there 
is good evidence for the existence of bivalent domains in mammals and zebrafish, in other 
organisms the picture is less clear and the presence of bivalent gene promotes has been 
questioned. In one study very few bivalent domains were detected in gastrula stage Xenopus 
embryos (Akkers et al, 2009). Another study in Drosophila embryos has been unable to 
identify bivalent domains (Schuettengruber et al, 2009). It is conceivable that inherent 
differences in gene regulation between these species account for this apparent discrepancy. 
Alternatively, bivalent domains in Xenopus or Drosophila might arise in different 
developmental stages than the ones studied (Vastenhouw & Schier, 2012).  
 
The above-described view of bivalent genes has been recently challenged by studies that 
suggest that bivalency is an artifact of heterogeneous cell populations and/or culturing 
conditions of ES cells (Hong et al, 2011; Marks et al, 2012). In order to establish bivalency 
at a given locus ChIP assays are often performed individually for each mark, which are 
unable to unequivocally establish the coexistence of both marks in the same cell. This led to 
the notion that bivalency could arise from the average of cells that carry either, but not both, 
marks at a given locus (Hong et al, 2011). Conventionally, ES cells are cultured in medium 
containing fetal calf serum. This requirement can be bypassed by using a specialized “2i 
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medium” that contains inhibitors of mitogen-activated protein kinase kinase (MEK) and 
glycogen synthase kinase-3 (GSK3), respectively. Cells grown in this medium are more 
homogeneous and exhibit tighter control of developmental gene expression. Notably, they 
display reduced levels of H3K27me3 at developmental promoters and fewer genes are 
classified as bivalent (Marks et al, 2012).  
 
Principally, H3K4me3 and H3K27me3 marks at a bivalent domain can be present on 
adjacent nucleosomes, the same nucleosome, or even the same copy of H3 within a 
nucleosome. Sequential ChIP can be used to demonstrate that H3K4me3 and H3K27me3 are 
present on the same nucleosome or on neighbouring ones. Bivalency has been demonstrated 
on candidate genes using this method (Bernstein et al, 2006; Pan et al, 2007; Alder et al, 
2010; Vastenhouw & Schier, 2012). However, to date no genome-wide sequential ChIP 
analysis has been published, which could interrogate the prevalence of true bivalent domains 
in a more general way. Using an approach combining mononucleosome ChIP with mass 
spectrometry-based quantitative profiling of histone modifications, a recent study showed 
that 15% of all H3 histones within H3K4me3-carrying mononucleosomes were marked with 
H3K27me3, arguing for a wide-spread presence of bivalently modified nucleosomes (Voigt 
et al, 2012). While it has been shown in these studies that bivalency within the same cell, at 
either the same or adjacent nucleosomes, does occur, questions remain regarding the exact 
position of the methylated histones within the nucleosome. It is unlikely that both H3K4me3 
and H3K27me3 are found on the same H3 histone as it has been shown that PRC2 is 
inhibited by the active H3K4me3 mark (Schmitges et al, 2011). Moreover, mass 
spectrometry-based studies found that H3K4me3 and H3K27me3 do not coexist on 
individual histones in HeLa cells (Young et al, 2009). Accordingly, Voigt and colleagues 
found that many nucleosomes are asymmetrically modified, with H3K4me3 and H3K27me3 
marks being present at opposite H3 tails (Voigt et al, 2012).  
 
Function of bivalent domains 
As mentioned above, the initial proposition that bivalent genes are kept in a primed state, 
which allows for either rapid activation or stable gene silencing upon differentiation while 
maintaining a reversible, silenced state in ES cells has received a lot of attention (Azuara et 
al, 2006; Bernstein et al, 2006). Genome wide studies later-on seemed to confirm this 
concept as resolution of bivalent genes and associated gene expression changes were 
observed upon differentiation (Mikkelsen et al, 2007; Pan et al, 2007; Zhao et al, 2007). 
However, from these studies it was not clear whether the observed effects are causative or 
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whether bivalency and its associated histone marks are a consequence of other factors such 
as the transcriptional status. 
 
It was initially thought that H3K27me3-mediated repression of lineage regulators was 
essential for maintenance of ES cell pluripotency (Boyer et al, 2006; Lee et al, 2006). 
Indeed, loss of components of the PRC2 complex led to a decrease of H3K27me3 levels 
concomitant with partial de-repression of genes normally targeted by Polycomb (Shen et al, 
2008; Pasini et al, 2007). However, despite the ectopic expression of transcription factors 
involved in lineage specification and a higher propensity to differentiate, cell viability and 
self renewal were not compromised in PRC2-deficient ES cells (Chamberlain et al, 2008; 
Leeb et al, 2010; Pasini et al, 2007). This could be explained by the fact that PRC1, which 
can be recruited to target genes independently of PRC2, is able to compensate for PRC2 loss. 
Indeed, a double knock out of RING1B and EED in ES cells resulted in more severe defects 
(Leeb et al, 2010). Many transcription factors required for differentiation are not expressed 
in ES cells. Therefore the effects observed from insufficient repression of lineage specific 
genes in Polycomb mutants might be underestimated because appropriate transcription 
factors are not present to increase aberrant expression. Additionally, one needs to bear in 
mind that disrupting Polycomb proteins does not only affect bivalent genes but also 
repetitive elements and telomeres, which are normal targets of Polycomb. While these 
studies demonstrated that ES cells are viable with strongly reduced H3K27me3 levels, it 
became apparent that this mark is required for proper differentiation. Although mutant ES 
cells can differentiate into ectoderm, mesoderm and endoderm, lineage regulators are not 
properly activated and ectopic activation of genes from alternative lineages might interfere 
with the execution of the proper developmental program (Pasini et al, 2007; Leeb et al, 
2010; Chamberlain et al, 2008; Shen et al, 2008). This is in accordance with severe 
phenotypes, observed in mice lacking components of the Polycomb system, most of which 
result in post-implantation embryonic lethality (Vastenhouw & Schier, 2012).  
 
With respect to H3K4me3, a recent study found that depletion of DPY-30, a core subunit of 
MLL histone methyltransferase complexes, results in a partial reduction of this activating 
mark, which is associated with improper activation of some lineage specific genes upon 
differentiation (Jiang et al, 2011). As observed with PcG depleted cells, depletion of DPY-30 
did not affect ES cell-specific gene expression (Jiang et al, 2011). In contrast, reduction of 
H3K4me3 levels by depletion of WDR5, another subunit of MLL complexes, led to severe 
defects in ES cell maintenance and reduction in the expression of pluripotency genes (Ang et 
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al, 2011). Knock-out studies of members of MLL complexes support an in vivo role for 
H3K4me3 in transcription regulation and lineage specification and many mutants show early 
embryonic lethality (Vastenhouw & Schier, 2012). All these studies however did not test the 
proposed function of H3K4me3 in poising for the expression of embryonic genes and 
facilitating expression upon differentiation. One very recent study, which implicated MLL2 
in the establishment of H3K4me3 at bivalent genes, did not detect substantial defects in 
rapid transcriptional induction after retinoic acid treatment of MLL2-depleted cells, 
questioning the poising model (Hu et al, 2013). As developmental promoters need to be 
protected from permanent silencing, through for example DNA methylation, mechanisms to 
keep them active need to be employed. H3K4me3 could play that role by preventing de novo 
DNA methylation (Ooi et al, 2007). Moreover, H3K4me3 interacts with factors of the 
transcription machinery such as TAF3 (Vermeulen et al, 2007). Such a permissive chromatin 
however can lead to spurious transcription that needs to be counter-balanced, presumably 
through the action of the Polycomb system. H3K27me3 might play a role in impeding 
deposition of H3K36me3 (Schmitges et al, 2011). Additionally, the ability of PCL3 to 
recognize H3K36me3 may be a trigger for increased PRC2 recruitment to dampen 
transcription (Cai et al, 2013). It is equally important to prevent PRC2 from excessive 
spreading. This can be achieved by a symmetrically H3K4 trimethylated nucleosome that 
inhibits PRC2 (Voigt et al, 2012). A recent study implicated a function for the transcriptional 
regulator UTF1 in balancing this system by limiting PRC2 recruitment and promoting 
mRNA degradation of aberrantly transcribed genes (Jia et al, 2012).  
 
Upon differentiation, bivalent domains need to be resolved. Activating transcription factors 
together with H3K27 demethylases might shift the balance towards activation. In contrast, 
removal of the activating stimuli in concert with H3K4 demethylase activity might shift 
genes to a repressed state (Voigt et al, 2013). All this evidence suggests that bivalent 








1.4. PhD Objectives 
The aim of this thesis is to explore the constraints on DNA sequence and genomic location 
that are required to impose both H3K4me3 and H3K27me3 at CGI sequences. It will be 
analysed whether DNA sequences with a high overall G+C content and a high CpG 
frequency are sufficient to establish novel marks of H3K4me3 and/or H3K27me3 
independent of their location. This will be achieved by introducing promoter-less CGI-like 
sequences into so called “gene deserts”, which are sequences devoid of transcriptional 
activity. After analysing the chromatin state of these sequences it should become clear 
whether primary DNA sequences at CGIs directly influence chromatin structure. 
Additionally, the relative contribution of CpG frequency versus G+C content will be 
investigated. To this end sequences will be generated that either contain few CpGs but have 
a high G+C content or many CpGs with a low G+C content. This study will provide insights 
into the influence of CGIs on chromatin structure.   
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2. Material and Methods 
2.1. Material and Reagents 
2.1.1. Bacterial reagents for cloning and recombineering  
LB medium:  
Bacto tryptone (10g/l), Bacto yeast extract (5g/l), NaCl (10g/l), pH adjusted to 7.0 with 
NaOH. Bacto agar (20g/l) was added if making LB agar. Solutions were autoclaved prior to 
use. LB agar plates were stored inverted at 4°C and LB broth was stored at R/T.  
SOC medium:  
Bacto-tryptone (20g/l), Bacto-yeast extract (5g/l), NaCl (0.5g/l), 1M KCl (2.5 ml/l) and, pH 
adjusted to 7.0 with NaOH, autoclaved and 20 ml of sterile 1 M glucose were added before 
use. 
Ampicillin stock solution:  
50 mg/ml ampicillin in dH2O. Filter sterilised (0.2µm filter) and stored at −20°C. Added to 
LB medium at a final concentration of 50µg/ml.  
Kanamycin stock solution:  
50 mg/ml kanamycin in dH2O. Filter sterilised (0.2 µm filter) and stored at −20°C. Added to 
LB medium at a final concentration of 50 µg/ml for high copy plasmids and 15 µg/ml for 
low copy plasmids. 
Chloramphenicol stock solution:  
30 mg/ml chloramphenicol in 96% ethanol. Stored at −20°C protected from light..  
Tetracycline stock solution  
c = 10 mg/ml dissolved in 75% ethanol. Stored at −20°C protected from light. Added to LB 
medium at a final concentration of 3 µg/ml for low copy number plasmids. 
Blasticidin stock solution 
c = 10 mg/ml dissolved in H2O. Stored at −20°C protected from light. Added to LB medium 
at a final concentration of 30 µg/ml for low copy number plasmids. 
L-arabinose stock solution:  
10% L-arabinose (Sigma A-3256) was prepared in ddH2O, fresh or frozen in small aliquots 
at -20°C. 50 µl stock solution per 1.4 ml LB or SOC was used for induction of 




Blue/white selection plates:  
LB plates containing the appropriate antibiotic were spread with 40μl X-gal (5-bromo-4-
chloro-3-indolyl-β-D- galactopyranoside; 40mg/ml) and dried at 37°C. Prepared on day of 
use.  
Orange G loading buffer (6×):  
0.198% (w/v) orange G, 12% (w/v) Ficoll, 120 mM EDTA pH 8.0, 4.2% (w/v) SDS. Stored 
at −20 °C  (long-term) or RT (short-term).  
Proteinase K stock solution:  
20 mg/ml proteinase K, 100 mM EDTA pH 7.5, 2% (w/v) SDS. Stored at −20 °C.  
RNase A stock solution:  
10 mg/ml RNase A in dH2O. Stored at −20°C. 
DNA Sequencing Buffer (2.5x):  
20 mM Tris HCl (pH8) and 5 mM MgCl2.  
TAE electrophoresis buffer (1x):  
40 mM Tris-acetate, 1 mM EDTA 
TE buffer pH7.5:  
10 mM Tris HCl pH 7.5, 1 mM EDTA 
Hyb+ Buffer for Southern blot: 
20xSSC, 50x Denhardts, 20% SDS, Dextran sulphate, ssDNA  
Wash buffers for Southern blot: 
2xSSC: 100ml SSC + 890ml H2O+ 10ml 20% SDS 
1xSSC:   50ml SSC + 950 ml H2O + 10ml of 20% SDS 
 
2.1.2. Cell culture reagents 
Cell culture reagents were obtained from Gibco unless otherwise stated 
2.1.3. ChIP reagents 
ChIP buffers 
Wash Buffer A 
0.25% Triton X-100  
10mM EDTA pH 8.0  
0.5mM EGTA pH 7.5  




Wash Buffer B 
0.2M NaCl 1mM  
EDTA pH 8.0  
0.5mM EGTA pH 7.5  
10mM Hepes pH 7.5 
 
Lysis buffer 
20% SDS  
0.5M EDTA  
1M Tris pH 8.1  
50X PI tablet 
1000x PMSF in isopropanol  
100x Na Butyrate 
 
Dilution buffer 
5M NaCl  
1M Tris pH 8.1  
0.5M EDTA  
10% Triton X-100  
20% SDS  
 
Wash Buffer 1   
20mM Tris pH8 
150mM NaCl  
2mM EDTA 
1% Triton X-100 
0.1% SDS 
 
Wash Buffer 2  
20mM Tris pH8 
500mM NaCl  
2mM EDTA 
1% Triton X-100 
0.1% SDS 
 
Antibody Source & Catalogue number Concentration 
α-H3K4me3 Abcam-8580 3 µl 
α-H3K4me1 Abcam-8895 5 µl 
α-H3K27me3 Millipore-07-449 5 µl 
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α-H3K9/K14ac Abcam 12179 5 µl 
α-H3 Abcam 1791 3 µl 
α-SUZ12 Abcam 12073-100 5 µl 
α-RNA Pol II N20 Santa-Cruz -899 20 µl 
α-RNA Pol II S5P Abcam 5131 5 µl 
α-RNA Pol II unphosphor. Abcam 817 5 µl 
α-GFP Chromotec GFP-TRAP_A gta-20 5 µl 
α-IgG Invitrogen 10500C 2 µl 
Table 1 List of antibodies used for ChIP 
 
2.1.4. Primers used in this study 
 
Mecp2-eGFP Forward Primer Reverse Primer 
Irak TSS AATGGGAGAACCGAGGTCTG TTTGGCTGGCTCTCAAACTG 
Mecp2 5 GATGATCCACAGGCAGCAAC TCAAAGAAGAGGCCCCAGTG 
Mecp2 7 CTCAAAAGAGCCCAGCTCTT GGCAGCTGCAGTGCTGAACC 
Mecp2 9 GACAGGGCATCAATGGCACC CCAGACAAGCTGTTGACCAG 
GFP A AAGGGCGAGGAGCTGTTCA CCGGTGGTGCAGATGAACTT 
GFP B GCGCACCATCTTCTTCAAGG TCTGCTTGTCGGCCATGATA 
GFP C TCAAGATCCGCCACAACATC ATGTGATCGCGCTTCTCGTT 
Mecp2 14 GATGATGGTGCTCCTTCTTA TCCACCCTTGGTGAGAAAAG 
Mecp2 15 CAGGGCTCTTCTCCAGGACC GAGCAGAAACCACCTAAGAA 
Mecp2 16 GATCTGAAAACAGAGGACCT GATTAGGTCTGGGTACCAAC 
Nanog PuroGFP Forward Primer Reverse Primer 
Nanog 11 CAGTGATTTGGAGGTGAATT CCCAGATGTTGCGTAAGTC 
Nanog 12 CAAACCTAGGACTTAGAACA GCACCTCACTGTCTCCAAA 
Nanog 13 GGGTCTTGGTATACACTGT AGGTTGGCCTTGAACTTATT 
Puro A TCTGGACCACGCCGGAGA CCAGGAGGCCTTCCATCTGT 
GFP B AAGGGCGAGGAGCTGTTCA CCGGTGGTGCAGATGAACTT 
GFP C TCAAGATCCGCCACAACATC ATGTGATCGCGCTTCTCGTT 
22 GCCTTAGTCAACTGACATCT CTGATGCCAAAGGACAGAAA 
23 GCCTTAGTCAACTGACATCT GGACAGTTGCCAGACAGAGG 
Gene desert 1 Forward Primer Reverse Primer 
Gd1_1=ChIP E19_1 AGCAATGGCAGAATGAGAGG TCAAACTGGACACAGGGACA 
Gd1_2=ChIP E19_2 GCACTGGGTAGCCATTTCAG TTCTTCGTTCTCCACGATCC 
Gd1_3=ChIP E19_3 GGATCGTGGAGAACGAAGAA TGTGTGCGTGTTTGTCTCTGT 
Gd1_7=ChIP E19_5 TTATTACGCCATGGCTCCAG CACAATTTGGGGCATGACAG 
Gd1_8=ChIP E19_7 GCAGAGCATGCTGTTGTTGG CCAGGTAGGTCTTTGGTGCTG 
Gd1_9=ChIP E19_8 CCAGCTGCTGACAGGGAATC TTGAATATGGCTTCTCTCTTTCCAC 
Gene desert 2 Forward Primer Reverse Primer 
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Gd2_1=ChIP L19_1 TGATGGTGGCATATTGCTTTC CAATGCTCCATTTCCCTCTCA 
Gd2_2=ChIP L19_3 GGAAGGGTCACTGTGTCAAGC GAGGCTGACCTTTCTCCTCCA 
Gd2_3=ChIP L19_6 TGACTCTCTGCCATGATGTGG CAGGAAAGCTGTTCCCACGA 
Gd2_4=ChIP L19_7 GCATTTCAGGCTGAGGTATTGG TGCAACCTGATCTCCAGCCTA 
Gd2_8=ChIP L19_17 CCATTCTTTCCTGCGGTCAG CAGCAGGCACTGAAACATGC 
Gd2_9=ChIP L19_19 GCCCATTTGGAATTGGCTCT TGGCAAGTTCTGTGTTTGCAG 
Gd2_10=ChIP L19_20 AGGCAGGGATGGGAAGATGT TCTTGCCTTAGGAAGCAGTGA 
Gd2_11=ChIP L19_21 TGGCAGTAAGTGACACCGCTATT TGGCTCTGAGGAGAGAAAGTGG 
PuroGFP  Forward Primer Reverse Primer 
PuroGFP_4= PuroC TCTGGACCACGCCGGAGA CCAGGAGGCCTTCCATCTGT 
PuroGFP_5=GFPA AAGGGCGAGGAGCTGTTCA CCGGTGGTGCAGATGAACTT 
PuroGFP_6=GFPD TCAAGATCCGCCACAACATC ATGTGATCGCGCTTCTCGTT 
ArtCGI Forward Primer Reverse Primer 
ArtCGI_5=ArtCGI 9 CAGGAGTTGACTCGGCAGGT CCAGATGCGGTTCAGGTGAC 
ArtCGI_6=ArtCGI 10 GCGTTCCCTCCTACCCTAGC CCTGGTTGGCAGTCGGTTAC 
ArtCGI_7=ArtCGI 12 GAAGCCCACCAGGGTGTCTC GGAGGCGGTCCAACTAGTCA 
High CpG / Low G+C Forward Primer Reverse Primer 
Hi/Lo 5= HighCpG 1a CGATAGCGAGGTTGGCACTC CGTCCGCATAATCTTCTGAACG 
Hi/Lo 6 = HighCpG 4 AAGTTTGTCGCGCATGAAAGA TCTGCGACAATCACGTTTGTTT 
Hi/Lo 7= HighCpG 5 TGTTCGTGTACGCTTCGATCAT CGATCTGAGAGGTCGCATCC 
Low CpG / High G+C Forward Primer Reverse Primer 
Lo/Hi 5= LowCpG 1 AAGCTGGACTTCCGTCATGC GGCAGGCTCAACATGTCCTT 
Lo/Hi 6= LowCpG 5 GGCTGGGTAGAGTCCCAAGG GGTCACCTGCCCTGGAGAG 
Lo/Hi 7= LowCpG 7 CCACCAGCATATGGCCTCTC GGCCGGCATCCTACAGAAG 
Table 2 ChIP primers for Q-PCR 
 
ArtCGI Forward Primer Reverse Primer 
BS_ArtCGI_6 TTGGTATTTATYGGGTGGGTATA ATCCAACTAATCAAAAAT 
High CpG / Low G+C   
BS_High_6 TGTGAAATTYGGTTTTATTTTTT RTTTATTTTATCATTTATCAT 





Table 3 Bisulfite primers 
 
 Forward Reverse 
E19_2F (2) CACTGACCCAGAGTGAACCA TGGCAGGGAAGGTAGCTATG 
Chr18 E19 Scr 
3’HR 1F (3) 
GCATCGCAAGAGGAAATGTG GCTGCACTATTGCTTGTTGC 




Chr18 E19 Scr 
5’HR 1 (5) 
CCCAGGAAATATTTATGGAATG AGTTCTTGCAGCTCGGTGAC 
E19 4F (6) CCATCTTGCCAGTTCCTCAT ACCCACCCCCTCAAAATAAC 
pBeloBAC 11 F (7) ACAGATTTGAGGGTGGTTCG CGCTGCTTCACCTATTCTCC 
   
   
Probe L19 5 ACAGGGAAGGGTCACTGTGT TGGCACCAGTAACAGCTGAA 
Probe L19 3 TTCAAAGAAAAGCTGTTTCCAA TACTGCCAGCAATGGGAGAT 
PuroGFP 1F+R GTCACCGAGCTGCAAGAACTC TTACTTGTACAGCTCGTCCATGC 
ArtCGI 1 CTAGCACAGGAGTTGACTCGG TGCTCCGGGAACGTCAC 
High CpG/Low G+C TCTATAGCACACGGGCCAAC AATGCTCTCTCGTTCATTCGT 
Low CpG/High G+C AGCTTGGCCCCTGGGGGA CAGGGGTTCAGCTGGCAG 
L19 3’ HR CCCATCCTCTTCAGAGATACCC ACACCCACGACACTGATTCG 
L19 5’ HR AATGAACAGGGCTTGGCTTC ACAATCTGCAGGGCATCTCC 
Table 4 Primers used to screen for the integration of BAC+ CGI-like sequence in 
mouse ES cell genome 
 
No neo PuroGFP   TATATCATGGCCGACAAGCA GCTGCACTATTGCTTGTTGC 
No Neo High CpG/Low G+C ACGAATGAACGAGAGAGCATT GGGTATCTCTGAAGAGGATGGG 
No Neo Low CpG/High G+C CAGGGCCTCAGTGAGAATCAT GGGTATCTCTGAAGAGGATGGG 
Scr_noNeo_ArtCGI_1F CGAAGGCAGCCTCCTACTG GGGTATCTCTGAAGAGGATGGG 
Table 5 Primers used to screen for excision of selection cassette 
 
 Forward Reverse 
Probe PuroGFP  GACGTAAACGGCCACAAGTT GAACTCCAGCAGGACCATGT 
Probe Art CGI TACGGTCCGACTTTTGCACT ACGTCGATTGTGCGACCT 
Probe High CpG Low G+C CTCCGACCAAAAACCGAACA GCGAAAACGCACAACTACCC 
Probe Low CpG High G+C CCCACCCTAGGGGATGCTAA GAAGCCCCTACCTCCAATGC 
Table 6 Primers used to amplify southern blot probes 
 
2.1.5. Cell-lines used and created in this study 
E14.Tg2a mouse ES cells were used throughout this study. Cfp1-GFP tagged mouse ES cells 
were obtained from Francis Stewart. The cell line was generated by BAC transgenesis of a 
Cfp1-GFP BAC construct. This BAC contains the whole Cfp1 gene with all the regulatory 
elements and GFP fused to the last codon of Cfp1 in order to create a C-terminal GFP tag. 
Cfp1-/- mouse ES cells were created in the laboratory of David Skalnik (Carlone & Skalnik, 
2001). Dnmt3a/3b double knock out mouse ES cells (DKOs) were used as discribed (Okano 
et al, 1999). 
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 Names in this thesis Clone names  Location in liquid N2 
Wt mES cells + Gene 
desert 1+ PuroGFP 
Cell line 1 1D2_C3 Tower1/Tray3/row10/column9 
Wt mES cells + Gene 
desert 2  + ArtCGI 
Cell line 1 
Cell line 2 







Cfp1-GFP mES cells + 
Gene desert 2 + ArtCGI 
Cell line 1 
Cell line 2 







Cfp1-/- mES cells + 
Gene desert 2 + ArtCGI 
Cell line 1 
Cell line 2 







Wt mES cells + Gene 
desert 2 + Low CpG / 
High G+C 
Cell line 1 
Cell line 2 








Wt mES cells + Gene 
desert 2 + High CpG / 
Low G+C 
Cell line 1 
Cell line 2 







DKO + ArtCGI  Cell line 1 





DKO + High CpG / Low 
G+C 
Cell line 1 
 
# 41 Tower1/Tray11/row10/column1 
Table 7 Cell-lines created in this study 
Selection cassette has been excised in all these cell lines 
2.2. Methods 
2.2.1. Bacterial methods 
Transformation of E. coli 
For transformation either 1 ng of plasmid DNA or 10 µl were mixed with 75 µl of thawed 
competent cell suspension and incubated on ice for 20 min. The cells were then heat shocked 
at 42 ̊C for 1.5 min and then returned to ice for 2 min. Pre-warmed 0.5 ml of LB media was 
added to the cells, which were then incubated with shaking at 37 ̊C for 1 h. Cells were then 
transferred to LB agar or LB broth containing selective antibiotics and incubated overnight 
at 37 ̊C.  
 
Plasmid preparation  
Plasmid DNA was purified from DH5α E.coli an endonuclease deficient (endA) and 
recombination deficient (recA) strain, which helps stable maintenance of the insert sequence,	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using either a Quiagen miniprep kit, Quiagen midiprep or maxiprep kit depending on the 
quantity of DNA needed.  
 
Recombineering 
Bacteria containing the gene desert BAC of interest was plated on a LB plate containing 
chloramphenicol and incubated o/n at 37°C. The next day 2 or 3 single colonies were picked, 
inoculated in 15 ml tubes containing 1.0 ml LB medium with chloramphenicol and incubated 
at 37°C o/n with shaking. On day 2 a 2 ml ependorf tube containing fresh 1.4 ml SOC 
medium was set up and inoculated with 30 µl of fresh overnight culture. A hole was 
punctured in the lid for air. Bacteria were cultured for 2-3 h at 37°C in thermomixer, shaking 
at 1000 rpm. In the meantime cuvettes for electroporation and sterile water were chilled on 
ice and bench top centrifuge was cooled to 2°C. In order to electroporated the Red/ET 
plasmid into the cells containing the BAC cells were centrifuged for 30 sec at 11000 rpm, 
the supernatant was discarded and the pellet resuspended in 1ml of chilled H2O. The 
centrifugation and resuspension step was repeated 2 times. After the last wash the pellet was 
resuspended in 40 µl of water and 20-40 ng of the Red/ET plasmid was added. As a control 
one reaction without Red plasmid was set up. Cells were electroporated at 1350 V, 10 µF, 
600 Ohms using an electroporation cuvette with a slit of 1 mm. Cells were resuspended in 
1ml of SOC and recovered for 1h at 37°C with shaking. Cells were divided on two plates 
(100µl and 900µl) containing chloramphenicol for selecting the BAC and tetracycline for 
selecting the Red plasmid. Plates were incubated at 30° for at least 15h protected from light.  
 
On day 3 2-3 colonies were picked and cultured in LB+ chloramphenicol and tetracycline 
over night at 30°C protected from light. On day 4 a 2 ml ependorf tube containing fresh 1.4 
ml SOC medium with the appropriate antibodies was set up and inoculated with 30 µl of 
fresh overnight culture. As a control one tube was set up with cells containing the BAC 
without the Red/ET plasmid. A hole was punctured in the lid for air. Bacteria were cultured 
for 2-3 h at 37°C in a thermomixer, shaking at 1000 rpm. In the meantime cuvettes for 
electroporation and sterile water were chilled on ice and bench top centrifuge was cooled to 
2°C. Then 50 µl of 10% L-arabinose was added to one of the experimental tubes and to one 
of the control tubes in order to induce the expression of the Red/ET recombination proteins. 
Another tube was left without induction as negative controls. All samples were incubated at 
37°C, shaking for 1 h. Afterwards cells were centrifuged for 30 sec at 11000 rpm, the 
supernatant was discarded and the pellet resuspended in 1ml of chilled H2O. The 
centrifugation and resuspension step was repeated 2 times. After the last wash the pellet was 
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resuspended in 40 µl of water and 200-300 ng of linearized DNA containing the CGI-like 
sequence, a kanamycin selection cassette and a 3’ and 5’ homology arm for recombination 
was added. Cells were electroporated at 1350 V, 10 µF, 600 Ohms using an electroporation 
cuvette with a slit of 1 mm. Cells were resuspended in 1ml of SOC and recovered for 1-2h, 
during which time recombination occurred, at 37°C with shaking. Cells were divided on two 
plates (100µl and 900µl) containing chloramphenicol for selecting the BAC and kanamycin 
for selecting the CGI-like construct. Plates were incubated at 37° o/n. On day 6 colonies 
were picked and either screened by colony PCR for the successful recombination or another 
o/n culture was set up to do minipreps and control digests.  
 
2.2.2. DNA manipulation 
Synthesis of CGI-like sequences 
CGI-like sequences were designed using the “Random Sequence by CpG parameters” tool 
found at the Wellcome Trust Centre for Cell Biology Galaxy server. Specifc paramaters for 
different CGI-like sequences were chosen regarding CpG frequency, G+C content and 
length. SP1 binding sites were avoided and restriction enzyme sites for HindII and EcoRI 
were attached to the 5’ and 3’ end respectively. The randomly obtained DNA sequence were 
synthesized by GeneArt ® Gene Synthesis from Life Technologies. The DNA was delivered 
as 5 µg lyophilized plasmid DNA. 
 
DNA gel electrophoresis  
DNA was resolved by gel electrophoresis using the Bio-Rad Sub-Gel system. Agarose gels 
(1-2%; depending on the size of the DNA fragment to be resolved) were prepared with TAE 
containing 0.5μg/ml ethidium bromide, a DNA intercalating agent that fluoresces in 
ultraviolet (UV) light. DNA samples were prepared in orange G loading buffer and size 
markers (1kb plus ladder; Thermo Scientific) in supplied 6x loading dye. Samples were 
loaded into the wells of the gel. Gels were run at constant voltage (80-110V) in TAE 
electrophoresis buffer and visualised under UV light.  
 
Restriction enzyme digest 
DNA digest were carried out as per manufacturers instructions (NEB). Briefly, DNA was 
diluted in appropriate digestion buffer, supplemented with 100 μg/ml	   Bovine Serum 
Albumin where appropriate and digested with 6U of restriction endonuclease per μg	   of 
DNA. Reactions were typically incubated at 37°C for 1-2hours.  
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Ligation 
Standard DNA ligation reactions were performed in a total of 20 µl containing 100 ng 
linearized vector, insert DNA (3x molar excess), T4 DNA ligase buffer and 1 µl T4 DNA 
ligase (NEB) and incubated o/n at 16°C.  
 
DNA extraction and precipitation  
DNA was extracted through mixing with 1 volume of phenol:chloroform:isoamyl alcohol 
(IAA) before precipitation by either 1 part isopropanol at RT or 3 parts 96% ethanol (EtOH) 
at -80°C along with 1/10th volume of NaOAC. After centrifugation at 15,700g for 15 
minutes pellets were washed with 70% EtOH before allowing to air-dry in a fume hood for 5 
minutes. Once all residual ethanol has evaporated the DNA pellets were resuspended in 
0.1M TE and stored at -20°C.  
 
Gel Extraction  
Gel extraction was used to purify a homogeneous population of DNA fragments for cloning 
or probe preparation. Fragments were resolved by agarose gel electrophoresis, cut out and 
extracted using the Zymoclean Gel DNA recovery kit. 
 
Measurement of DNA concentration  
DNA solutions were measured at OD260nm and OD280nm using a Nanodrop-1000 
spectrophotometer (Thermo Scientific). The purity of the DNA was determined using 
OD260nm:OD280nm ratio, with a value greater than 1.8 indicating the absence of protein or 
phenol contaminants from the sample. An automated read out of the DNA concentration was 
determined through the use of Beer’s law [Concentration in ng/µl = (Absorbance OD260nm 
x Extinction coefficient dsDNA 50ng/µl/cm) / pathlength cm].  
 
Polymerase Chain reaction (PCR)  
PCR was used to amplify DNA molecules of interest from a starting template and was used 
primarily to test primers for qPCR, for Colony PRC to screen for successful recombination 
or BAC integration and in bisulfite genomic sequencing. Reactions were generally carried 
out in a 20µl volume and consisted of DNA template (0.1-50ng), 400nM forward and reverse 
primers, 400µM dNTPs (Abgene), 2.5mM MgCl2, Red Hot Taq reaction buffer (Abgene) 
and 1.5U Red Hot Taq (Abgene). PCR amplification of bisulfite-treated DNA was carried 
out in the presence of 3% dimethyl sulfoxide (DMSO). PCR reactions were set up on ice. 
PCR cycling was carried out on a G-Storm thermal cycler and typical conditions were as 
follows: initial denaturation at 94°C for 2min followed by 30 cycles of denaturation at 94°C 
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for 30sec, primer annealing at appropriate temperarure for 30sec and primer extension at 
72°C for 30sec. An additional 72°C primer extension phase for 5min was carried out at the 
end of the 30 cycles to amplify any incomplete DNA molecules. In general, to determine the 
optimal annealing temperature (Tanneal) for a particular primer pair a range of temperatures 
was tested (using the gradient feature of the thermal cycler over a range of 53-64°C). PCR 
amplification of bisulfite-treated DNA was carried out for 40 cycles with longer step times: 
94°C for 40sec, Tanneal for 50sec and 72°C for 50sec. PCR products were resolved by 
agarose gel electrophoresis.  
 
DNA sequencing  
DNA sequencing was performed using the BigDye Terminator v3.1 Cycle Sequencing kit 
(Applied Biosystems). Sequencing reactions were carried out in a volume of 10μl and 
contained 4μl of 2.5x sequencing buffer, 2μl BigDye Terminator, 500nM primer and 3.5μl 
DNA (prepared for sequencing as above). Reaction conditions consisted of initial DNA 
denaturation at 94°C for 10sec followed by 24 cycles of DNA denaturation at 94°C for 
30sec, primer annealing at 50°C for 20sec and extension at 60°C for 4min. Sequencing 
reactions were then passed onto the Gene Pool Sequencing Service (School of Biological 
Sciences) where they were cleaned up and run on an ABI 3730 capillary sequencer.  
 
Preparation of BAC DNA for transfection of mouse ES cells 
BAC DNA was prepared using the Nucleobond® Kit from Machery Nagel following the 
manufacturers instructions. BAC DNA was linearized using an appropriate restriction 
enzyme. An aliquot of the linearized BAC DNA was run on an agarose gel to check for 
complete linearization and the rest was purified using phenol:chloroform:IAA extraction and 
ethanol precipitation.  
 
Genomic DNA extraction from ES cells  
Cells were trypsinized, washed in PBS and pellet resuspended in 1ml lysis buffer containing 
100 mM NaCl, 10 mM TrisCl, pH 8, 25 mM EDTA, pH 8, 0.5% SDS and 0.1 mg/ml 
proteinase K added freshly. Cells were incubated o/n at 55°C. The next day RNAse A was 
added and incubated for 1h at 37°. Samples were extracted twice with an equal volume of 
phenol/chloroform/isoamyl alcohol. The aqueous phase was transferred to new tube and 
DNA precipitated with 1/10 volume of 3 M NaAc and 1.5 volume of 100% ethanol. DNA 
was washed with 70% ethanol and resuspended in an appropriate volume of TE. 
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Preparation of genomic DNA from 96-well plates 
Once a colony growing in a 96-well has reached confluency, the medium was aspirated off 
and 100 µl of lysis buffer were added and returned to the incubator over night. Cell lysates 
were stored at 4°C until all cells were lysed. Then 150 µl of ice-cold isopropanol were 
added, the plate was sealed, inverted 2-3 times and placed on a shaker. Plate was spun down 
for 30 min, isopropanol poured off and 50 µl 70% Ethanol was added and plate centrifuged 
for 30 min. Supernatant was removed and plate placed on a heat block for 3 min to evaporate 
excess alcohol. Finally 50 µl of TE was added and placed over night at 4°C to promote 
resuspension. 
 
Determining copy number by qPCR 
In order to determine the copy number of BAC+CGI-like sequence integrated in the mouse 
genome a standard curve of BAC plasmid DNA was created, where the BAC is present at 
300,000 copies, 30,000 copies, 3,000 copies, 300 copies and 30 copies. The mass of a single 
plasmid was calculated multiplying the plasmid length with the mass of a double stranded 
DNA molecule. This number was used to calculate the required amount of plasmid DNA 
needed to achieve the different copy numbers. The Ct values obtained from the qPCR were 
used to blot a standard curve. This standard curve was used to calculate the copy number of 
the clones of interest per cell. Of each clone 200ng DNA was used per qPCR reaction and it 
was assumed that each cell contains 6pg of DNA. As a control and to normalize to a known 
copy number the Sox2 gene, a gene that exists as a single copy per haploid genome (or 2 
copies per human cell), was used. 
 
To make a standard curve for Sox2 mouse genomic ES cell DNA in which the gene of 
interest is present at 300,000 copies, 30,000 copies, 3,000 copies, 300 copies and 30 copies 
was prepared. First the mass of DNA per mouse genome was calculated. Then the mass of 
the genome was divided by the copy number of the gene of interest per haploid genome. 
With this value the mass of gDNA containing the 300,000 to 30 copies was determined and 
the dilution serial pipetted. For the qPCR 5µl of gDNA was used per reaction and the 
obtained standard curve was used to calculate the amount of Sox2 present in the clones 
measured. This value was used to normalize the obtained values for the BAC integrations as 






Between 20 and 25 µg of DNA was digested o/n at 37°C with the appropriate restriction 
enzyme in a volume of 30-50 µl. The next day samples were run on a 0.7% gel in 1x TAE 
during the day at around 50V. Hyb+ buffer was prepared and frozen in aliquots. Gel was 
photographed with a fluorescent ruler, excess gel was cut and remaining gel put into HCl 
solution for 15 min while shaking. Gel was rinsed with water and neutralized in 0.4M NaOH 
for 45 min. In the mean time filter paper and membrane were cut to size of gel and 
membrane was pre-wet and incubated in NaOH for 5 min. A dry plot was assembled and left 
o/n at RT. The next day 25 ml of Hyb+buffer was pre-warmed to 65°C. Filter was placed in 
2x SSC for 5 min, pre hybridized for 2h at 65°C. Around 50 ng of probe was labelled using 
the megaprime kit. Unincorporated nucleotides were removed using G50 column. Labelled 
probe was added to 15 ml of hyb+ buffer and leave rotating at 65° C o/n. The next day blot 
was washed twice with pre-warmed 2xSSC. Level of radioactivity was checked with Geiger 
counter and if still very hot, blot was washed with 1x SSCe washing once more for 30 min. 
Membrane was put into phospho imager and exposed for 1h–over night. 
 
Quantitative PCR (qPCR)  
qPCR was used to assess enrichment of specific regions in ChIP samples and to determine 
the copy number of BAC DNA into the mouse genome. To carry out qPCR SYBR Green 
technology was used. SYBR Green is a fluorescent dye that binds to DNA and, when 
included in a PCR reaction, allows fluorescence to be used as a read-out for the amount of 
DNA synthesised in real-time. qPCR reactions (10µl) contained SYBR Green SensiMix 
(Quantace), 250nM primers and 3ul ChIP DNA or 5ul DNA for the determination of copy 
numbers. PCR was carried out using a Roche Lightcycler and cycling conditions were as 
follows; initial denaturation at 94°C for 10min followed by 45 cycles of denaturation at 94°C 
for 10sec, primer annealing at Tanneal for 10sec and primer extension at 72°C for 15sec. 
Data were collected at the end of each amplification cycle. After amplification, melting 
curves for PCR products were generated by denaturing the DNA at 94°C for 1min and then 
increasing the temperature from 35°C to 95°C in increments of 0.1°C. A single melt curve 
indicates the presence of a single PCR product whilst multiple melt curves could indicate the 
presence of multiple PCR products or primer dimers that would interfere with DNA 
quantification. Using the Roche Lightcycler software, SYBR Green fluorescence 
measurements were plotted relative to cycle number to generate curves for each PCR 
reaction and the 2nd derivative maximum method was used to determine the cycle threshold 
values (Ct) for each sample. An arbitrary measure of DNA quantity was calculated using the 
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formula 2-Ct. This value was then compared to that of a reference sample (for example input 
DNA in a ChIP reaction). qPCR reactions were carried out in duplicate or triplicate.  
 
Bisulfite genomic sequencing 
Bisulfite conversion of genomic DNA was carried out using the EpiTect Bisulfite Kit from 
Quiagen. The converted DNA was used for PCR amplification of region of interest and 
reaction run on an agarose gel. Band was excised and used for cloning using the Stratage 
blunt end cloning kit. The next day colonies were screened for the integration of the 
fragment and positive clones were sent for sequencing 
 
2.2.3. Protein manipulation 
Chromatin Immunoprecipitation (ChIP) 
Chemical crosslink of chromatin was performed via addition of 1% formaldehyde for 10 
minutes at 37°C directly to the medium in tissue culture dishes. Then, 500µl 2.5M glycine 
was added in order to stop the crosslinking process. After 5 minutes incubation while 
shaking, cells were washed twice with 1x PBS. If acetylation was examined, sodium 
butyrate, an HDAC inhibitor was added. In the next step, cells were centrifuged for 5 
minutes at 1.200 rpm at 4°C and washed in wash buffer A and B (each buffer contained 
PMSF to a final concentration of 1µg/ml, 1x Proteinase Inhibitor Complete Mix (Roche) to 
inhibit protease activity and 10mM sodium butyrate). After each wash, cells were kept on ice 
for 10 minutes. Finally, cells were resuspended in lysis buffer, also containing PMSF, 
Proteinase Inhibitor Complete Mix and sodium butyrate at concentrations indicated above. In 
the next step, chromatin was sheared to an appropriate size (400-600 base pair fragments) by 
sonication of the cell lysate using a twin Bioruptor for 15 cylces, 30 sec on, 30 sec off on 
high setting. After completion of sonication lysate was centrifuged for 10 minutes at 14.000 
rpm at 4°C to collect cellular debris. In order to check for successful sonication 10 µl of 
sonicated chromatin were used and 100 µl Chelex 100 Resin by BiorRadb (10%; 0.1g in 1ml 
H2O) were added. Mixture was vortexed, boiled for 10 min at 99 °C, vortexed and cooled 
down at RT for 2-3 min. Then 1µl RNAse was added for 30 min at 37 °C and then 2µl 
Proteinase K for 30 min-1h at 55 °C. Samples were spun down and 50 µl supernatant was 
loaded with loading dye on a 2% agarose gel and let run shortly. Chromatin concentration 
was measured by Nanodrop and 30 µg were used for ChIP with antibodies against histone 
modifications. For proteins 150 µg chromatin was used. For the input fraction, 15 µg was set 
aside, lysis buffer was added to 50 µl and input chromatin was stored at 4 °C. For the ChIP 
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required amount of chromatin was made up to 900µl with dilution buffer in the presence of 
PMSF, Proteinase Inhibitor Complete Mix and sodium butyrate. Antibodies were added as 
specified and incubated o/n rotating at 4 °C. Per IP 50 µl of magnetic protein G Life 
Technology dynabeads were used. Beads were washed on a magnetic rack 3 x with TE, 
blocked with 1/10 volume of BSA and left rotating o/n at 4 °C. The next day 50µl of blocked 
beads were added to the supernatant of IPs and incubated rotating for 1-4 hours at 4 °C. IPs 
were washed 3x with 1ml ice-cold wash buffer 1, 2x with wash buffer 2 and 1x with TE. 
After each wash IPs were spun for 2 min at 1200rpm, the supernatant was removed, the next 
wash buffer added and incubated rotating at RT for 2 min. On last wash, all supernatant was 
removed and 100µl of freshly prepared 10% Chelex was added. To the input fraction 50 µl 
of freshly prepared 10% Chelex was added. Samples were boiled at 100°C for 12 min, left to 
cool at RT 2 µl of 20mg/ml Proteinase K was added to each sample, incubated at 55 °C for 
30’ at 1000 rpm on thermomixer. The samples were boiled at 100 °C for 10’. Tubes were 
shortly spun and 60 µl supernatant was transferred to fresh tube. Each sample was made up 
to 300µl total volume with 10mM Tris pH8+0.1 mM EDTA, stored at -20 °C and 3 µl DNA 
was used for Q-PCR. Input was diluted 1:10 and also 3 µl were used for Q-PCR.  
 
2.2.4. Manipulation of mouse ES cells 
Culturing mouse ES cells 
E14.Tg2a mouse ES cells were cultured in Glasgow MEM medium supplemented with 15% 
FBS, 1% sodium pyruvate, 1% non-essential amino acids, 0.1% β-mercaptoethanol, 
100U/ml penicillin, 100 µg/ml streptomycin and leukemia inhibitory factor (LIF; gift from J. 
Guy) on gelatinised tissue culture plastic ware. Cells were split when reaching around 80% 
confluency in a ratio between 1:8-1:16 using trypsin. Cells were cultured at 37°C with 5% 
CO2. 
 
Transfection mouse ES cells with BAC DNA 
Between 0.5 and 2 µg of linearized BAC DNA was used to transfect 60% confluent mouse 
ES cells growing in a 6-well plate using Lipofectamine LTX Plus by Invitrogen. In 
short, DNA was made up with OptiMem (from GIBCO) to 500 µl, 2.5 µl PLUS reagent was 
added and incubated for 5 min at RT. Afterwards 6.25 µl Lipofectamine was added and 
incubated for 30 min at RT. The solution was then added drop-wise to the ES cells. Cells 
were split in a range of different ratios (25-0.1% of transfected cells) 24 h after transfection 
and plated onto 10 cm2 dishes. The next day selection medium containing the appropriate 
 82 
antibody (G418 250 µg/ml or Blasticidin 3 µg/ml) was added to the cell. Cells were grown 
until colonies were ready to be picked (8-10 days post transfection).  
 
Colony picking 
Colonies were picked by sucking them into a tip containing 5 µl of PBS using a p20 pipette. 
Each colony was transferred into one well of a v-bottom 96-well plate. Once 48 colonies 
were picked, 20 µl of trypsin was added to each well and cells were trypsinized for 5 min at 
37°C and dissociated by pipetting up and down to obtain single cell suspension. Cells were 
transferred to a new flat-bottom 96-well plate and cultivated in selection ES cell medium 
until most wells reached confluency.  
 
Splitting and Freezing of 96-well plates 
Colonies growing in a 96-well plate were split by transferring half of the cells in a new 96-
well plate. The other half was transferred into 24-well plates. Cells in the 96-well plate were 
grown to confluency and used for genomic DNA extraction. Cells in the 24-well plates were 
grown to confluency, trypsinized, resuspended in 100 µl of normal ES cell medium, 
transferred to new 96-well plate, 100 µl of freezing medium (80% FCS, 20% DMSO) were 
added, plate was sealed and stored at -80°C.  
 
Excision of the selection cassette by Flp/Dre 
Cells for excision of the selection cassette were grown to confluency in a T75 flask without 
antibiotics, fed 4 h before electroporation, trypsinized, washed in PBS, centrifuged for 5 min 
at 1300 rpm and resuspended in 700 µl PBS. Then 50 µg of circular plasmid containing Flp 
or Dre were added, mixture was transferred to a cuvette and electroporated at 250V and 500 
µF using a BioRad electroporator. Cells were left to recover for 20 min at RT and diluted in 
10 ml of medium. Electroporated cells were transferred in different dilutions. For a typical 
experiment 50%, 25%, 10%, 5%, 1%, 0.1% and 0.01% of the electroporated cells were 
transferred to 10-cm dishes. The next day medium was changed and cells cultured until 
colonies were big enough for picking.  
 
As an improved version, a transient selection step with puromycin 0.8 µg/ml introduced. 
After the cells were electroporated, medium was changed the next day and 24h later 
puromycin was added for 48h after which cells were grown in normal medium until colonies 
were ready to be picked. For the DKO cell-lines this step was omitted, as the cells were 
already resistant to puromycin.  
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Differentiation of mES cells into neural precursor cells 
Rapidly growing mES cells with good ES cell morphology were plated in bacterial dishes 
(4x106 cells/dish) in 15ml EB medium (normal ES cell medium with only 10% FBS and no 
LIF to encourage the formation of embryonic bodies). After 4 days in EB medium RA was 
added to begin neuronal differentiation. Medium was changed every 2 days. On day 8 cells 




3. Does an artificial CGI impose an alternate 
chromatin structure in a gene desert? 
3.1. Introduction 
Despite many years of intensive research the functional significance of CpG islands (CGIs) 
with respect to chromatin structure and transcription is still not clear. This thesis will 
therefore aim to analyse the role of the dinucleotide CpG as a signalling module.  
 
In a recent study Thomson and co-workers introduced an artificial, promoterless DNA 
sequence that shows typical characteristics of CGIs  regarding length, CG content and CpG 
frequency into the genome at sites that lack H3K4me3. The DNA inserted at the untranslated 
region of the Nanog gene comprises the promoterless EGFP (700bp with 60 CpGs) coding 
sequence adjacent to a puromycin resistance gene (600bp with 93 CpGs). We term this 
insertion “PuroGFP” and the cell line “Nanog-PuroGFP”. In another experiment the 
promoterless eGFP coding sequence was fused to the 5’ end of the X-linked gene MeCP2, 
called “MeCP2-eGFP”. These CpG island-like insertions recruited Cfp1 and created new 
marks of H3K4me3 despite the absence of a promoter. Notably no RNA Polymerase was 
detected (Thomson et al, 2010). This data indicates that one function of non-methylated CpG 
islands is to genetically influence the local chromatin environment by interaction with Cfp1 
and possibly other CpG-binding proteins (see Figure 2.2.4-1 taken from (Thomson et al, 
2010)).  
 
A caveat of this study is that the CGI-like sequences were in both cases introduced into a 
transcriptional unit. Therefore it cannot be excluded that the observed effects on Cfp1 
recruitment and chromatin establishment are due to its integration site and not a general 
feature of CGI-like sequences. In order to address this issue the present work focuses on the 
analysis of different CGI-like sequences in so-called gene desert regions, which are 
characterized by the absence of CpG islands and modified histones and which do not have 
any indication of transcription. Additionally, the relative contribution of CpG frequency 
versus G+C content will be investigated.  
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Figure 2.2.4-1 Artificial promoterless CpG-rich sequences recruit Cfp1 and generate 
new H3K4me3 peaks in mouse ES cells. 
a: The ES cell line carries adjacent promoterless eGFP and bacterial puromycin-resistance 
sequences (black bars) inserted together within the untranslated region of the Nanog gene. 
c: The eGFP sequence was inserted within the untranslated region of the Mecp2 gene. The 
positions of CGIs and H3K4me3 peaks at this locus in wild-type ES cells are shown below 
the map. DNA methylation within the insertion was determined by bisulphite sequencing of 
306-bp (eGFP) and 275-bp (Puro) segments of the inserted sequence. b/d: ChIP qPCR 
across the region containing the insertion using antibodies against Cfp1, RNA polymerase II 
(Pol2) and H3K4me3. The dotted line plots CpG density in a 500-bp window with a 100-bp 
step size. Vertical strokes below the graph indicate positions of CpGs. e: Bisulphite 
sequence analysis determined the methylation status of input and DNA immunoprecipitated 
by the Cfp1 and H3K4me3 antibodies. The percentage of non-methylated CpGs is shown 
below each panel (taken from (Thomson et al, 2010)).  
 
3.2. Results 
3.2.1. A novel mark of H3K27me3 is created at a promoter-less CGI-
like sequence 
Previously the influence of a promoterless CGI-like sequence on H3K4me3 establishment 
alone was analysed (Thomson et al, 2010). As it was recently published that GC rich 
sequences are attracting Polycomb proteins (Mendenhall et al, 2010) we wondered if the 
aforementioned Mecp2-GFP and Nanog-PuroGFP tagged cell-lines are not only establishing 
a novel peak of H3K4me3 peak but also H3K27me3. Firstly, we wanted to confirm that a 
promoterless CGI-like sequence creates a novel peak of H3K4me3 over the inserted 
sequence in the recombinant cell lines used in the original study. Indeed, as Figure 3.2.1-1 
shows both cell lines display H3K4me3 over the insertion. Several control regions were 
included in each experiment in order to provide information about the level of enrichment 
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observed over the integrated sequence in relation to active and bivalent gene promoters. 
Promoter regions of highly expressed house keeping genes such as ActinB or GAPDH as 
well as the pluripotency gene Sox2 were used as examples for genes that display high levels 
of active chromatin marks and RNA Pol II at their transcription start sites. Two genes from 
the Hox cluster, HoxC8 and HoxA9, were used as examples for bivalent genes, which show 
both H3K4me3 and H3K27me3 marks at their promoter regions. An inconspicuous 
intergenic region on mouse chromosome 15 (denoted as “m15”) that does not exhibit any 
signs of transcription or H3K4 and H3K27 methylation was used as a negative control region 
(note that not all controls have been used in each experiment) (Clouaire et al, 2012). The 
H3K4me3 levels observed at the Mecp2-eGFP and Nanog-PuroGFP insertion were slightly 
higher than at the HoxC8 bivalent gene promoter HoxC8. As expected H3K4me3 levels over 
the active gene promoters Sox2 and ActinB are much higher, whereas the negative intergenic 
control region on mouse chromosome 15 (m15) showed only very low levels of H3K4me3. 
When looking at the H3K27 modification, a novel mark of H3K27me3 can be observed over 
the inserted DNA fragments in both cell lines. Consistently, Suz12, a member of the PRC2 
complex, that is responsible for establishment of H3K27me3, was also found over the 
inserted CGI-like sequences. In both cell lines H3K27me3 and Suz12 levels were lower over 
the inserted CGI than over the HoxC8 bivalent gene promoter, but still clearly higher than 
adjacent flanking regions.  
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Figure 3.2.1-1 H3K4me3 and H3K27me3 marks are present at Mecp2-eGFP and Nanog-
PuroGFP  
Panel shows gene structure of Mecp2 (A) and Nanog (B) and depict the inserted CGI like 
sequence (GFP and PuroGFP) in 3’UTR of respective gene. Arrows indicate TSS and 
direction of transcription. Black boxes indicate position of primers used in ChIP qPCR. ChIPs 
with antibodies against H3K4me3, H3K27me3 and Suz12 were performed. Y-axis: % of 
Input. Controls: TSS of active genes Sox2 and Act4, of bivalent gene HoxC8; m15= negative 
control region on mouse chromosome 15 indicating background levels. Error bars indicate 
standard deviation of PCR replicates. 
 
 
3.2.2. Insertion of the PuroGFP artificial CGI in gene desert by 
Recombination mediated cassette exchange 
We wanted to test if the effect of a promoterless CGI-like sequence on chromatin structure 
was due to its integration site within genes. We therefore introduced the same PuroGFP 
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sequence as previously into a gene desert region and asked if a novel peaks of H3K4me3 and 
H3K27me3 were nevertheless created. Only the CGI-like sequence PuroGFP was chosen as 
this construct stayed unmethylated in contrast to the eGFP construct, which gained dense 
DNA methylation to about 70% (Thomson et al, 2010). 
 
The initial approach to create a mouse ES cell line containing the puroGFP sequence in a 
gene desert was to employ recombination mediated cassette exchange (RMCE) (see Figure 
3.2.2-1). This method allows targeted introduction of different DNA sequences into the same 
genomic locus. It is based on the use of two different targeting constructs where the first is 
introduced into the genome by homologous recombination. This creates a platform in a 
defined genomic locus where different CGI-like sequences can be introduced via a cassette 
exchange mediated by Cre recombinase. In this manner only one homologous recombination 
event is required for inserting several DNA sequences at the same locus. The first targeting 
construct contains a neomycin resistance cassette flanked by heterotypic Lox sites for 
selection in G418 media. The advantage of heterotypic Lox sites is that LoxP and Lox511 do 
not recombine with each other but rather they allow a cassette exchange. Furthermore it 
possesses the 5’ part of the hypoxanthine-guanine phosporibosyltransferase (hprt) gene that 
is non functional in this construct but can be activated by the second construct. It consists of 
the remaining 3’ region of the hprt gene and a multiple cloning site for the introduction of 
the CpG islands between heterotypic lox sites. This construct will be then used for 
transfecting the mES cells that contain the docking platform at the desired locus. A plasmid 
that expresses the recombinase cre will be co-transfected with the construct containing the 
CpG island. This will result in a cassette exchange between the first and second construct at 
the heterotypic lox sites. Cells that have undergone a successful cassette exchange will be no 
longer resistance to G418 as the neomycin resistance gene is not present anymore; instead 
the hprt gene is reconstituted. Cells with a functional hprt gene are able to synthesise nucleic 
acids through a purine salvage pathway. As a result these cells will survive in hypoxanthine 
aminopterin tymidine (HAT) containing media, which blocks de novo nucleic acid synthesis 
and forces cells to use the alternate salvage pathway. Therefore cells can be double selected 
for HAT resistance and through replica plating as well for neomycin sensitivity. Once cells 
have been identified that contain the PuroGFP, FLP recombinase is used to excise the 
promoter of the hprt gene. This is necessary as the aim of this experiment is to test the effect 




Figure 3.2.2-1 Overview of recombination mediated cassette exchange 
A: The first construct is inserted into a defined location on mouse chromosome X creating a 
docking platform. B: Upon transfection with Cre cassette exchange takes place inserting a 
CGI like sequence and reconstituting a functional hprt gene. C: Upon transfection with Flp 
the hprt gene is excised leaving the CGI behind flanked only by frt and Lox511 sites.  
 
We selected 2 different gene loci on the mouse X chromosome (X:44163816‐44168855 and 
X:106815842‐106823676) with no CpG island or H3K4me3 present. We chose the X 
chromosome since it is present as a single copy in male mES cells. In order to identify a 
region of the mouse genome that qualifies as a gene desert both data sets generated in our lab 
and published data from databases such as Ensemble or USCS were mined. CxxC affinity 
purification, a method that was developed in the lab to enrich for unmethylated CpG islands 
with subsequent high throughput sequencing allowed to identify regions within the genome 
with no CpG islands (Illingworth et al, 2008). ChIP of H3K4me3 and the initiation form of 
RNA polymerase II followed by Solexa sequencing permitted the identification of regions 
that lack open chromatin and show no sign of transcription According to the “Ensemble 
Mouse” assembly from 2007 there are no genes, pseudogenes or other transcripts annotated 
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within 200kb up‐ and downstream of the selected loci. Care was taken to avoid highly 
repetitive regions as this could impair homologous recombination. Homologous arms for 
Gene desert 1 and 2 were PCR amplified from mouse ES cells DNA and sequentially cloned 
into the first targeting construct. One homology arm was designed shorter, 1,7 and 1,3 kb 
respectively, in order to allow for PCR screening. The longer homologous arm was designed 
to have at least 3 kb. ES cells were transfected with the 1st construct and 500 colonies were 
picked to identify clones that have undergone homologous recombination by PCR and 
Southern blot. However such a clone could not be identified.  
 
One potential reason for the failure to obtain cells that have undergone homologous 
recombination is that introduction of the docking platform into a gene desert region might be 
less frequent than normally expected. According to the definition we tried to identify regions 
that are devoid of genes and histone modifications that are associated with open chromatin. 
The regions chosen therefore are rich in heterochromatic marks, which presumably strongly 
impaired the frequency of homologous recombination. Additionally the length of the 
homology arms might have been too short to allow efficient homologous recombination. As 
a consequence we decided to employ a different strategy to obtain a mouse ES cells line that 
contains a CGI-like sequence in a gene desert. 
 
3.2.3. Insertion of puroGFP into gene desert by random integration 
into the mouse genome 
In order to circumvent the problem of inefficient homologous recombination in a gene desert 
an approach was chosen that relies on the random integration of a gene desert containing the 
puroGFP sequence into mouse ES cells. This method is based on first introducing the CGI-
like sequence into a human gene desert containing BAC by recombineering in bacteria. 
Subsequently the linearized human gene desert containing the puroGFP sequence is 
randomly integrated into mouse ES cells. After selection for integration of the construct the 
selection cassette can be excised using Flp-recombinase. Finally the chromatin state of 
different cell lines containing only the CGI with a remaining frt and loxP site in a gene 
desert can be analysed by ChIP. Figure 3.2.3-1shows an overview of this method.  
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Figure 3.2.3-1 Insertion of CGI in gene desert into mouse genome by random 
integration 
A: Cloning of CGIs into plasmid into which the homology arms for the gene desert and a 
selection cassette have been cloned. B: The linearized construct from A is used to transfect 
a human BAC containing a gene desert. Integration occurs via homologous recombination in 
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C: The linearized construct from C is used for transfecting mouse ES cells. Colonies with a 
random integration of the BAC are screened for low copy integration. D: Positive clones are 
transfected with Flp/Dre to excise selection cassette. Colonies are screened for successful 
excision by PCR and Southern blotting. E: Clones containing a CGI in gene desert without 
selection cassette are used for analysis of chromatin modification and DNA methylation. The 
gene desert regions either side of the CGI-like sequence provides insulator function that 
protect against positional effects and allow to study the influences of base composition on 
local chromatin establishment without stimuli from adjacent genes. 
 
3.2.3.1. Identification	  of	  human	  gene	  desert	  
In a first step a human gene desert was identified to ensure unambiguous discrimination 
between the endogenous mouse genome and the newly integrated DNA. Genome wide 
H3K4me3 and RNA PolII ChIP-seq data of human ES cells and data from CAP of human 
sperm generated in our laboratory was used to identify a 132.46 kb region on chromosome 
18 that satisfied the criteria of a gene desert and that we termed “Gene desert 1” (see Figure 
3.2.3-2) (Illingworth et al, 2008; 2010). According to the “Ensemble Human” assembly from 
2007 there are no genes, pseudogenes or other transcripts annotated within the 132.62 kb 
selected locus on human chromosome 18 (Flicek et al, 2012). Two homology arms, one 250 
and the other 550 bp corresponding to regions in the middle of Gene desert 1 were amplified 
and cloned into a plasmid containing a neomycin selection cassette under a dual prokaryotic 
and eukaryotic promoter flanked by frt sites (Figure 3.2.3-1A). Subsequently the PuroGFP 
CGI-like sequence was cloned into that plasmid. The plasmid containing the homology arms, 
the CGI and a neomycin selection cassette was used to engineer a bacterial artificial 
chromosome (BAC) containing the identified Gene desert 1 by recombineering (Figure 
3.2.3-1B).  
 
Figure 3.2.3-2 Genomic location of human Gene desert 1 
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A: Location of human Gene desert 1 on mouse chromosome 18. B: ChIP-Seq profiles for 
RNA Polymerase II and H3K4me3 and CAP seq profiles at Gene desert 1 and a gene rich 
example region for comparison.  
 
3.2.3.2. Recombineering	  of	  CGI	  like	  sequences	  
Recombineering is a highly efficient and precise method for genetically engineering DNA in 
vivo, usually in E. coli, that relies on homologous recombination mediated by bacteriophage 
based systems such as the Red/Ed system. This method does not depend on restriction 
enzymes and is therefore more versatile than traditional cloning as the sequence of the 
homology region can be chosen freely. Moreover the size limit for fragments that can be 
recombineered is much less stringent than for other cloning methods and fragments up to 80 
kb can be cloned into low-copy plasmids (Zhang et al, 1998). Initially the pRed/ET plasmid 
containing the phage protein pairs RecE/RecT or Redα/Redβ that are under the control of an 
arabinose inducible temperature sensitive promoter is electroporated into the BAC-
containing bacteria. Double-stranded break repair (DSBR) is initiated by the recombinase 
protein pairs, where RecE or Red α, a 5’-> 3’ exonucleases, digests one strand of the DNA 
from the DSB. The DNA binding proteins RecT/Redβ binds and coats the single strand and 
the protein-nucleic acid filament aligns with homologous DNA (Figure 3.2.3-3A). As a 
second step the linearized plasmid containing homology arms, a selection cassette and the 
PuroGFP is electroporated into the BAC containing the Red plasmid. Upon induction with 
arabinose recombination occurs and selection for successful recombination is achieved by 




Figure 3.2.3-3 Schematic representation of principle of recombineering 
A: Principle of recombineering. B: Stepwise description of recombineering. For description 




Clones were initially screened by PCR with primers spanning the 5’ and 3’ border and an 
internal primer pair for proper homologous recombination. Restriction enzyme digests with 
different enzymes (only BamHI shown) were performed to confirm the integrity of the whole 
140kb BAC. As the size of the BAC is much bigger than conventional plasmids, achieving 
good band separation on an agarose gel proved to be difficult. However, despite the fact that 
some of the bands are visible only as one band in comparison with the in silico digest it is 
clear that the PuroGFP has been integrated (Figure 3.2.3-4A & B). Finally the integration 
was confirmed by sequencing along key elements of the BAC (5’ and 3’ border, PuroGFP 
and frt flanked neomycin cassette).  
 
Figure 3.2.3-4 Introduction of CGI-like sequence into Gene desert 1 via 
recombineering 
A: PCR screen to identify successful recombination. Red lines indicate amplicons that span 
5’HR, 3’HR and an internal region. Numbers indicate clones that showed successful 
recombineering -: Water was used as a negative control. B: Control digest with BamHI to 
confirm recombination. In silico digest left panel, control digest right panel. Red box indicates 
diagnostic band.  
 
3.2.3.3. Transfection	   of	   ES	   cells	   and	   excision	   of	   selection	   cassette	  
	  
Mouse ES cells were transfected with the linearized BAC containing PuroGFP in Gene 
desert 1 leading to random integration. The ~ 70kb gene desert flanking puroGFP on either 
side provides insulator function protecting against positional effects. Successfully transfected 
cells were selected by addition of G418 and neomycin resistant colonies were picked and 





modified BAC (see Figure 3.2.3-5). Since the integration of the BAC construct into the 
mouse genome happens randomly it is not possible to determine the proper integration by 
Southern blot, as is a usual approach for generating transgenic cell lines. 
 
Figure 3.2.3-5 Screening of mouse ES cells for the integration of human gene desert 
BAC containing PuroGFP 
Scheme on top indicates human gene desert BAC with PuroGFP CGI (grey bar) randomly 
integrated in genome (depicted by nucleosomes) of mouse ES cells. Red lines indicate 
primer amplicons. +: As a positive control BAC DNA from Gene desert 2 with the integrated 
CGI was used. -: As a negative control wt genomic DNA without transfected BAC was used. 
Table on the right denotes distance of primer from PuroGFP CGI. Red crosses indicate the 
clones that were chosen for selection cassette excision.  
 
To eliminate the possibility of integration site effects, 3 different clones were expanded and 
electroporated with Flp in order to excise the selection cassette. This step is necessary in 
order to be able to analyse the chromatin at the CGI without an adjacent active promoter that 
could influence the result of the experiment. Resulting colonies were picked and initially 
screened by PCR using a primer pair that spanned the selection cassette. In the event of 
successful excision the size of the expected band drops from 2 kb to 0.5 kb. This screening 
method was chosen because a band is expected in either case, allowing assessing proper 
PCR conditions (Figure 3.2.3-6A&B). Clones that were positive for excision of the selection 
cassette were expanded further to perform Southern blot analysis. In contrast to PCR that 
relies on the amplification of DNA and is therefore prone to be biased, southern blotting 
does not require amplification. Here, the absence of the selection cassette can be shown by 
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the increase of the probed fragment from 1.5 to 12 kb (Figure 3.2.3-6 C&D). Figure 3.2.3-6 
D shows clones that were positive in the PCR screen. However, only one of these was 
positive by Southern blot as well, proving the necessity of the Southern blot screen. As we 
aimed to analyse several cell lines clones with a different parental BAC integration were 
screened. Although several clones seemed positive by PCR, none had lost the selection 
cassette. Despite screening of more than 400 colonies from 3 different cell lines no 
additional clones with successful excision of the cassette were identified. When Southern 
blots were performed it became clear that all positive looking clones from the PCR screen 
(data not shown) were in fact mixed colonies (Figure 3.2.3-6 E). In summary, only one clone 
with the PuroGFP CGI-like sequence in gene desert 1 without the selection cassette was 
obtained for ChIP analysis.  
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A: Scheme of PCR screen to identify clones without the selection cassette, indicated by a 
decrease of amplicon from 2kb to 0.5 kb (black line). B: PCR screen for the excision of the 
selection cassette. For Clones that were positive for the first crude screen (data not shown) 
the PCR was repeated (panel B). Clone numbers in red were taken further for Southern 
screen. C: Scheme of Southern screen. Red box denotes probe. Successful excision shown 
through increase of band from 1.5 kb to 12 kb. D: Clones from PCR screen. Red clone 
number indicates successful excision. E: Southern screen of more clones from different 
parental integrations (PCR screen not shown). Only mixed colonies were identified, no 
further clones of different parental integrations were obtained. 
 
3.2.4. Both H3K4me3 and H3K27m3 marks are present at puroGFP in 
gene desert 
In order to answer the question weather the PuroGFP CGI-like sequence used previously 
within genes is sufficient to create a bivalent domain outside transcriptional units the 
chromatin state of the one cell line was analysed by ChIP. Using an antibody against 
H3K4me3 we found that as in the work by Thomson and co-workers (Thomson et al, 2010) 
the promoterless PuroGFP sequence created a novel peak of H3K4me3. As can be seen in 
Figure 3.2.4-1 a defined peak was observed just over the CGI-like sequence that was not 
present in the adjacent gene desert regions. This suggests that the underlying CpG and G+C 
rich DNA influences local chromatin establishment. When looking at the level of H3K4me3 
over the CGI it is notable that the height of the peak corresponds to the height of the bivalent 
gene HoxC8. As expected the H3K4me3 levels at an active gene like ActinB are higher. An 
inconspicuous region on mouse chromosome 15 was used as a negative control. Published 
genome wide ChIP data show that there is no histone H3 methylation at lysine 4 present at 




Figure 3.2.4-1 A novel peak of H3K4me3 is established over PuroGFP in Gene desert 1 
A: Schematic showing the position of primer pairs used for ChIP. (length of amplicons not 
drawn to scale) B: Distance of primers from integrated CGI in kb. C: H3K4me3 ChIP, 2 
independent X-links. Y-axis: % of Input of H3K4me3 over % of Input of pan-H3 antibody. 
Controls: TSS of active gene Actin, of bivalent gene HoxC8; m15= negative control region on 
mouse chromosome 15 indicating background levels. Error bars indicate standard deviation 
of PCR replicates.  
 
Furthermore ChIP with antibodies against H3K27me3 was performed to investigate if this 
repressive chromatin mark is present at the inserted PuroGFP CGI-like sequence. Figure 
3.2.4-2 B shows that H3K27me3 is established over the CGI-like sequence. In contrast to the 
H3K4me3 ChIP, this ChIP with an antibody against H3K27me3 shows a signal not only 
directly over the CGI but spreading into adjacent gene desert regions. This spreading of 
H3K27me3 has been observed by others (Schwartz & Pirrotta, 2007) and is thought to be 
caused by the ability of PRC2 to bind to the same mark it deposits, providing a model for the 
propagation of H3K27me3 during replication (Hansen et al, 2008; Margueron et al, 2009). It 
has to be noted that the primer pairs investigating the chromatin state at the gene desert 
region are quite close to the integration site of the CGI-like sequence. Therefore, it cannot be 
excluded that the gene desert region itself could have a role in establishing the H3K27me3 
mark. For future experiments it will be interesting to analyse the presence of H3K27me3 
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further away from the integration site towards the end of the gene desert (see 4.2.1). Again 
the level of H3K27me3 at the CGI-like sequence is similar to that of the bivalent gene 
HoxC8. In order to strengthen the evidence that H3K27me3 is indeed present at the CGI, 
ChIP with antibodies against Suz12, a subunit of the PRC2 complex was performed. Panel C 
of Figure 3.2.4-2 indicates that Suz12 is recruited to the PuroGFP CGI-like sequence but is 
absent from adjacent gene desert regions. As before the levels are comparable to that of 
HoxC8. These results indicate that the PuroGFP sequence that contains a high frequency of 
































































 H3K27me3 ChIP 















































A: Schematic showing the position of primer pairs used for ChIP. (length of amplicons not 
drawn to scale) B: H3K27me3 ChIP in 2 independent X-links. Y-axis: % of Input of H3K4me3 
over % of Input of pan-H3 antibody. C: Sux12 ChIP, Y-axis % Input. Controls: TSS of active 
gene Actin, of bivalent gene HoxC8; m15= negative control region on mouse chromosome 
15 indicating background levels. Error bars indicate standard deviation of PCR replicates.  
 
 
3.3. Summary and Discussion 
CpG islands are short stretches of unmethylated DNA with a high CpG density and an 
overall high G+C content that punctuate the globally heavily methylated and CpG poor bulk 
genome. Moreover they are associated with the TSS of many genes, which adds to the notion 
that these islands are functionally important sequences. However, many questions remain 
regarding their active influence on processes like chromatin structure establishment. In this 
chapter earlier findings that indicated promoterless CGI-like sequences can recruit a histone 
methyltransferase complex and establish a novel domain of H3K4me3 (Thomson et al, 
2010) were confirmed and extended. The establishment of the active chromatin mark 
H3K4me3 over the inserted CGI-like sequence was confirmed for both cases: the Nanog-
puroGFP insertion and the Mecp2-eGFP construct 
 
3.3.1. Polycomb is recruited to a promoterless CGI-like sequence at 
the Nanog-PuroGFP and Mecp2-eGFP loci 
Polycomb group repressor proteins play a crucial role in regulating gene expression patterns 
through differentiation by conferring a repressive chromatin environment at target genes. 
The exact recruiting mechanism of polycomb proteins has not been completely clarified. In 
Drosophila the recruitment of PcG complexes is mediated by specific DNA elements called 
Polycomb response elements (PREs). Sequence specific DNA binding proteins, such as 
PHO, recognize PREs and recruit polycomb proteins (Ringrose & Paro, 2007). Some reports 
suggested the existence of a mammalian PRE and implied a role for YY1, the mammalian 
orthologue of the Drosophila protein PHO, in Polycomb recruitment (Lo et al, 2012; Sing et 
al, 2009). Yet genome-wide analysis in mammals did not show a clear overlap between YY1 
and PcG target genes (Xi et al, 2007). When looking at genome wide studies of Polycomb 
occupancy, it becomes apparent that there is a strong correlation of Polycomb binding to 
promoters with CGIs (Ku et al, 2008). Recent studies suggest that the accessible chromatin 
state usually found at CGIs is owed at least partially to the zinc finger-CxxC domain-
containing proteins that specifically recognize and bind to unmethylated CpGs and recruit 
chromatin modifying activities (Thomson et al, 2010; Blackledge et al, 2010). Given the fact 
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that most polycomb proteins are recruited to CGIs it is interesting to speculate if a similar 
mechanism plays a role for polycomb targeting. To date a clear preference for unmethylated 
CpGs has not been demonstrated for the PRC2 complex but Jarid2, a member of this 
complex, has been shown to preferentially bind to GC rich DNA sequences (Peng et al, 
2009; Li et al, 2010). It has been suggested that CG rich DNA is sufficient to recruit 
polycomb proteins (Mendenhall et al, 2010; Lynch et al, 2011). 
 
Indeed it is shown here that the H3K27me3 histone mark that is established by a member of 
the PRC2 complex is present at the promoterless CGI-like sequence GFP and puroGFP that 
have been integrated into the 3’UTR of Mecp2 and Nanog, respectively. This suggests that a 
sequence with the characteristics of a CGI but stemming from an unrelated organism is 
capable of recruiting the polycomb complex to locations previously not marked with this 
modification.  
 
3.3.2. Introduction of CGI-like sequences into a gene desert region 
In this chapter the above-discussed finding within genes were extended to a gene desert 
region. To this end only the PuroGFP CGI-like sequence was taken further and a cell line 
was created by random integration that contained the PuroGFP sequence in a gene desert 
region. As each construct will integrate into a different genomic locus making comparisons 
potentially challenging, measures where taken to prevent negative effects of the random 
integration approach. Long genomic stretches of human gene desert BACs either side of the 
integrated CGI-like sequence provide insulator function to protect against positional effects. 
The idea to create several cell lines of the gene desert 1 with puroGFP all integrated into 
different genomic loci failed due to inefficient excision of the selection cassette. The 
construct used in this study to confer antibiotic resistance was an frt flanked neomycin gene 
under a PGK promoter. The frt sites are recognized by the recombinase Flp, which leads to 
the excision of the selection cassette. It has been shown that the efficiency of Flp mediated 
recombination is less than that achieved with the traditional Cre recombinase that recognizes 
LoxP sites (Ringrose et al, 1998). For this study it was not possible to use the Cre/LoxP 
system because the bacterial backbone of the human gene desert BAC contains one 
remaining LoxP site. Undesirable recombination events could occur between this residual 
LoxP site and the LoxP sites flanking the neomycin gene that could potentially lead to 
excision of the CGI. It was therefore necessary to use the less efficient Frt/Flp system. 
However, for different constructs the protocol for excision of the selection cassette was 
improved to increase the efficiency of excision (see chapter 4.2.1).  
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3.3.3. Polycomb levels at CGIs integrated in gene desert are higher 
than in active genes 
In this chapter the influence of the promoterless CGI-like sequence PuroGFP on chromatin 
establishment was analysed in the 3’UTR of the Nanog gene and in a human gene desert. 
The levels of H3K27me3 over the insertion within the Nanog gene are markedly lower than 
that of the bivalent control gene HoxC8 but still clearly above background (Figure 3.2.1-1). 
In contrast when looking at the same insertion in a gene desert region, where there are no 
influences of neighbouring genes expected, the H3K27me3 intensity is higher in both 
replicates reaching levels similar to that of HoxC8 (see Figure 3.2.4-2). The higher levels of 
H3K27me3 correspond to higher levels of Suz12, a component of the PRC2 complex. 
Whereas Suz12 levels at the insertion within the Nanog locus was around 5 times lower than 
that of the bivalent control gene. This result is not surprising giving the fact that the Nanog 
gene is highly expressed in mouse ES cells in order to maintain pluripotency. It is therefore 
conceivable that the recruitment of Polycomb to a CG rich sequence within an active gene, 
albeit at the 3’UTR, is restricted and counteracted by activating processes. This is consistent 
with recently emerging ideas about polycomb recruitment that favour the view that PcG 
proteins are constantly sampling theoretically favourable binding sites, mostly CG rich 
sequences, for permissiveness to bind. If favourable conditions are found then binding of 
PcG is enhanced through positive feedback mechanism. On the other hand processes such as 
transcription, can lead to the domination of activating signals by recruiting activating 
histone-modifying enzymes. Mendenhall and co-workers showed that a constitutively active 
CpG island is able to recruit PRC2 after excision of a cluster of activating motifs 
(Mendenhall et al, 2010). This view was confirmed by a study that showed competition 
between PcG recruitment and transcriptional activation by inserting or excising a small 
promoter element and showing that the presence of the promoter is incompatible with PcG 
binding (Lynch et al, 2011). Low gene expression might be already enough to inhibit full 
PcG establishment as the GFP CGI-like sequence integrated at the 3’UTR of Mecp2, a gene 
that is expressed at very low levels in ES cells, shows similar levels of H3K27me3 and 
Suz12 to the Nanog-PuroGFP integration. However, this remains speculative and more 
examples are needed to be able to draw conclusions about quantitative levels of H3K27me3 





3.3.4. H3K4me3 is created at basal levels over CGI-like sequence but 
transcription is needed for full establishment 
In contrast to H3K27me3, H3K4me3 levels of the puroGFP construct within a gene desert 
region are similar to the levels observed when this sequence was integrated into the 3’ UTR 
of the Mecp2 and Nanog genes. In both scenarios H3K4me3 signals were found to be around 
the height of the bivalent control gene HoxC8, but much less compared to the levels 
observed at the TSS of active genes. This indicates that although there is a basal level of 
H3K4me3 recruited to promoterless CGIs, presumably via a CxxC domain-mediated 
targeting mechanism, the levels of H3K4me3 are markedly increased by productive 
transcription. Several studies have high lightened the importance of RNA polymerase II 
dependent recruiting mechanism of H3K4 methyltransferases (Guenther et al, 2007; Lee & 
Skalnik, 2008; Ng et al, 2003). For example, Wdr82 recruits the Setd1A histone 
methyltransferase complex to TSSs of transcribed genes via the interaction with the Ser5 
phosphorylated form of RNA PolII (Lee et al, 2007a).  
 
In summary it can be concluded that the promoterless CGI-like sequence puroGFP can 
influence local chromatin establishment by recruiting histone-modifying enzymes that form 
a bivalent chromatin domain over the integration site, indicated by the presence of both 
H3K4me3 and H3K27me3.  
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4. A artificial CGI-like sequence is sufficient to 
establish bivalent chromatin in a gene desert 
region 
4.1. Introduction 
4.1.1. Establishment of bivalent domains 
Bivalent domains that are marked by the coexistence of the permissive chromatin mark 
H3K4me3 and the repressive mark H3K27me3 are thought to play an important role by 
keeping developmental genes silenced but poised for activation upon differentiation (Azuara 
et al, 2006; Bernstein et al, 2006). However, many questions remain regarding their 
establishment and biological significance. Especially the notion that key developmental 
genes are specifically targeted by PcG and Set containing proteins to establish a bivalent 
domain might be misleading as it has been shown in earlier studies that CG rich sequences 
are sufficient to recruit the PRC2 complex (Mendenhall et al, 2010; Lynch et al, 2011) and 
an H3K4 methyltransferase (Thomson et al, 2010). These results have been recapitulated in 
chapter 3, where it was shown that the promoterless PuroGFP CGI-like sequence formed a 
bivalent domain in a gene desert. Therefore it is conceivable that a bivalent domain is the 
default state of a CpG rich sequence with a high G+C content in the absence of any other 
activating or repressing cues.  
 
4.2. Results 
4.2.1. Both H3K4me3 and H3K27m3 marks are present at artificial CGI 
while RNA Polymerase II is not detected 
 
To demonstrate that the observed results are not due to some specific characteristic of the 
PuroGFP sequence, which was created from the coding region of two exogenous genes, but 
constitute a more general mechanism of bivalent domain formation at CpG and G+C rich 
sequences a synthetic CGI-like sequence was analysed. This sequence was generated 
randomly with the constraint to have similar parameters to endogenous CGIs in terms of 
length, number of CpGs and G+C content. This artificial CGI like sequence (ArtCGI) is 
1055 bp long, has a G+C content of 69.5 % and 12 CpGs per 100 bp. Moreover, care was 
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taken to avoid the core consensus motive of the ubiquitous transcription factor Sp1 
(CCGCCC). This was deemed important because earlier studies have found that Sp1 sites are 
required to keep the hamster and mouse aprt gene, respectively, promoter methylation free 
(Brandeis et al, 1994; Macleod et al, 1994). Macleod et al showed that mutating Sp1 sites 
leads to methylation of the aprt CGI. As I want to study the influence of the base 
composition of CGIs on local chromatin establishment, the presence of a transcription factor 
binding site that could influence the methylation status of the CGI and therefore presumably 
chromatin formation was considered detrimental. However, since CGIs are GC rich and are 
located at the promoter regions of genes they are naturally rich in transcription factor binding 
sites (Qian et al, 2006). Therefore other transcription factor binding sites are likely to be 
present in the synthesized artificial CGI.  
 
As described in the previous chapter the artificial CGI was cloned into the plasmid 
harbouring the homology arms for recombineering into the human Gene desert 1 BAC with a 
neomycin resistance cassette (Figure 3.2.3-1). However, the recombineering step into the 
132kb big BAC containing Gene desert 1 proved to be too challenging. Despite many 
attempts no correct recombination events were identified, presumably due to additionally 
recombination events within repetitive region in the gene desert. Care was taken to avoid 
repetitive regions as it was anticipated that the presence of those elements could potentially 
interfere with homologous recombination. Nevertheless some degree of repetitiveness could 
not be avoided. In order to circumvent this problem a different human gene desert region 
was selected that is smaller than the one previously used. We chose to obtain a BAC (BAC-
L19) containing a 47 kb region on human chromosome 1. This region has been used for a 
similar approach (Mendenhall et al, 2010) therefore we expected it to be favourable to 
engineering. Figure 4.2.1-1 shows the genomic location and ChIP Seq profiles of H3K4me3 
and RNA Pol II as well as CAP-Seq of gene desert 2. 
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Figure 4.2.1-1 Genomic location of gene desert 2 
A: Location of human gene desert 2 on mouse chromosome 1. B: ChIP-seq profiles for RNA 
Polymerase II and H3K4me3 and CAP-seq profiles at gene desert 2 and a gene rich 
example region for comparison. 
 
As hoped, recombineering of the artificial CGI into gene desert 2 proved to be more 
efficient. Again mouse ES cells were transfected with the linearized BAC containing the 
selection cassette and the artificial CGI. Clones resistant to G418 were picked and screened 
for the integration of the construct. The number of BAC molecules integrated into the mouse 
genome was one concern that was addressed by determining transgene copy number by 
quantitative PCR. Figure 4.2.1-2 shows the measured copy number for several clones. Three 
clones that showed a low copy number integration for all 3 primer pairs (1, 1-2 and 4 
respectively) were expanded further in order to excise the selection cassette.  
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Figure 4.2.1-2 Copy number of artificial CGI in mouse ES cells in gene desert 2 
Mouse ES cell clones with integrated artificial CGI were analysed by Q-PCR for copy 
number integration. 3, 7 and 10 respectively refers to the primer pair used in the PCR. 
Values normalized to that of Sox2 = 2 copies per cell. Red boxes indicate chosen cell lines. 
Error bars indicate standard deviation of PCR triplicates. Scheme above indicates construct 
inserted in gene desert 2 and position of primers (not drawn to scale). 
 
Engineering the PuroGFP cell line showed that the limiting step in the procedure is 
identifying clones that have undergone successful excision of the selection cassette. 
Therefore I tried to optimize the Flp transfection protocol in order to increase the number of 
positive clones. This was achieved by adding an additional selection step that ensured only 
cells that did uptake the Flp plasmid were able to survive. Applying a transient selection with 
puromycin increased the number of positives by PCR screen from around 5/100 to more than 
30/100 (see Materials and Methods, section 2.2.4). Figure 4.2.1-3 panel A shows the PCR 
screen after the improved protocol. Positive clones were taken forward and Southern blot 
analysis was performed. Figure 4.2.1-3 B shows positive clones for all three cell lines.  
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Figure 4.2.1-3 Identification of cell lines with excised selection cassette 
A: PCR screen: Black line at bottom of scheme denotes amplified region. Red arrow 
indicates an example positive clone. B: Southern Blot screen: Red filled box indicates 
location of probe. Clones that depict a 3.6 kb band = excision of cassette are indicated in 
red. Red box denotes which clones were taken further for ChIP analysis 
 
Three independent cell lines containing the artificial CGI in a gene desert region were 
analysed with antibodies against H3K4me3 in two independent experiments. The ChIPs in 
Figure 4.2.1-4 show the expected patterns at the control regions, high levels of H3K4me3 at 
the active genes Sox2 and GAPDH, lower levels at the bivalent gene HoxC8 and no 
enrichment over the negative control region m15. As with the PuroGFP the artificial CGI 
established a novel mark of H3K4me3 over the integrated sequence. Histone H3K4 
methylation levels were found in all three cells lines to levels similar or slightly higher than 
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primer pairs were designed spanning the whole gene desert length. The table in Figure 
4.2.1-4 B indicates the distance of the specific primers from the integrated artificial CGI. No 
enrichment of H3K4me3 was found at the gene desert region demonstrating that it is 
specifically the randomized CpG and G+C rich sequence that is responsible for the 
establishment of the active chromatin mark H3K4me3.  
 
Figure 4.2.1-4 An artificial CGI-like sequence establishes a novel peak of H3K4me3  
A: Scheme on top indicates gene desert 2 (grey bar) and the integration site of CGI-like 
construct. Black boxes indicate bacterial backbone from BAC. Black bars indicate position of 
primers used for Q-PCR (length of amplicons not drawn to scale). B: Table shows the 
distance from each gene desert primer pair from the CGI in kb. C: H3K3me3 ChIP, 2 
independent X-links for 3 cell lines. Y-axis: % of Input of H3K4me3 over % of Input of pan-
H3 antibody. Controls: TSS of active genes Sox2 and GAPDH, of bivalent gene HoxC8; 
m15= negative control region on mouse chromosome 15 indicating background levels. Error 
bars indicate standard deviation of PCR replicates.  
 
Again H3K27me3 ChIPs were performed to establish if the artificial CGI promotes the 
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Prim. Dist. 
from CGI 
1 19.3 kb 
2 4.7 kb 
3 1.8 kb 
4 1.2 kb 
CGI 
8 5 kb 
9 9.8 kb 
10 16 kb 
11 24 kb 
1st X-link
2nd X-link






sequence, H3K27me3 is found over the artificial CGI spreading into adjacent gene desert 
regions. This is despite the fact that for this experiment gene desert primers were designed 
up to 24 kb away from the integration site. However, a decline of H3K27me3 levels can be 
observed the further away from the integration site the primer pair is located. Additionally 
Suz12 is recruited to the artificial CGI but not to the adjacent gene desert region further 
strengthening the notion that a bivalent CGI has been created. Having shown that a bivalent 
domain is established over the artificial CGI in a gene desert we wanted to further 
characterize the chromatin state at the inserted sequence. 
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Figure 4.2.1-5 H3K27me3 and Suz12 ChIP of artificial CGI in gene desert 2 
A: Scheme on top indicates gene desert 2 (grey bar) and the integration site of CGI-like 
construct. Black boxes indicate bacterial backbone from BAC. Black bars indicate position of 
primers used for Q-PCR (length of amplicons not drawn to scale). B: H3K427me3 ChIP, 2 
independent X-links for 3 cell lines. Y-axis: % of Input of H3K4me3 over % of Input of pan-
H3 antibody and C: Suz12 ChIP, 1 X-link for 3 cell lines. Y-axis: % input. Controls: TSS of 
active genes Sox2 and GAPDH, of bivalent gene HoxC8; m15= negative control region on 
mouse chromosome 15 indicating background levels. Error bars indicate standard deviation 
















Originally, H3K4me1 was thought to be enriched only at enhancer elements (Heintzman et 
al, 2007). However, in recent years it has become apparent that H3K4me1 is not restricted to 
enhancers but is also present at broad regions of 5’ ends of actively transcribed genes and 
even in some cases at noncoding sequences (Calo & Wysocka, 2013). Interestingly, there 
exists a subclass of enhancer, so called poised enhancers that are predominantly found in 
pluripotent ES cells and are marked by the coexistence of H3K4me1 and H3K27me3 
together with members of the PRC2 complex (Rada-Iglesias et al, 2011). Therefore, we were 
interested to analyse the artificial CGI for presence of H3K4me1. Performing ChIP with an 
antibody against H3K4me1 we found an enrichment of this mark at the artificial CGI 
compared to the negative control region m15. The levels were similar to that at the 
transcription start site of HoxC8 and slightly higher than at the TSS of Sox2 (Figure 4.2.1-6). 
It will be interesting in the future to include a primer pair located to an enhancer region in 
the experiment in order to get information about the relative levels at the CGI in comparison 
to a region where H3K4me1 is expected to be highly enriched.  
 
 
Figure 4.2.1-6 H3K4me1 ChIP of artificial CGI in gene desert 2 
Scheme on top indicates gene desert 2 (grey bar) and the integration site of CGI-like 
construct. Black boxes indicate bacterial backbone from BAC. Black bars indicate position of 
primers used for Q-PCR (length of amplicons not drawn to scale): H3K3me1 ChIP for 3 cell 
lines. Y-axis: % of Input of H3K4me3 over % of Input of pan-H3 antibody. Controls: TSS of 
active gene Sox2, of bivalent gene HoxC8; m15= negative control region on mouse 
chromosome 15 indicating background levels. Error bars indicate standard deviation of PCR 
replicates. 
 
As it is has been shown that the transcriptional machinery is able to recruit H3K4me3 
methyltransferases to chromatin, the establishment of H3K4me3 over the artificial CGI 
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CGIs (Ruthenburg et al, 2007). The majority of CGIs co-localize with H3K4me3, RNA Pol 
II and Cfp1 as was determined by ChIP-Seq in our laboratory (Thomson et al, 2010). There 
is, however, a small percentage of CGIs (7 %) that are characterized by lack of PolII despite 
the fact that there are prominent peaks of H3K4me3 and Cfp1 present (Thomson et al, 
2010). This raised the possibility that in some cases RNA Pol II is not required and that the 
underlying CGI sequence is sufficient for the establishment of H3K4me3. This notion was 
supported by the fact that the promoter-less CGI like sequence created a novel peak of 
H3K4me3 but no RNA Pol II was detected. We were therefore interested to investigate if 
RNA Pol II is recruited to the artificial CGI. Figure 4.2.1-7 shows the ChIP results for all 
three cell lines for two independent replicate experiments. Panel A shows the ChIP results 
with an antibody that recognizes the N-terminus of the RNA polymerase and does therefore 
not distinguish between the phosphorylation states of the C-terminal domain (CTD). From 
the first experiment it became clear that no RNA Pol II was detected over the artificial CGI 
in any of the cell lines. As expected there were clear signals detected at the TSS of active 
genes such as Sox2 and GAPDH. In the 2nd experiment cell line 2 shows a signal over the 
insertion. However, when looking at the negative control region m15, this region shows a 
high signal as well, indicating that this ChIP shows higher background levels than normal 
and that the detected Pol II signal is likely to be noise rather than true enrichment. In order to 
strengthen the finding 2 additional antibodies were used that recognize the unphosphorylated 
form of the CTD and the serine 5 phosphorylated one respectively. Similarly no RNA Pol II 
signal, or only levels comparable to that of m15, was detected over the artificial CGI with 
these antibodies (see panel B and C of Figure 4.2.1-7).  
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Scheme on top indicates gene desert 2 (grey bar) and the integration site of CGI-like 
construct. Black boxes indicate bacterial backbone from BAC. Black bars donate position of 
primers used for Q-PCR (length of amplicons not drawn to scale). A: PolII-N20 ChIP, B: 
PolII- unphosphorylated, C: PolII S5P for all three cell lines in 2 biological replicates. Y-axis: 
% of Input. Controls: TSS of active genes Sox2 and GAPDH, of bivalent gene HoxC8; m15= 
negative control region on mouse chromosome 15 indicating background levels. Error bars 
indicate standard deviation of PCR replicates. 
 
Fitting with the absence of RNA Pol II, acetylated histones levels were low over the artificial 
CGI. High levels of acetylated histone 3 and 4 are usually associated with H3K4me3, gene 
promoters and high levels of gene expression. However, as with many histone modifications 
the exact role and way of establishment remain elusive. A recent study confirms the high 
correlation of H3K9/K14 acetylation in mouse ES cells with H3K4me3. Moreover, the levels 
of H3K9/K14ac directly correlate with the CpG content of the promoters attesting the 
importance of sequences underlying specific histone modifications (Karmodiya et al, 2012). 
They also provide evidence that those marks occur at bivalent promoters. Figure 4.2.1-8 
shows ChIP experiments using an antibody against H3K9/K14 acetylation. In all cell lines 
H3K9/K14 acetylation levels seemed to be similar to that of the bivalent gene HoxC8. In the 
case of the artificial CGI in gene desert it seems that high CpG density is sufficient to recruit 
HATs to low levels, maybe through interaction with H3K4me3. However, the presence of 
the transcription machinery is likely to be necessary in order to establish full levels of 
acetylated histones. In summary we conclude that an artificial CGI like sequence influences 
local chromatin structure and establishes a bivalent domain. As expected for a construct that 
lacks a proper promoter sequence no Polymerase was detected and accordingly only low 
levels of acetylation were present. 
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Figure 4.2.1-8 Low levels of H3K9/K14ac established over artificial CGI in gene desert  
Scheme on top indicates gene desert 2 (grey bar) and the integration site of CGI-like 
construct. Black boxes indicate bacterial backbone from BAC. Black bars indicate position of 
primers used for Q-PCR (length of amplicons not drawn to scale): H3K9/K14ac ChIP for 3 
cell lines in 2 biological replicates. Y-axis: % of Input of H3K4me3 over % of Input of pan-H3 
antibody. Controls: TSS of active gene Sox2, of bivalent gene HoxC8; m15= negative control 
region on mouse chromosome 15 indicating background levels. Error bars indicate standard 
deviation of PCR replicates. 
 
 
4.2.2. An artificial CGI-like sequence is enough to be protected from 
DNA methylation in mouse ES cells 
As it is unclear if CpG clusters are sufficient to stably perpetuate non-methylated CpG 
islands or if transcription is required additionally to maintain the non-methylated state, we 
analysed the methylation status of the introduced artificial CGI in gene desert 2. Figure 
4.2.2-1 shows that all three lines display only low levels of methylation. This is on one side 
surprising as some previous studies found that CpG rich clusters become methylated in 
absence of transcription. For example point mutations that prevent transcription factor 











DNA methylation (Brandeis et al, 1994; Macleod et al, 1998). When CpG rich sequences 
from the E.coli genome were inserted into the mouse gene most sequences became heavily 
methylated (Lienert et al, 2011). Also more than half of cells carrying the promoter-less 
eGFP insertion at the Mecp2 locus had acquired dense methylation in ES cells despite the 
presence of a CpG cluster (Thomson et al, 2010). On the other side there have been reports 
that histone methylation on lysine 4 interferes with Dnmt activity by inhibiting the 
interaction of Dnmt3L, a partner of Dnmt3a and 3b, with chromatin (Ooi et al, 2007). 
Additionally there is evidence that the ADD domain of Dnmt3a and 3b that binds to 
unmethylated H3 is inhibited by H3K4me3 (Zhang et al, 2010b). My data suggests that a 
high CpG frequency and high G+C content might be enough in ES cells to protect against de 
novo DNA methylation.  
 
Figure 4.2.2-1 Artificial CGI in gene desert 2 remains unmethylated in mouse ES cells 
Bisulfite sequencing of 3 cell lines containing the artificial CGI construct in gene desert 2. 
Scheme on top shows the inserted construct with the flanking gene desert arms and the 
remaining frt and LoxP sites. Scale is in bp. Blue vertical lines show position of CpGs. 
Sequenced amplicon is highlighted by yellow box. A methylated CpGs is depicted by a filled 
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4.2.3. Differentiation of mouse embryonic stem cells into neuronal 
precursors leads to loss of H3K4me3 activity and gain of 
Polycomb at artificial CGI in a gene desert 
 
As described above the artificial CGI inserted in a human gene desert created a bivalent 
chromatin state in mouse ES cells. A classic view of the characteristic of bivalent domains is 
that they keep key developmental genes in pluripotent cells poised for activation. Upon 
differentiation the repressive state can either be overcome by strong, activating stimuli or 
stay stably repressed in absence of transcriptional activation. Since the artificial CGI is 
comprised of a promoter-less CpG and G+C rich sequence in a gene desert and no 
transcriptional stimuli are expected we anticipated that repressive mechanism would take 
over. The 3 mouse ES cell lines containing the artificial CGI were differentiated into neural 
precursor cells (NPCs). Figure 4.2.3-1panel A shows the differentiation protocol used. When 
performing ChIP with antibodies against H3K4me3 from undifferentiated mouse ES cells 
and NPC it became apparent that the H3K4me3 levels were reduced in the NPCs at the CGI-
like sequence in cell lines 1 and 2 (Figure 4.2.3-1 B). This effect could not be observed for 
cell line 3. However, when one compares H3K4me3 levels of the bivalent control genes it 
becomes apparent that in cell lines 1 and 2 the levels of K4me3 are reduced or the same in 
NPCs compared to ES cells. In cell line 3, however, this effect seems to be reversed. It 
shows higher levels of K4m3 at the control genes HoxC8 and HoxA9 in NPCs cells 
compared to ES cells. Additionally the H3K4me3 levels at the CGI are more than 5 fold 
higher than at the control genes, which is not the case for cell line 1 and 2. Therefore upon 
differentiation in cell line 3 a greater reduction of H3K4me3 needs to be achieved compared 
to the other 2 cell lines. When looking at the H3K27me3 ChIP in ES cells versus NPCs 
(Figure 4.2.3-2) it seems that the H3K27me3 over the inserted CGI-like sequence remain 
high in cell line 1 and to a lesser degree in cell line 2. Again the control levels in cell line 3 
in ES cells are different, as levels at the bivalent control genes are not significantly higher 
than over the negative control region m15. In summary, there seems to be a reduction of 
H3K4me3 levels at the artificial CGI in NPCs compared to ES cells whereas H3K27me3 
levels remain high. However, these results are very preliminary as the differentiation 
experiment was only performed once with every cell line. Clearly more biological replicates 
are needed in order to draw conclusions on the fate of chromatin over an inserted 
promoterless CGI. Additionally it is necessary to check for proper differentiation by 
analysing appearance of neural specific markers and decrease of pluripotency gene 
expression. The observed mixed results could also indicate that differentiating ES cells until 
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NPCs was not enough and that further differentiation into mature neurons would be required. 
Moreover, it would be interesting to determine the DNA methylation state of the artificial 
CGI in NPCs in comparison with ES cells to ask whether the unmethylated state can be 
perpetuated in differentiated cells or if the CGI-like sequence becomes methylated in 
absence of transcription.   
 
 
Figure 4.2.3-1 Reduced levels of H3K4me3 over artificial CGI in neural precursor cells 
A: Undifferentiated mouse ES cells were cultured for 4 days without leukemia inhibitory 
factor (LIF) and then another 4 days in the presence of retinoic acid (RA), all panels show 
10x magnification. B: Scheme on top indicates gene desert 2 (grey bar) and the integration 
site of CGI-like construct. Black boxes indicate bacterial backbone from BAC. Black bars 
indicate position of primers used for Q-PCR (length of amplicons not drawn to scale): 
H3K4me3 ChIP for 3 cell lines in ES cells versus neural precursor cells. Y-axis: % of Input of 
H3K4me3 over % of Input of pan-H3 antibody. Controls: TSS of bivalent genes HoxC8 and 
HoxA9; m15= negative control region on mouse chromosome 15 indicating background 
levels. Error bars indicate standard deviation of PCR replicates 
B
Cell line 2Cell line 1 Cell line 3
4 days without LIF  + 
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Figure 4.2.3-2 H3K27me3 levels over artificial CGI remain high in neural precursor 
cells 
Scheme on top indicates gene desert 2 (grey bar) and the integration site of CGI-like 
construct. Black boxes indicate bacterial backbone from BAC. Black bars indicate position of 
primers used for Q-PCR (length of amplicons not drawn to scale): H3K27me3 ChIP for 3 cell 
lines in ES cells versus neural precursor cells. Y-axis: % of Input of H3K4me3 over % of 
Input of pan-H3 antibody. Controls: TSS of bivalent genes HoxC8 and HoxA9; m15= 
negative control region on mouse chromosome 15 indicating background levels. Error bars 
indicate standard deviation of PCR replicates.  
 
4.2.4. Cfp1 is detected at artificial CGI in gene desert 
 
We have shown that an artificial CGI-like sequence establishes H3K4me3 and H3K27me3 
histone marks. It was also shown that Suz12, a component of PRC2, is present, strengthening 
the notion that a bivalent domain is created. In case of H3K4me3, testing for the presence of 
the corresponding histone methyltransferase was not as straight forward. We attempted to 
perform a ChIP with antibodies against Cfp1. Since the signal of H3K4me3 at the CGI is 
much lower than that detected at TSS and the ChIP efficiency of the α-Cfp1-antibody is 
significantly lower than that of an α-H3K4me3 antibody we suspected that our α-Cfp1 
antibody did not provide enough sensitivity to detect this protein at the integrated CGI.  
 
As an alternative we obtained a transgenic Cfp1-GFP tagged mouse ES cell line from Francis 
Stewart’s laboratory. This line can then be used to integrate the artificial CGI within a gene 
desert and ask by performing an anti-GFP ChIP if Cfp1 is present at the inserted CGI. The 
cell line was generated by BAC transgenesis of a Cfp1-GFP BAC construct. This BAC 
contains the whole Cfp1 gene with all the regulatory elements and GFP fused to the last 









codon of Cfp1 in order to create a C-terminal GFP tag. Since the Cfp1-GFP tagged ES cells 
already contain a neomycin selection cassette it was not possible to use the previously used 
BAC construct with the artificial CGI as this construct is also based on selection with 
neomycin. In order to avoid that problem the neomycin cassette was exchanged with a 
blasticidin-containing cassette flanked by Rox sites. This cassette exchange was performed 
by amplifying the blasticidin gene with PCR primers that contained 50 bp homology arms 
corresponding to the artificial CGI and the 3’ homology arm from the original gene desert 2 
plus ArtCGI BAC. The neomycin cassette was then exchanged with this amplified 
blasticidin construct by recombineering. Successfully recombined clones were identified by 
control digest and sequencing. The Cfp1-GFP tagged cell line was then transformed with the 
BAC containing the gene desert 2 with the artificial CGI-like and the blasticidin cassette in 
it’s middle. As described before ES cell colonies were screened for the presence of the full 
length BAC. Three cell lines were expanded further and in a second targeting step the 
selection cassette was excised using a Dre recombinase that recognizes Rox sites 
(Anastassiadis et al, 2009). Southern blots were performed to identify the successful excision 
of the cassette (not shown) and all three lines were used for ChIP experiments. Initially 
ChIPs with antibodies against H3K4me3 and H3K27me3 were performed to show that the 
artificial CGI establishes a bivalent domain in those Cfp1-GFP tagged ES cells just in wt ES 
cells. Figure 4.2.4-1 shows that all three cell lines have H3K4me3 levels equal or a little higher 
than that of the TSS of the bivalent genes HoxC8 and HoxA9. As before no signal was 
detected over the flanking gene desert region. As in the wild type ES cells a clear peak of 
H3K27me3 was observed over the inserted CGI spreading into the adjacent gene desert.  
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Figure 4.2.4-1 A bivalent domain is established at artificial CGI in Cfp1-GFP tagged ES cells 
Scheme on top indicates gene desert 2 (grey bar) and the integration site of CGI-like 
construct. Black boxes indicate bacterial backbone from BAC. Black bars indicate position of 
primers used for Q-PCR (length of amplicons not drawn to scale). A: H3K4me3, B: 
H3K27me3 ChIP for 3 cell lines. Y-axis: % of Input of H3K4me3 over % of Input of pan-H3 
antibody. Controls: TSS of active genes Sox2 and GAPDH and of bivalent genes HoxC8 and 
HoxA9; m15= negative control region on mouse chromosome 15 indicating background 
levels. Error bars indicate standard deviation of PCR replicates 
 
Once it was established that a bivalent domain was formed over the artificial CGI in Cfp1-
GFP cells we wanted to know if Cfp1 is present as well. Thus a ChIP with an antibody 
against GFP was performed with three cell lines in two replicate experiments (except cell 
line 3). For these ChIPs beads already coupled to an anti-GFP antibody were used (GFP-
TRAP system, see material and methods). As can be seen in Figure 4.2.4-2 there is a clear 
enrichment of Cfp1 over the TSS of the active genes Sox2 and GAPDH in the Cfp1-GFP 
tagged cells in comparison to wt ES cells. In cell line 1 there is also clear difference in Cfp1 
levels at active genes versus bivalent genes and at the negative control region m15. Both 
differences are much less pronounced in cell lines 2 and 3. When looking at Cfp1 signal over 
the artificial CGI in the 1st X-link experiment it becomes apparent that in all three cell lines 
there is a clear enrichment in Cfp1-GFP tagged cells in contrast to wt ES cells containing the 












artificial CGI. The percentage of input that was precipitated over the island is in all lines 
similar (around 0.1%) despite the fact that the enrichment over control genes was less in cell 
line 2 and 3. A second X-link for cell line 1 and 2 shows a strong signal over the CGI that is 
not present in wt cells. The enrichment seems considerably higher than over the active 
control genes, which is surprising as it is expected that Cfp1 levels at active genes are higher 
than at bivalent regions. This was not the case for the H3K4me3 ChIPs where K4me3 levels 
were consistently higher at active genes than over the inserted CGI. It is not clear why in this 
second experiment there is a discrepancy between levels of H3K4me3 and Cfp1 in 
comparison to active genes. Despite this variation it is seems that Cfp1 is present at the 
inserted artificial CGI specifically and not at the adjacent gene desert region. This confirms 
previous results that a CpG rich sequence attracts the histone methyltransferase SET1A/B 
presumably via the CxxC domain of Cfp1 (Thomson et al, 2010). 
 
 
Figure 4.2.4-2 GFP Cfp1 is detected at artificial CGI in gene desert 2 
Scheme on top indicates gene desert 2 (grey bar) and the integration site of CGI-like 
construct. Black boxes indicate bacterial backbone from BAC. Black bars indicate position of 
primers used for Q-PCR (length of amplicons not drawn to scale). Anti GFP-ChIPs with 
beads already coupled to GFP antibody (GFP-TRAP beads) is shown  for 3 cell lines. Y-axis: 
% of Input. Controls: TSS of active genes Sox2 and GAPDH and of bivalent genes HoxC8 
and HoxA9; m15= negative control region on mouse chromosome 15 indicating background 
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4.2.5. Cfp1 is not required for the formation of H3K4me3 at CGI in gene 
desert 
In order to investigate if the formation of a bivalent domain at the inserted artificial CGI-like 
sequence is dependent on Cfp1 the artificial CGI was introduced into Cfp1 -/- mouse ES 
cells. Cfp1 null mouse ES cells were created in the laboratory of David Skalnik (Carlone & 
Skalnik, 2001). As this deletion proved to be embryonic lethal no viable Cfp1 null mice were 
obtained. It was, however, possible to acquire mouse ES cells from blastocysts (Carlone et 
al, 2005). Since those Cfp1-/- cells were already resistant to neomycin it was again necessary 
to transform them with a BAC construct containing a blasticidin selection cassette (described 
in 4.2.4). Again three independent cell lines with low copy number integration were chosen 
and after excision of the selection cassette they were analysed by ChIP. It was also 
confirmed that the Cfp1 gene was really deleted by performing PCRs across this region. 
Figure 4.2.5-1 shows the result of H3K4me3 and H3K27me3 ChIPs in all 3 cell lines. As 
previously reported H3K4me3 levels were strongly reduced at CGIs of strongly expressed 
genes (Clouaire et al, 2012). This reduction can be seen in panel A where the H3K4me3 
signal at the actively transcribed genes Sox2 and GAPDH was similar to that of the bivalent 
genes HoxC8 and HoxA9. This was not the case in wt ES cells where the H3K4me3 levels at 
active genes were much higher (for example see Figure 4.2.1-4). Concerning the H3K4me3 
levels over the ArtCGI it is obvious that an H3K4me3 domain was established at the inserted 
CGI-like sequence even in the absence of Cpf1. Again the strength of the signal was similar 
or slightly higher than that of the bivalent control genes. Also H3K27me3 is established over 
the CGI in Cfp1 deficient cells in the same manner as observed in Cfp1-wt cells. This is 
expected as the PRC2 complex writing the H3K27me3 mark should not be altered in Cfp1 
deficient cells (Figure 4.2.5-1panel B). In summary while Cfp1 may contribute to the 
formation of an H3K4me3 peak at the artificial CGI, its presence is not necessary.  
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Figure 4.2.5-1 Cfp1 is not required for H3K4me3 establishment over artificial CGI in 
gene desert 2 
Scheme on top indicates gene desert 2 (grey bar) and the integration site of CGI-like 
construct. Black boxes indicate bacterial backbone from BAC. Black bars indicate position of 
primers used for Q-PCR (length of amplicons not drawn to scale). A: H3K4me3 ChIP for 3 
cell lines. B: H3K27me3 ChIP for 3 cell lines. Y-axis: % of Input of H3K4me3 or H3K27me3 
over % of Input of pan-H3 antibody. Controls: TSS of active genes Sox2 and GAPDH and of 
bivalent genes HoxC8 and HoxA9; m15= negative control region on mouse chromosome 15 
indicating background levels. Error bars indicate standard deviation of PCR replicates 
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4.3. Discussion 
Unlike with the PuroGFP construct, 3 different cell lines were obtained containing the 
artificial CGI thanks to an improved Flp transformation protocol. Having different cell lines 
available for analysis offers the possibility to examine potential effects of different 
integration sites. All three cell lines show the same histone modification patterns, presence 
of Suz12 and absence of RNA polymerase II, suggesting that the insulator function gained 
by the human gene desert BAC is sufficient to protect against positional effects. One concern 
of adopting the strategy presented here for integrating CGI-like sequences in a gene desert 
was that integration of multiple copies might influence the results. In order to circumvent 
this issue, quantitative PCR was employed to analyse copy number integration. Ideally only 
cell lines with a single copy would have been used for this study, which proved to be 
challenging. Therefore clones with a low copy number (1, 1-2 and 4) were taken forward 
(Figure 4.2.1-2). When levels of different histone modifications or proteins over the CGI are 
compared between the different cell lines it seems that the slight differences in determined 
copy numbers do not influence the result. Cell line 3 proved to have the highest number of 
integrations but this is not reflected in higher levels of any of the analysed modifications in 
comparison with the other two cell lines. In summary we conclude that the chosen approach 
is suitable to analyse the influence of base composition on chromatin establishment.  
 
4.3.1. Is the bivalent domain observed at the artificial CGI truly 
bivalent?  
The results presented above indicate that a CpG rich sequence with an overall high G+C 
content integrated in a gene desert region is able to recruit histone-modifying enzymes to 
create a bivalent domain. This is in agreement with earlier findings that G+C rich DNA can 
recruit the Set1 complex via Cfp1 and create a novel domain of H3K4me3 (Thomson et al, 
2010) and polycomb group proteins to establish H3K27me3 (Mendenhall et al, 2010; Lynch 
et al, 2011). 
 
Although ChIP experiments are highly informative regarding the genomic localization and 
the correlation of different marks can be assessed in cell populations, they don’t provide 
information about physical co-existence of modifications on the same nucleosome. 
Therefore it cannot be ruled out that the appearance of a bivalent domain at the artificial CGI 
constitutes an average cell population where the CGI in some cells is marked by H3K4me3 
and in others by H3K27me3. Indeed, Hong and co-workers, for example, found that by 
fractionating human ES cells into different subpopulations according to cell specific 
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markers, apparent bivalent domains can be resolved into monovalent signatures (Hong et al, 
2011). Another study claims that the occurrence of bivalent domains is largely due to ES 
culture medium containing foetal bovine serum (Marks et al, 2012). They show that 
culturing ES cells in a serum free medium, the so-called 2i (inhibitors of two kinases Mek 
and GSK3) medium leads to changes in H3K27me3 deposition whereas the pattern of 
H3K4me3 is similar between the different culturing conditions. Cells treated with 2i medium 
exhibit reduced prevalence of the repressive histone modification H3K27me3 at promoters 
and higher levels at satellite regions, while the global levels stay the same. Only around 1000 
bivalent domains were detected, compared to more than 3000 in serum-cultured ES cells 
(Marks et al, 2012). In the future it would be interesting to assess if the bivalent domain 
detected at the artificial CGI is caused by culturing cells in serum containing medium.  
 
Sequential ChIP is a method that resolves the issue about cell average bias and provides 
information about the chromatin state on mononucleosomes. It relies on a first IP with, for 
example, an antibody against H3K4me3 followed by a second IP with an antibody against 
H3K27me3. In some studies sequential ChIPs were used in order to address the question of 
whether bivalent domains exist within one cell on the same nucleosome. Bivalent domains 
were demonstrated to exist in zebrafish (Vastenhouw et al, 2010) and in human (Pan et al, 
2007) and mouse embryonic stem cells (Voigt et al, 2012) but were not detected in Xenopus 
or Drosophila embryos (Akkers et al, 2009; Schuettengruber & Cavalli, 2009). However, it 
needs to be taken into account that results obtained by re-ChIP experiments might be biased 
by insufficient antibody specificity, contamination with initial antibody or 
oligonucleosomes. If oligonucleosomes are present in the material used for ChIP the 
possibility remains that the marks identified are actually present on neighbouring 
nucleosomes. It was shown that H3K4me3 and H3K27me3 cannot co-occur on the same H3 
tail (Young et al, 2009) but as each mononucleosome contains two copies of each histone it 
is conceivable that one H3 copy could be marked by K4me3 whereas the other one is marked 
by K27me3. A recent report has asked if asymmetrically modified nucleosomes occur by 
antibody based affinity purification of mononucleosomes followed by mass spectrometry 
analysis (Voigt et al, 2012). The authors found that H3K4me3 and H3K27me3 coexist in 
vivo on the same nucleosome but on opposite H3 tails. 
 
In the future it would be interesting to perform sequential ChIP analysis on the cell lines 
carrying the artificial CGI in a gene desert in order to address the question if both H3K4me3 
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and H3K27me3 marks occur at the same nucleosome or if in fact the observed bivalency is a 
result of cell population average.  
 
4.3.2. CpG islands and enhancers 
In Figure 4.2.1-6 it was shown that low levels of H3K4me1, a mark correlated with 
enhancers, were established over the artificial CGI. However, it is not clear what the 
apparent co-occurrence of H3K4me1 and H3K4me3 at the artificial CGI means. Do these 
two marks occur at the same nucleosome or is this an effect of population average and there 
are some cells that have H3K4me1 and others that show H3K4me3? Alternatively H3K4me1 
might be a transient state on the way to K4me3. 
 
Enhancers are thought to activate transcription by delivering important accessory factors to 
promoters in order to enhance either the formation of the pre-initiation complex or the 
transition from initiation to elongation (Calo & Wysocka, 2013). H3K4me1 and H3K27ac 
are the major histone modification types found adjacent to H2A.Z//H3.3 containing 
nucleosomes, which are histone variants commonly found at enhancers (Jin & Felsenfeld, 
2007). During enhancer activation H3K4me1 presence precedes nucleosome rearrangement 
and H3K27ac formation, indicating that this chromatin mark might pre-mark enhancer 
regions before they actually become fully activated. H3K4me1 might be established at 
ubiquitous genomic loci that allow recruitment of activating histone-modifying enzymes. 
This mark could then offer a window of opportunity within which enhancer activation can 
occur (Calo & Wysocka, 2013). One possible function of H3K4me1 could be to keep distal 
regulatory regions from being targeted for de novo DNA methylation. The fact that the 
artificial CGI-like sequence analysed in this study showed low levels of H3K4me1 and 
absence of methylation supports this notion.  
 
It might seem surprising that enhancers are not globally marked by H3K4me3, given the fact 
that one of the pathways to establish this mark is via interaction with the serine 5 
phosphorylated form of RNA PolII, which is enriched at most enhancers (Bonn et al, 2012). 
A recent study offered an explanation by showing that deletion of Cfp1, a member of the 
Set1 histone methyltransferase complex, results in a depletion of H3K4me3 from active CGI 
containing promoters and in the ectopic appearance of H3K4m3 at distal regulatory elements 
such as enhancers (Clouaire et al, 2012). Rescue experiments with a mutant that is deficient 
in the CpG binding domain CxxC does not prevent the aberrant accumulation of H3K4me3 
at enhancers but re-establishes H3K4me3 levels at promoters (Clouaire et al, 2012). This 
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suggests that one main function of Cfp1 is to restrict recruitment of H3K4me3 histone 
methyltransferases to CpG rich regions.  
 
Interestingly, there exists a class of enhancers that are enriched for H3K4me1, but lacking 
H3K27ac, are also marked by H3K27me3 and bound by the Polycomb complex PRC2 (Calo 
& Wysocka, 2013). These so called “poised enhancers” are located near poised or bivalent 
promoters, characterized by the simultaneous presence of H3K4me3 and H3K27me3 and 
also association with PRC2. Taken together, the fact that H3K4me1 and me3 as well as 
H3K27me3 marks were found at the artificial CGI could mean that a CpG rich / G+C rich 
sequences recruit histone-modifying enzymes by default setting the stage towards a more 
accessible chromatin waiting for further instructions by, for example, transcription factors.  
 
4.3.3. Is a high CpG density and high G+C content enough to be kept 
free of DNA methylation? 
In the present study it was shown that artificial CGI-like sequences introduced into human 
gene desert 2 did not become methylated (Figure 4.2.2-1). Despite many years of research 
the exact rules that govern DNA methylation establishment are still not known. Initially it 
has been proposed that transcription is required to prevent a DNA sequence from becoming 
methylated, as it provokes high levels of H3K4me3 methylation (Takeshima et al, 2009; 
Brandeis et al, 1994; Macleod et al, 1994). However, despite the presence of H3K4me3, no 
form of RNA PolII was detected over the inserted CGI-like sequence indicating that 
transcription is not always necessary for keeping a region methylation free.  
 
This is in accordance with a recent study by Lienert at al, where around 50 different 
sequences were inserted into a transcriptionally inert locus. These sequences autonomously 
recapitulated correct DNA methylation in absence of transcription (Lienert et al, 2011). 
However these authors argue against CpG density alone as the parameter that keeps a 
sequence methylation free, as they found that 7 out of 10 sequences from the E.coli genome 
that had an average length of 780 bp and varied in CpG density from 4.4 to 6.8 CpGs per 
100 bp, became methylated. This CpG frequency though is on the lower end of what 
normally constitutes a CGI. The 3 fragments that did not become methylated were among 
those with the higher CpG frequency, although some other fragments with the same CpG 
density did become methylated. In those cases where the fragments stayed unmethylated, the 
active chromatin mark H3K4me2 was detected suggesting that the modification state of the 
H3 tail plays a role, which is in accordance with work implicating H3K4 methylation in 
 131 
inhibiting de novo DNA methylation (Ooi et al, 2007). In agreement with this, the artificial 
CGI-like sequence tested in the present study displayed presence of H3K4me3 and absence 
of DNA methylation. They suggest that so called methylation determining regions (MDRs) 
are responsible for conferring a certain methylation pattern and the absence of these regions 
in E. coli sequences is responsible for their susceptibility to DNA methylation even though 
they contain a high CpG density (Lienert et al, 2011). Another study supports this view by 
showing that the maintenance of unmethylated states is not dependent on “CpGness” but on 
the presence of sequence specific motives (Straussman et al, 2009). Additionally, 
cooperative binding of the transcription factors Sp1, Nrf-1, and YY1 in normal monocytes 
correlates with protection from CGI methylation in leukaemia cells (Gebhard et al, 2010). It 
is likely that a combination of transcription factor binding sites, attraction of histone 
modifying enzymes via CpG density and transcription are responsible for establishing a 
specific DNA methylation pattern.  
 
4.3.4. Are other histone methyltransferases compensating for the 
absence of Cfp1? 
In comparison to yeast, which has only one H3K4 methylase, mammals carry at least six 
H3K4 methyltransferases: Set1A, Set1B, MLL1, MLL2. MLL3 and MLL4, which are all 
part of complexes that are related to the yeast Set1 complex (COMPASS) (Eissenberg & 
Shilatifard, 2010). Interestingly, deletion of any one of the MLL family members has only 
minimal effects on global H3K4me3 levels, suggesting redundancy among the MLL 
complexes (Wang et al, 2009). In contrast, deletion of WDR5, RbBP5, and Ash2L, integral 
shared core subunits that are necessary for the methylation activity of these complexes, 
greatly reduces H3K4 methylation levels (Dou et al, 2006).  
 
The finding here that a novel mark of H3K4me3 is created over the artificial CGI in absence 
of Cfp1, which is a subunit of both the Set1A and B histone methyltransferase complexes, 
suggests that there might be compensating activities present. Two candidates MLL1 and 
MLL2, H3K4me3 methyltransferases that contain CxxC domains, are expressed in mouse 
ES cells (Glaser et al, 2006; Jiang et al, 2011). Consistently, mouse ES cells are viable in the 
absence of Cfp1 but their failure to differentiate implicates a role for Cfp1 in lineage 
commitment (Carlone et al, 2005). Moreover, loss of Cfp1 in mice results in early 
embryonic lethality (Carlone & Skalnik, 2001). There have been reports that implicate MLL 
proteins in roles during early development, whereas Set1 becomes the dominant H3K4 
methyltransferase at later developmental stages (Ardehali et al, 2011; Mohan et al, 2011) 
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(Wu et al, 2008). This indicates that the contribution of CxxC proteins to chromatin 
establishment changes during differentiation. Contrary to depletion of Cfp1, which is only 
present in Set1 complexes and results in a decrease of H3K4me3 at active genes without 
affecting non-productive genes (Clouaire et al, 2012) , depletion of subunits shared by Set1 
and MLL1/2 complexes leads to a more pronounced reduction in H3K4me3 at active and 
poised genes (Ang et al, 2011; Jiang et al, 2011). The chromatin at the inserted artificial 
CGI-like sequence resembles more poised genes with respect to medium H3K4me3 levels, 
no RNA polymerase II and the presence of H3K27me3. Therefore, it is possible that 
H3K4me3 at artificial CGI insertions depends on other CxxC domain proteins, such as 
MLL1 and/or MLL2 even though Cfp1 was shown to be present at the artificial CGI. Indeed, 
very recently it was shown that MLL2 is the H3K4 methyltransferase in mammals that is 




5. High CpG frequency is sufficient to establish a 
bivalent domain in gene desert region 
5.1. Introduction 
As discussed in chapter 4 an artificial CGI-like sequence is enough to establish a novel peak 
of H3K4me3 and H3K27me3. It is less clear, however, what features exactly are responsible 
for creating those chromatin marks. Is it the frequency of CpGs, is it the G+C content, is it 
both and are the requirements different for H3K4me3 and H3K27me3? In the case of the 
establishment of H3K4me3 one hypothesis is that the high density of CpG in CGIs is crucial 
as it attracts H3K4 methyltransferases. This could be either the Set1 complex via the CxxC 
domain of Cfp1 or other CxxC domain containing methyltransferases such as MLL1 or 2. 
But is a high CpG frequency sufficient or does the overall G+C content play a role as well? 
How Polycomb proteins are recruited to their target genes has not been definitely resolved 
either. It is known that components of the PRC2 complex, which contains the enzyme 
responsible for methylating H3K27, correlate strongly with CGIs. To date though it is not 
clear how these proteins are recruited to CGIs. So far no CxxC containing proteins have been 
shown to perform this function. Also it is unclear if CpGs are indeed the responsible factor. 
A recent report showed that a GC rich sequence from E. coli is sufficient to recruit 
Polycomb proteins (Mendenhall et al, 2010). However, in this study a distinction between 
CpGs and G+C content was not made and it remains unknown what feature of CGIs attract 
Polycomb proteins.  
 
5.2. Results 
5.2.1. A high G+C content is not sufficient for creation of bivalent 
domain 
In order to answer those questions two additional CGI like sequences with perturbed base 
composition were created. One sequence has the same length of 1000bp as the average CGI 
and contains a G+C content of 64.4%, typical of CGIs. In contrast the number of CpGs is 
reduced to 10, which corresponds to an observed-over-expected CpG ratio of 0.1, a value 
typical for the bulk genome. In addition to these base composition requirements, Sp1 binding 
sites were avoided, but otherwise the sequence was designed randomly. This sequence will 
be referred to as Low CpG / High G+C (Lo/Hi) and its exact sequence can be found in the 
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appendix. Figure 5.2.1-1 shows an overview of this Low CpG / High G+C sequence in 
comparison with the base composition of the PuroGFP and the first artificial CGI described 
in the previous chapters.  
 
 
Figure 5.2.1-1 Overview of CGI like sequences used in this study 
A: Colored dots represent the different sequences used in this study. Their position depends 
on CpG frequency and G+C content. Pink box indicates parameters typically for CGIs. B: 
Table showing length and base composition of constructs. O/e = observed over expected 
CpG ratio. Note that the formula calculating the o/e ratio (Nr of CpGs /(Nr of C × Nr of G)) × 
Nr of nucleotides in the sequence) takes the overall G+C content into account. Therefore the 
High CpG/ Low G+C sequence has an unusually high o/e ratio. C: Different constructs are 
blotted depending on % of G+C, CpGs per 100 bp or CpGs observed over expected. X-axis 
length in bps of CGI like construct flanked either side by 1 kb gene desert. 
 
The Low CpG / High G+C sequence was introduced into gene desert 2 as described in 
Chapter 4. ES cells were transfected with the construct and screened for low copy number 
integration (Figure 5.2.1-2). The three cell lines marked with a red box showed a copy 
number of around one and were therefore chosen for further use. The selection cassette was 
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excised using Flp and positive clones for each cell line were identified by PCR and Southern 
blot, expanded and analysed by ChIP. 
 
 
Figure 5.2.1-2 Copy number analysis of Low CpG / High G+C sequence in gene desert 
Mouse ES cell clones with integrated Low CpG / High G+C construct were analysed by Q-
PCR for copy number integration. 3 and 10 respectively refers to the primer pair used in the 
PCR. Values normalized to that of Sox2 = 2 copies per cell. Red boxes indicate chosen cell 
lines. Error bars indicate standard deviation of PCR triplicates. Scheme above indicates 
construct inserted in gene desert 2 and position of primers (not drawn to scale).  
 
Figure 5.2.1-3 shows 2 independent biological replicates of ChIP with anti H3K4me3 
antibodies in all three cell lines. Strikingly, the H3K4me3 signal was absent completely over 
the inserted Lo/Hi sequence for cell lines 1 and 2 with the signal remaining high as expected 
over the active positive control genes GAPDH and Sox2. This result suggests that in order to 
create a novel H3K4me3 mark a high frequency of CpGs is necessary and that an overall 
high G+C content is not sufficient for establishment of this mark, strengthening the notion 
that CpGs are important for attracting histone-modifying enzymes via their CxxC domain. 
However, in cell line 3, there is a low but significant amount of H3K4me3 detected over the 
Lo/Hi insertion.  
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Figure 5.2.1-3  Is a high G+C content sufficient to esablish a novel H3K4me3 peak over 
the Low CpG / High G+C construct in gene desert 2? 
H3K3me3 ChIP, 2 independent X-links for 3 cell lines. Scheme on top indicates gene desert 
2 (grey bar) and the integration site of CGI-like construct. Black boxes indicate bacterial 
backbone from BAC. Black bars indicate position of primers used for Q-PCR (length of 
amplicons not drawn to scale). Y-axis: % of Input of H3K4me3 over % of Input of pan-H3 
antibody. Controls: TSS of active genes Sox2 and GAPDH, of bivalent gene HoxC8; m15= 
negative control region on mouse chromosome 15, indicates background levels. Error bars 
indicate standard deviation of PCR replicates.  
  
 
A possible explanation for the presence of H3K4me3 observed in the third cell line would be 
failed excision of the selection cassette. If the neomycin indeed was not excised properly this 
could mean that the neomycin gene adjacent to the inserted Lo/Hi sequence is still present. 
As this gene was active during the selection process it is expected that high levels of 
H3K4me3 mark the promoter region of neomycin, which could influence the chromatin state 
of the adjacent Lo/Hi sequence. In order to test this hypothesis, the third cell line (Cell line 3 
clone E10) was reanalysed and as can be seen in Figure 5.2.1-4 the selection cassette was 
indeed not excised completely. In contrast other clones from this cell line 3, E12 and G9 
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(same integration of BAC but different clone after transfection with Flp) did not show any 
traces of the cassette. When a ChIP was performed with clone E12 it became apparent that 
indeed our hypothesis was correct as the H3K4me3 signal was totally abolished over the 
integrated Lo/Hi sequence. This result confirms that it is essential to go through the process 
of excising the selection cassette. The presence of an active gene nearby can influence the 
establishment of chromatin at the inserted sequences, which would impede the interpretation 
of sequence influence on chromatin. In summary it can be concluded that a sequence with 
low frequency of CpGs but high G+C content is not sufficient of H3K4me3 establishment, 
emphasizing the importance of the CpG dinucleotide.   
 
 
Figure 5.2.1-4 Presence of the selection cassettes disturbs analysis of Low CpG / High 
G+C influence on chromatin establishment 
A: PCR screen to check for absence of selection cassette in different clones of cell line 3 
after Flp transfection. Red box shows band that indicates incomplete excision of neo 
cassette. B: H3K4me3 and H3K27me3 ChIP of cell line 3 clone E12. Error bars indicate 
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After showing that a high G+C content is not sufficient to create an H3K4me3 mark over the 
inserted region we wanted to know if it is adequate to recruit Polycomb proteins and 
establish the H3K27me3 mark. Figure 5.2.1-5 depicts the H3K27me3 and Suz12 ChIPs in all 
three cell lines. It is apparent that the introduced Lo/Hi sequence does not recruit Polycomb 
proteins, seen by the absence of Suz12 and H3K27me3 with levels in the region of those 
found in the negative control region m15. The bivalent control gene HoxC8 shows as 
expected a good signal of both, H3K27me3 and Suz12 indicating the reliability of the ChIP 
experiment. This finding demonstrates that CpGs are not only essential for the recruitment of 
a H3K4 methyltransferase that mediates the establishment of H3K4me3 but also for the 
recruitment of Suz12. Interestingly, cell line 3, which was the only one showing an 
H3K4me3 peak, did not display an H3K27me3 signal as expected if its is due to the presence 
of the active neomycin gene as shown above (Figure 5.2.1-4).  
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Figure 5.2.1-5 A high G+C content is not succificient to recruit Polycomb to Low CpG / 
High G+C construct in gene desert 2 
A: H3K427me3 ChIP, 2 independent X-links for 3 cell lines. Y-axis: % of Input of H3K4me3 
over % of Input of pan-H3 antibody and B: Suz12 ChIP, 1 X-link for 3 cell lines. Y-axis: % 
input. Scheme on top indicates gene desert 2 (grey bar) and the integration site of CGI-like 
construct. Black boxes indicate bacterial backbone from BAC. Black bars indicate position of 
primers used for Q-PCR (length of amplicons not drawn to scale). Controls: TSS of active 
genes Sox2 and GAPDH, of bivalent gene HoxC8; m15= negative control region on mouse 



















5.2.2. High CpG frequency is not enough to protect a sequence from 
DNA methylation in mouse embryonic stem cells 
Having shown that CpGs are important for the establishment of a bivalent domain we 
wanted to know if an overall high G+C content plays a role in attracting histone-modifying 
proteins as well. Therefore a sequence was designed that contains a high number of CpGs, 
similar to that conventionally found in CGIs but with a G+C content of 40,3%, which is 
comparable to that of the bulk genome, and much lower than the ~65% found in CGIs. 
Figure 5.2.1-1 shows the base composition of this High CpG / Low GC (also referred to as 
Hi/Lo) sequence in comparison to other sequences used in this study. The exact sequence 
can be found in the appendix. As before three independent ES cell lines that have integrated 
the Hi/Lo sequence in gene desert 2 were established. Figure 5.2.2-1 displays the number of 
integrations of the different BAC clones and indicated the 3 cell lines that were taken further 
in order to excise the selection cassette.  
 
 
Figure 5.2.2-1 Copy number analysis of High CpG / Low G+C sequence in gene desert  
Mouse ES cell clones with integrated High CpG / Low G+C construct were analysed by Q-
PCR for copy number integration. 3 and 10 respectively refers to the primer pair used in the 
PCR. Values were normalized to that of Sox2 = 2 copies per cell. Red boxes indicate chosen 
cell lines. Error bars indicate standard deviation of PCR triplicates. Scheme above indicates 
construct inserted in gene desert 2 and position of primers (not drawn to scale). 
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Once the excision of the selection cassette was confirmed by Southern blot the clones were 
expanded and a ChIP with anti H3K4me3 antibodies was performed (Figure 5.2.2-2). 
Unexpectedly, no signal of H3K4me3 was detected over the inserted Hi/Lo sequence, 
despite the presence of a high density of CpGs. This result was confirmed in two 
independent biological replicate experiments for all three cell lines. The control genes 
showed the expected pattern of strong enrichment over the active genes GAPDH and Sox2, 
slight enrichments over the bivalent gene HoxC8 and no enrichment over the negative 
control region m15. This result indicates that a high density of CpGs is not sufficient to 
recruit a H3K4 methyltransferase and establish H3K4me3 and that the A+T rich 
environment is for some reasons detrimental to its recruitment.  
 
Figure 5.2.2-2 A high CpG density in an A+T rich background is insufficient to 
establish an H3K4me3 domain 
H3K3me3 ChIP, 2 independent X-links for 3 cell lines. Scheme on top indicates gene desert 
2 (grey bar) and the integration site of CGI-like construct. Black boxes indicate bacterial 
backbone from BAC. Black bars denote position of primers used for Q-PCR (length of 
amplicons not drawn to scale). Y-axis: % of Input of H3K4me3 over % of Input of pan-H3 
antibody. Controls: TSS of active genes Sox2 and GAPDH, of bivalent gene HoxC8; m15= 
negative control region on mouse chromosome 15, indicates background levels. Error bars 
indicate standard deviation of PCR replicates.  
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Next, I wanted to examine the effect of high CpG density but low overall G+C content on 
the recruitment of Polycomb as it is conceivable that a different mechanism is responsible 
for attracting the PRC2 complex. Figure 5.2.2-3 shows the result of the H3K27me3 and 
Suz12 ChIPs. Again, the signal over the inserted sequence shows no enrichment relative to 
flanking gene desert regions. Especially when looking at the Suz12 ChIP it seems that there 
is no enrichment over the inserted Hi/Lo sequence in comparison with the negative control 
region m15. In summary, we conclude that a high density of CpGs in an A+T rich 
environment is not sufficient to establish either of the characteristic histone marks of a 
bivalent domain.  
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Figure 5.2.2-3 A high GpG content in an AT rich background is not sufficient to recruit 
Polycomb  
A: H3K427me3 ChIP, 2 independent X-links for 3 cell lines. Y-axis: % of Input of H3K4me3 
over % of Input of pan-H3 antibody. B: Suz12 ChIP, 1 X-link for 2cell lines. Y-axis: % input. 
Scheme on top indicates gene desert 2 (grey bar) and the integration site of CGI-like 
construct. Black boxes indicate bacterial backbone from BAC. Black bars indicate position of 
primers used for Q-PCR (length of amplicons not drawn to scale). Controls: TSS of active 
genes Sox2 and GAPDH, of bivalent gene HoxC8; m15= negative control region on mouse 
chromosome 15, indicates background levels. Error bars indicate standard deviation of PCR 
replicates.  
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5.2.3. DNA methylation masks the effect of high CpG frequency in an 
A+T rich background on establishment of bivalent domain 
We decided to investigate why the CpG rich but G+C poor sequence was not able to 
establish a bivalent domain. One hypothesis is that the CpGs in this combination become 
methylated. This theory was tested by bisulfite sequencing of an amplicon that spans around 
¼ of the High CpG / Low G+C construct. Indeed Figure 5.2.3-1 shows that in all three cell 
lines this sequence becomes heavily methylated unlike the other artificial CGI like sequence 
that stayed almost completely unmethylated (Figure 4.2.2-1).  
 
 
Figure 5.2.3-1 Construct with a high CpG density in an A+T rich environment becomes 
heavily methylated 
Bisulfite sequencing of 3 cell lines containing the High CpG / Low G+C construct in gene 
desert 2. Scheme on top shows the inserted construct with the flanking gene desert arms 
and the remaining frt and LoxP sites. Scale is in bp. Blue vertical lines show position of 
CpGs. Sequenced amplicon is highlighted by yellow box. A methylated CpGs is depicted by 
a filled black circle, an unmethylated CpG by an empty white circle.  
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5.2.4. Masking effects of DNA methylation can be overcome using 
DNMT3a/3b double knock out mouse ES cells 
In the previous section it was shown that a possible reason why a sequence with many CpGs 
but a low G+C content (High CpG / Low G+C) does not attract histone-modifying enzymes 
could be that they become heavily methylated. However, it is not clear if the High CpG / 
Low C+G sequence is intrinsically unable to form an H3K4m3 peak and therefore is getting 
methylated, as unmodified nucleosomes are good substrates for DNMTs. Or does this 
sequence become de novo methylated and therefore recruitment of histone modifying 
complexes is impeded, which results in the absence of H3K4me3? To test this question we 
analysed the Hi/Lo sequence in a system with reduced DNMT activity, which offers the 
possibility to investigate the effect of the Hi/Lo sequence on chromatin establishment 
without the masking effect of DNA methylation. This can be either achieved by knocking 
down the enzymes responsible for DNA methylation in the ES cell lines that have already 
integrated the sequence or treating them with a general demethylating agent. Alternatively, 
Dnmt knock out cells could be used for transformation with the BAC containing the Hi/Lo 
sequence. Treating cells with a demethylating agent such as 5-azacytidine has severe side 
effects as this agent has also DNA damaging effects. Moreover the demethylation achieved 
with this agent is usually incomplete (Yang et al, 2006; Palii et al, 2008). Knocking down 
the Dnmts by small interfering RNA (siRNA) would be another possibility. This would have 
the advantage that the existing cell lines with the integrated Hi/Lo sequence could be used 
for the siRNA knockdown. Therefore, no additional cell lines would need to be created, 
which is a time consuming process. However, at least the two de novo Dnmts 3a and 3b 
would need to be targeted and it is uncertain if residual activity would still methylate the 
inserted Hi/Lo sequence. Therefore, it was decided to use Dnmt3a/3b double knock out ES 
cells as it has been shown that they have almost no DNA methylation (Okano et al, 1999). 
Using Dnmt1 and Dnmt3a/3b triple knock out ES cells would have been possible (Tsumura 
et al, 2006). However, these cells are already resistant to neomycin, puromycin, hygromycin 
and blasticidin, making further manipulation challenging. It has been shown that in the 
Dnmt3a/3b double knock out ES cells (DKO) the presence of the maintenance DNA 
methyltransferase Dnmt1 cannot ensure proper levels of DNA methylation in absence of the 
de novo Dnmts, that are usually highly expressed in ES cells (Okano et al, 1998b). 
Moreover, using the DKOs, which are resistant to neomycin, puromycin and hygromycin, 
allows the use of blasticidin for the introduction of CGI like sequences.  
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In order to establish if the DKOs are a suitable system to study the effect of the Hi/Lo 
sequence on chromatin establishment it was necessary to confirm that these cells display a 
low DNA methylation level. Figure 5.2.4-1 shows that while wt ES cells are heavily 
methylated (97.5 %), Intracisternal A-particle (IAP) transposable elements in DKOs are 
widely unmethylated (16 %) despite the fact that those elements are among the most highly 
methylated elements that are even resistant to the global demethylation wave during early 
embryonic development (Seisenberger et al, 2012).  
 
 
Figure 5.2.4-1 IAP elements are widely unmethylated in Dnmt3a/3b KO ES cells 
Primers for bisulphite analysis are located in the 5’LTR of the IAP genome in order to amplify 
a 258-bp fragment containing up to 11 CpG dinucleotides spanning the IAP promoter 
(sequences obtained from (Lane et al, 2003)). A methylated CpGs is depicted by a filled 
black circle, an unmethylated CpG by an empty white circle. 
 
Having shown that DNA methylation is strongly reduced at IAP elements we were confident 
that DKO ES cells could be used in order to answer the question of whether a High CpG / 
Low G+C sequence is able to attract histone modifying enzymes that establish H3K4me3 
and/or H3K27me3. As can be seen in Figure 5.2.4-2 DKO ES cells seem grossly normal and 
comparable to the morphology of wt ES cells, although they show a little reduction in their 
growth rate and tend to grow more in patches.  
97.5 % methylated 16 % methylated 
Dnmt3a/3b - /- mES cells  wt mES cells  





Figure 5.2.4-2 Dnmt3a/3b double knock out ES cells display similar morphology as wt 
ES cell 
Representative pictures of wt versus Dnmt3a/3b KO ES cells cultured in ES medium 
containing 15 % FBS. 10 X magnification 
 
As a first step we wanted to ask whether an artificial CGI-like sequence with high CpG 
frequency and a high G+C content can create a novel bivalent domain in a gene desert 
introduced into Dnmt3a/3b knock out cells. This control is designed to demonstrate that the 
observed creation of a bivalent domain of an artificial CGI-like sequence is not specific for 
wt ES cells but also occurs in the DKOs. Since the ArtCGI was already cloned into a vector 
containing a blasticidin resistance gene for the creation of the Cfp1-/- + ArtCGI and Cfp1-
GFP + ArtCGI cell lines no new vector needed to be constructed. As described above DKOs 
were transfected with a gene desert containing BAC, where the ArtCGI and a blasticidin 
cassette were integrated via recombineering. Low Copy number integrations were selected 
and the clones expanded for transfection with DRE to excise the selection cassette. Clones 
were screened by PCR and Southern blot for the excision of the blasticidin cassette Positive 
clones were expanded and used for ChIP analysis with antibodies against H3K4me3 and 
H3K27me3.  
 
Wt ES cells Dnmt3a/3b -/- ES cells
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Figure 5.2.4-3 Copy number analysis of ArtCGI in gene desert in DKOs 
Mouse ES cell clones with integrated ArtCGI construct were analysed by Q-PCR for copy 
number integration. 3, 7 and 10 respectively refers to the primer pair used in the PCR. 
Values were normalized to that of Sox2 = 2 copies per cell. Red boxes indicate chosen cell 
lines. Error bars indicate standard deviation of PCR triplicates. Scheme above indicates 
construct inserted in gene desert 2 and position of primers (not drawn to scale).  
 
Figure 5.2.4-4 shows that the artificial CGI-like sequence integrated in a gene desert and 
randomly transfected into Dnmt3a/3b KO cells established a bivalent domain de novo. When 
the H3K4me3 signal over the ArtCGI is compared to the levels at the control genes, it 
becomes clear that it is a bit higher than over the bivalent genes HoxC8. Cell line 2 seems to 
have a stronger signal of H3K4me3 and H3K27me3 over the CGI in comparison to the 
bivalent control genes than cell line 1. But overall the chromatin established over the 
integrated CGI seems to resemble that of bivalent control genes.  
 
In order to analyse the High CpG / Low G+C sequence it was necessary to perform a 
cassette exchange recombineering step that aimed to excise the neomycin gene and replace it 
with a blasticidin gene flanked by Rox sites, since the DKOs are already resistant to many 
antibiotics. As this cassette exchange proved to be straight forward for the ArtCGI construct 
(see 4.2.4) the same was expected for the Hi/Lo construct. However, despite many attempts 
no positive colonies that had undergone successful recombineering were obtained. It is 
possible that this additional recombineering step in an already 57kb big construct led to 
different rearrangements via non-homologous recombination. Despite the fact that care was 
taken to avoid gene desert regions with high amount of repetitive sequences for 
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recombineering this could not be excluded absolutely and might be one of the reasons why 
no positive clones were obtained.  
 
Figure 5.2.4-4 An artificial CGI-like sequence forms a bivalent domain in Dnmt3a/3b 
KO cells 
Scheme on top indicates gene desert 2 (grey bar) and the integration site of CGI-like 
construct. Black boxes indicate bacterial backbone from BAC. Black bars indicate position of 
primers used for Q-PCR (length of amplicons not drawn to scale). A: H3K4me3 ChIP; B: 
H3K27me3 ChIP for 2 cell lines. Y-axis: % of Input of H3K4me3 or H3K27me3 over % of 
Input of pan-H3 antibody. Controls: TSS of active genes Sox2 and GAPDH and of bivalent 
genes HoxC8 and HoxA9; m15= negative control region on mouse chromosome 15 
indicating background levels. Error bars indicate standard deviation of PCR replicates 
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As an alternative approach it was decided to create a new construct for BAC recombineering 
that contains the Hi/Lo sequence together with homology arms for the gene desert and the 
blasticidin resistance cassette. This construct can then be used to introduce into an 
unmodified gene desert 2 containing BAC. It was hoped that by using a fresh BAC the 
recombineering efficiency would rise. Unfortunately, despite optimizing different parameters 
like antibiotic concentration or method of amplifying constructs no positive clones were 
obtained. Ultimately a different strategy was adopted that involved co-transfection of DKO 
ES cells with a linearized gene desert 2 BAC and the Hi/Lo sequence only together with a 
plasmid containing the blasticidin selection cassette. It was assumed that those cells that 
would take up the plasmid carrying the resistance gene and therefore survive the drug 
selection would also take up the BAC with the Hi/Lo sequence. We hoped that by screening 
enough colonies these clones could be identified and used for analysing the effect of a High 
CpG low G+C sequence on establishment of chromatin without the influence of DNA 
methylation.  
 
Although some colonies were obtained that were resistant to blasticidin they were much 
fewer in number than those obtained during other transformation experiments. The colonies 
were also smaller and less likely to survive picking. In the end around 70 colonies were 
available for screening and among them 1 colony was found to have integrated the BAC 
with the Hi/Lo sequence. As there was no selection cassette present within the BAC 
construct it was not necessary to excise the cassette and this one clone could be expanded 
and analysed directly. First a bisulfite sequencing experiment was performed to establish the 
methylation status of the High CpG / Low G+C sequence. Consistent with the fact that the 
two de novo Dnmts have been knocked out and even IAP elements proved to be largely 
unmethylated in these cells the Hi/Lo construct was found to be almost completely 
unmethylated, 0.05% methylation in DKOs versus around 80-90 % in wt ES cells (see 




Figure 5.2.4-5 Construct with a high CpG density in an A+T rich environment stays 
unmethylated in Dnmt3a/3b KO cells 
Bisulfite sequencing of the clone containing the High CpG / Low G+C construct in gene 
desert 2 in Dnmt3a/3b KO cells. Scheme on top shows the inserted construct with the 
flanking gene desert arms and the remaining frt and LoxP sites. Scale is in bp. Blue vertical 
lines show position of CpGs. Sequenced amplicon is highlighted by yellow box. A methylated 
CpGs is depicted by a filled black circle, an unmethylated CpG by an empty white circle.  
 
 
Without the masking effects of DNA methylation it should now be possible to analyse the 
potential of the Hi/Lo sequence to establish a permissive or bivalent chromatin environment. 
Three independent X-link experiments were performed with the DKO + Hi/Lo cell line. 
Figure 5.2.4-6 shows the result of the ChIPs with H3K4me3 and H3K27me3 antibodies. The 
first ChIP experiment showed that the CpG rich sequence formed a novel peak of H3K4me3 
over the integrated sequence that was not present at the adjacent gene desert to levels 
between the two bivalent control genes HoxC8 and HoxA9. Also a H3K27me3 signal was 
clearly detected over the CpG rich sequence that spread into the adjacent gene desert just as 
seen for the artificial CGI (see for example Figure 4.2.1-5). However, when after this initial 
result the experiment was repeated in parallel for X-link 2 and 3 no clear peak of H3K4me3 
could be detected at the High CpG / Low G+C construct. In contrast H3K27me3 was still 
present, similarly to X-link 1. It is not clear why there is this discrepancy between the 
H3K4me3 ChIP of X-link 1 and 2/3. It is conceivable that during the few (around 3) 
additional passages of the cells that occurred between X-link 1 and X-link 2/3 some residual 
DNA methylation was acquired that is detrimental to the recruitment of Cfp1 but that did not 
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influence the establishment of H3K27me3. Repetition of the ChIPs additionally to bisulfite 
analysis of the later passage clone would be necessary to unequivocally conclude if high 
CpG density is enough to recruit Cfp1 and establish a novel domain of H3K4me3. Moreover, 
it would be important to obtain additional cell lines to confirm the results.  
 
 
Figure 5.2.4-6 A bivalent domain is established over the High CpG / Low G+C 
sequence in Dnmt3a/3b KO ES cells 
Scheme on top indicates gene desert 2 (grey bar) and the integration site of the High CpG / 
Low G+C construct. Black boxes indicate bacterial backbone from BAC. Black bars denote 
position of primers used for Q-PCR (length of amplicons not drawn to scale). A: H3K4me3 
ChIP; B: H3K27me3 ChIP in 3 X-link experiments. Y-axis: % of Input of H3K4me3 or 
H3K27me3 over % of Input of pan-H3 antibody. Controls: TSS of active genes Sox2 and 
GAPDH and of bivalent genes HoxC8 and HoxA9; m15= negative control region on mouse 
chromosome 15 indicating background levels. Error bars indicate standard deviation of PCR 
replicates 
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In this chapter it was shown that a sequence containing a low number of CpGs (like in the 
bulk genome) in a high GC rich environment is neither sufficient for H3K4me3 nor for 
H3K27me3 establishment. This result shows that a high density of CpGs is needed not only 
needed to attract Set1 but also for Polycomb recruitment. When looking at a sequence with 
the reverse base composition (high CpG density in an AT rich background) it was found that 
neither mark was created due to de novo DNA methylation of the inserted sequence. The 
finding that an overall high GC content is needed to protect a DNA sequence from becoming 
methylated is somewhat surprising as the sequence studied here contains a similar number of 
CpGs as found in most CGIs that stay constitutively unmethylated.  
 
5.3.1. Why does a CpG rich sequence in a G+C poor (A+T rich) 
background become DNA methylated? 
One possibility is that this sequence might resemble repetitive elements and might be 
targeted for de novo methylation as a genome defence mechanism. Indeed for example the 
consensus sequence for a full-length pericentric major satellite repeat (taken from (Bulut-
Karslioglu et al, 2012)) contains a G+C content of 38%, which is very similar to that found 
on average in bulk genomic DNA outside CpG islands. However, the observed over 
expected CpG density of 0.88 in the major satellite repeat is much higher than that usual for 
the bulk genome (below 0.6) and resembles more the CpG density of a CGI, albeit a weak 
one. Both the artificial and the puroGFP tested in this study had an observed over expected 
CpG value of 1 and a G+C content of between 66 and 69%. In contrast, the High CpG / Low 
G+C sequence contained the roughly the same number of CpGs per 100bp but showed a 
G+C content of only 40%, which is similar to that found in the major satellite repeat. In vivo 
pericentromeric repeats are heavily methylated and failure to do so is linked to genomic 
instability (Ehrlich, 2003), offering an explanation for the observed de novo methylation of 
the Hi/Lo sequence. 
 
How are DNMT3A and/or DNMT3B recruited to the inserted High CpG / Low G+C 
sequence? It has been reported that Suv39h-mediated H3K9 trimethylation can recruit 
Dnmt3b to major satellite repeats present in pericentric heterochromatin (Lehnertz et al, 
2003). In addition G9a, a histone methyltransferase, has been implicated in recruiting 
DNMT3A and 3B independently of its methyltransferase activity, as a point mutation in the 
SET domain of G9a did impede heterochromatin formation but not de novo methylation 
(Epsztejn-Litman et al, 2008). It seems that the ankyrin domain of G9a physically interacts 
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with the catalytic domain of DNMT3A and 3B. SETDB1 another H3K9 methyltransferase 
was shown to interact with DNMT3A and 3B but not with DNMT1 (Li et al, 2006). The 
histone modification H3K9me3 is bound by proteins such as heterochromatin proteins 1 
(HP1) thus forming a heterochromatic structure. It has been reported that HP1 directly 
interacts with DNMT1 resulting in increased DNA methylation (Smallwood et al, 2007). A 
recent study describes how a subset of all major H3K9 methyltransferases coexist in large 
multimeric complexes and how they are recruited to major satellite repeats (Fritsch et al, 
2010). Given the resemblance of the High CpG / Low G+C sequence to major satellite repeat 
it is conceivable that the High CpG / Low G+C sequence attracts histone-modifying 
enzymes that either through mediation of H3K9 methylation or through direct interactions 
recruit DNMTs. Therefore it would be interesting to analyse if H3K9me3 is established over 
the Hi/Lo sequence or if the histone methylases Suv39 or G9a can be detected at that region.   
 
5.3.2. Why are H3K4me3 and H3K27me3 establishment inhibited by 
DNA methylation? 
In this chapter it was shown that a sequence with a high CpG frequency but low G+C 
content becomes heavily methylated (see Figure 5.2.3-1). The observed DNA methylation is 
the reason why neither H3K4me3 nor H3K27me3 were detected over the inserted sequence 
despite the presence of a high density of CpGs. This was determined by Dnmt3a/3b KO 
cells, which proved to be permissive for the creation of H3K4me3 and H3K27me3 (see 
Figure 5.2.4-6). So why is DNA methylation detrimental to the establishment of a bivalent 
domain? That DNA methylation and H3K3me3 establishment could be mutually exclusive is 
maybe not so surprising considering the fact that DNA methylation is regarded as a 
repressive mark, whereas H3K4me3 is considered to be an activating chromatin mark. In the 
case of H3K27me3 the situation is not as clear, as both systems, Polycomb and DNA 
methylation, are part of a cells silencing mechanism.  
 
It has been suggested that DNA methylation inhibits H3K4me3 by using Dnmt1 -/- 
fibroblasts, which showed only very low levels of DNA methylation. For many genes in 
these cells lack of DNA methylation was sufficient to partially establish novel H3K4me3 
peaks at loci previously devoid of H3K4me3 (Lande-Diner et al, 2007). Another study 
suggested that H3K4 and DNA methylation are largely antagonistic during spermatogenesis 
(Brykczynska et al, 2010). This notion confirms findings in somatic cells. For example, 
Mohn and colleagues showed that those promoters that gained DNA methylation during 
differentiation from ES cells into neurons lost H3K4 methylation (Mohn et al, 2008). The 
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incompatibility between DNA methylation and H3K4me3 at CGIs has also been predicted 
based on studies in human primary cells (Weber et al, 2007). Also, DNA methylation and 
the presence of the H3K4me3 mark were found to be mutually exclusive in ES cells 
(Isagawa et al, 2011). The above-mentioned studies correlate DNA methylation with the lack 
of H3K4me3. However, the exact mechanism of how DNA methylation influences H3K4 
methyltransferases is less clear. It is likely that methylated CpGs interfere with the 
recruitment of H3K4 methyltransferases, presumably through the abrogation of CxxC 
domain binding. As discussed in Chapter 1.2.5 and 1.3.2, the H3K4 methyltransferases 
MLL1 and MLL2 possess a CxxC domain that enables specific binding to unmethylated 
CpGs. Also SET1A and SET1B associate with a CxxC domain containing protein, Cfp1 
(Long et al, 2013). Alternatively, methylated CpG moieties could attract histone lysine 
demethylases, which could contribute to the observed absence of H3K4me3 at methylated 
loci (Lande-Diner et al, 2007).  
 
There have been numerous studies analysing the compatibility between Polycomb and DNA 
methylation. Several reports have shown antagonism or mutual exclusiveness between 
H3K27me3 and DNA methylation (Kondo et al, 2008; Lindroth et al, 2008; Bartke et al, 
2010; Wu et al, 2010b). In one study prostate cancer cells were compared to normal prostate 
cells using ChIP-microarrays and around 5% of promoters were identified that gained 
H3K27me3 in cancer cells (Kondo et al, 2008). The authors found that genes enriched with 
H3K27me3 had no detectable DNA hypermethylation, and most genes showing DNA 
hypermethylation had no enrichment for H3K27me3 (Kondo et al, 2008).  
 
However, some groups have reported that genes marked by PcG in embryonic stem cells are 
more susceptible to DNA methylation in cancer (Schlesinger et al, 2006; Ohm et al, 2007). It 
remains unclear whether this is an indirect effect due to for example low occupancy by 
transcription factors, or a direct consequence of PcG proteins recruiting DNA 
methyltransferases, as suggested by a previous report (Viré et al, 2006). Conversly, other 
studies were unable to confirm an effect of EZH2 on DNA methylation as knock down of 
EZH2 had no effect on silencing by DNA methylation (Kondo et al, 2008). During normal 
differentiation of ES cells to neural precursors it was shown that many gene sequences 
undergo de novo DNA methylation, and a large portion of these are initially marked by the 
Polycomb complex (Mohn et al, 2008; Meissner et al, 2008). 
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Another evidence for the antagonism between Polycomb and DNA methylation came from a 
study that analysed the imprinted Rasgrf1 locus, which shows DNA methylation on the 
paternal allele and histone H3 lysine 27 trimethylation on the maternal allele at a 
differentially methylated domain (Lindroth et al, 2008). In this study it was shown that these 
two methylation marks are mutually antagonizing, whereby one blocks the placement of the 
other. Manipulations that cause aberrant changes in the levels of one of these marks had the 
opposite effect on the other mark (Lindroth et al, 2008). 
 
A recent study used nucleosomes methylated on DNA and on histone H3 to identify 
crosstalk between these two distinct classes of modification by SILAC nucleosome affinity 
purification (SNAP) (Bartke et al, 2010). The authors found that the PRC2 complex, which 
recognizes H3K27 methylation, is negatively regulated by DNA methylation. They suggest 
that this may enable PRC2 to associate preferentially with a specific chromatin state that is 
not silenced completely and can respond to external stimuli, such as poised genes (Bartke et 
al, 2010). One report proposed that DNMT3A dependent non-promoter DNA methylation 
promotes expression of neurogenic genes in postnatal neural stem cells by functionally 
antagonizing Polycomb repression (Wu et al, 2010b). The author show that it is not the 
DNMT3A binding but the DNA methylation activity of this enzyme that antagonizes 
Polycomb binding (Wu et al, 2010b).  
 
A very recent work presented sequential ChIP- bisulfite-sequencing (ChIP-BS-seq) as an 
approach to quantitatively assess DNA methylation patterns associated with chromatin 
modifications or chromatin-associated factors directly (Brinkman et al, 2012). Brinkman and 
colleagues found that H3K27me3 and DNA methylation are compatible throughout most of 
the genome, except for CpG islands, where these two marks are mutually exclusive 
(Brinkman et al, 2012). Upon loss of DNA methylation in DNMT1 and 3A/3B triple knock 
out (TKO) cells, accumulation of H3K27me3 in broad local enrichments and a decrease of 
sharp localized H3K27me3 peaks were observed suggesting that DNA methylation prevents 
H3K27me3 deposition locally and at a megabase scale (Brinkman et al, 2012). 
 
From all these studies it seems that loci that show dense DNA methylation are incompatible 
with H3K27me3 whereas loci that are marked by H3K27me3 can preferentially gain DNA 
methylation in certain circumstances. How the observed mutual exclusiveness of DNA 
methylation and H3K27me3 within regions of high CpG density is achieved mechanistically 
is not yet clear. It is possible that, as with the recruitment of H3K4 methyltransferases, 
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methylated CpGs inhibit the recruitment of polycomb proteins. Direct evidence for this idea 
came from the fact that recognition of CpGs via the CxxC domain of KDM2B, a subunit of 
PRC1, is abrogated by DNA methylation (Farcas et al, 2012). As it has not been shown 
formally how PRC2 is recruited to its target genes the exact mechanism of how DNA 
methylation inhibits PRC2 is not known. However, the fact that PRC2 occupancy and 
unmethylated CGIs is highly correlated (Ku et al, 2008) makes it likely that unmethylated 
CpGs play a role in the recruitment of PRC2. 
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6. Discussion 
6.1.1. A high CpG frequency in CGIs is required for establishment of 
bivalent domains 
In this study it was shown that H3K4me3 and H3K27me3 are established de novo at a 
sequence in a gene desert region that shows a high CpG frequency and an overall high G+C 
content thereby creating a bivalent domain. This result indicates that the establishment of a 
bivalent domain is a default mechanism that can occur at CGI-like sequences in the absence 
of other cues, such as transcriptional activators. Additionally it was shown that the presence 
of a high CpG density is required for the recruitment of H3K4/K27 methyltransferases. A 
high G+C content alone is not sufficient for the establishment of a bivalent domain (See 
Figure 5.2.1-3 and Figure 5.2.1-5). This specific requirement for CpGs is in accordance with 
the view that many histone-modifying proteins, which are found at CGIs, possess a CxxC 
domain that enables the recognition of unmethylated CpGs.  
 
Establishment of H3K4me3 
It seems that a basal level of H3K4me3 is established in absence of transcription. The 
creation of the H3K4me3 is likely to be independent of the H3K4 methyltransferases 
SET1A/1B as cells deficient in Cfp1, a subunit of these complexes, are still able to write this 
chromatin mark (see Figure 4.2.5-1). This is consistent with the observation that SET1A/1B 
mediate the bulk of the H3K4 trimethylation in mammalian cells (Wu et al, 2008) and that 
depletion of Cfp1 leads to loss of H3K4me3 only at active genes (Clouaire et al, 2012). 
However, Cfp1 is present at the integrated CGI like sequence (see Figure 4.2.4-2). Other H3K4 
methyltransferases such as MLL1 or MLL2, which also possess a CxxC domain that could 
play a role in recruiting HMTs to unmethylated CpGs, might be responsible for the creation 
of the H3K4me3 peak observed at the PuroGFP insertion and the artificial CGI (Bach et al, 
2009; Birke et al, 2002). Indeed, it was shown that MLL2 is the H3K4 methyltransferase in 
mammals that is responsible for trimethylating H3K4 at bivalent genes (Hu et al, 2013). This 
is consistent with the levels of H3K4me3 observed at the inserted CGI-like sequences that 
were lower than at the gene promoter of actively transcribed genes like GAPDH or Sox2 and 
showed more similarity with those at the bivalent control genes HoxC8 and HoxA9. For 
future experiments it will be interesting to investigate which H3K4 methyltransferase is 
responsible for H3K4me3 at artificial CGI-like sequences. MLL2 might be the best 
candidate as it has been shown that this enzyme is responsible for establishing H3K4m3 at 
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bivalent genes (Hu et al, 2013). Therefore, MLL2 knock out ES cell could be used or MLL2 
could be knocked down using shRNAs in cells already deficient for Cfp1. Alternatively, the 
role of other H3K4 methyltransferases could be examined.  
 
Establishment of H3K27me3 
As well as H3K4me3, H3K27me3 was detected at the artificial CGI-like sequences to levels 
similar to those found at the promoter region of bivalent genes. This finding was 
strengthened by the presence of Suz12, a member of the PRC2 complex. As the core PRC2 
complex does not contain any DNA-binding domains itself, the mechanisms of its 
recruitment to gene loci have remained elusive. Even though PRC2 localizes to 
unmethylated CGIs, no CxxC domain-containing proteins are known to interact with PRC2. 
JARID2, an interactor of PRC2, does not possess a CxxC domain but shows binding 
preference to CG rich DNA (Li et al, 2010). Equally, AEBP2, a zinc finger protein that co-
localizes with PRC2 binds DNA with low specificity (Kim et al, 2009). Additionally, 
orthologues of Drosophila Polycomb-like (PCL), also interact with PRC2 and have been 
implicated in its recruitment (Margueron & Reinberg, 2011; Simon & Kingston, 2013). 
Alternatively to DNA binding, many subunits of the PRC2 interact with nucleosomes that 
promote recruitment to chromatin without relying on DNA sequence-specific binding. For 
example, the PRC2 subunits EED and RBAP46/48 bind to histones H3 and H4. EED also 
binds to H3K27me3. PCL proteins contain PHD and Tudor domains via which additional 
interactions with nucleosomes can be formed. It has been proposed that the sum of relatively 
weak unspecific interaction can in the end lead to PRC2 recruitment (Klose et al, 2013; 
Margueron & Reinberg, 2011; Voigt et al, 2013). Additionally, it has been suggested that 
rather than being actively recruited to specific loci, PRC2 is sampling potentially permissive 
regions and does bind unless excluded by antagonistic signals (Farcas et al, 2012; Klose et 
al, 2013; Voigt et al, 2013). This means that prevention of binding could be a way of 
regulating PRC2 recruitment. Furthermore, KDM2B-PRC1 complexes continually probe 
unmethylated CpG loci for their susceptibility to repression, and stable recruitment may 
further depend on pre-existing repressive determinants (Mendenhall et al, 2010; Farcas et al, 
2012).  
 
This view of PRC2 recruitment partially fits with the data presented in this thesis that show 
H3K27me3 establishment at an isolated CGI-like sequence. The presence of PRC2 might be 
owed to the fact that no excluding activities such as productive transcription prevent 
recruitment in a gene desert region. Similar observations have been made by showing that 
 160 
introduction of ectopic CGIs is sufficient to recruit PRC2 as long as these sequences are 
devoid of activating signals (Lynch et al, 2011; Mendenhall et al, 2010). Lynch and 
colleagues showed that replacing the normally non-bivalent mouse α-globin locus with the 
CGI containing human α-globin locus created an ectopic bivalent domain (Yuan et al, 2012; 
Lynch et al, 2011). The authors further demonstrated that the presence of H3K27m3 
diminishes with transcriptional activation.  
 
However, as discussed above, it was shown in this work that CpGs are needed for the 
establishment of H3K27me3. Moreover, a high G+C content was not sufficient to recruit the 
PRC2 complex. This indicates that recruitment of different Polycomb subunits to generally 
G+C rich DNA, as was for example proposed for JARID2, is likely to be not sufficient for 
successful Polycomb recruitment but that some specific CpG binding activity is needed for 
the recruitment of PRC2.  
 
In the future it might be interesting to investigate if and which PRC1 complex is present at 
the artificial CGI and to answer the question if KDM2B can be detected. It might be 
tempting to speculate that the PRC1 complex, for which a specific CpG binding activity has 
been shown in form of the CxxC domain of KDM2B, might be in certain cases responsible 
for the recruitment of PRC2. Maybe the PRC1 variant containing KDM2B is initially 
recruited to CGIs. This recruitment could lead to H2AK119ub and chromatin compaction, 
which might recruit PRC2, as it has been shown that PRC2 is stimulated by the presence of 
nucleosomes (Schmitges et al, 2011; Yuan et al, 2012). This model of PRC1 mediated PRC2 
recruitment is however very speculative as there are not sufficient data to demonstrate its 
validity and it is likely that a range of mechanisms is contributing to PRC2 recruitment. 
Nonetheless, knockdown experiments of different PRC1 and PRC2 components could shed 
light on the order of recruitment at ectopically introduced CGIs.  
 
Establishment of bivalent domains 
In summary, these data indicate that unmethylated CpGs in CGIs mediate recruitment of 
both SET1/MLL and PRC2 activities, as both H3K4me3 and H3K27me3 are established at 
ectopically introduced CGIs. See Figure 6.1.1-1 for a potential model of how CGIs influence 
chromatin. Despite the fact that it has been argued that H3K4me3 and H3K27me3 cannot 
coexist because PRC2 is inhibited by active chromatin marks (Voigt et al, 2012; Schmitges 
et al, 2011) a recent study has proposed a model of how PRC2 recruitment to nucleosome 
containing H3K4me3 can be achieved (Voigt et al, 2012). The authors found that 
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nucleosomes with only one H3K4me3 mark could still be methylated by PRC2 whereas 
inhibition of PRC2 required the presence of H3K4me3 on both copies of H3 (Voigt et al, 
2012; 2013). Thus, the resulting asymmetric conformation with H3K4me3 and H3K27me3 
occupying opposite H3 tails allows the coexistence of active and repressive marks within 
single nucleosomes at bivalent loci (Voigt et al, 2012; Voigt et al, 2013). A way of how 
bivalent domains are established could be that CGI-like sequences attract MLL/SET1 
complexes to create basal levels of H3K4me3. If additional activating cues trough binding of 
transcription factors, assembly of the transcription machinery and productive transcription 
occur, H3K4me3 is reinforced while PRC2 is excluded. In cases where no such additional 
activating forces occur, basal levels of H3K4me3 could be further diminished by recruiting 
an H3K4me3 demethylase that can compete with H3K4me3 deposition, leading to the 
removal of H3K4me3 from at least one copy of H3 in a nucleosome. This would allow the 
PRC2 complex to methylate H3K27 on the opposite H3 tail. PRC1 variants that are recruited 
to CGIs via the CxxC containing protein KDM2B could cooperate with PRC2 and reinforce 
each other as PRC1 compacts chromatin, which stimulates PRC2. Further, H3K27me3 
demethylases could play a role in preventing excessive H3K27me3, thereby maintaining 
equilibrium of both marks at bivalent loci.  
 
Fate of bivalent domains upon differentiation 
For future experiments it would be interesting to further investigate the fate of bivalent 
domains upon differentiation. Therefore we want to design two constructs that resemble the 
CGI of the Aprt promoter, as the CGI of this gene is well studied (Macleod et al, 1994; 
Brandeis et al, 1994). One construct will have the same sequence as the Aprt CGI, whereas 
the other will contain the Aprt CGI with mutated SP1 binding sites. It is thought that the 
construct with the mutated SP1 sites will behave like the artificial CGI presented in this 
thesis and form a bivalent domain, as it contains a CpG rich and G+C rich sequence. Upon 
differentiation Polycomb is suggested to take over as activating cues are absent. In contrast, 
the Aprt CGI sequence with intact SP1 binding sites should loose Polycomb as it contains 
transcription factor binding sites and should recruit the transcriptional machinery. In this 
case differentiation is thought to result in the maintenance of the activating H3K4me3 and 
H3K27me3 would be expected to be absent. This would allow testing the hypothesis that 
CGIs are nucleating sites of bivalent domain in absence of transcription that can be resolved 













































Figure 6.1.1-1 Model of how CGIs influence chromatin 
A: A CGI like sequence with high CpG density (Capital letters in red) and a high G+C 
content (Capital letters in black) in a gene desert creates a bivalent chromatin structure by 
default. This is characterized by the presence of H3K4me3, which might be established by 
MLL1/2 and/or SET1A/B, and by H3K27me3, which is established by the PRC2 complex. It 
is possible that the PRC1 complex might be recruited as well via the CxxC domain 
containing protein KDM2B. B: The presence of high CpG density is essential for H3K4 and 
H3K27 methyltransferases recruitment. A sequence that retains the same, high G+C 
content, but has very little CpGs (like the bulk genome) does neither attract H3K4me3 nor 
H3K27me3. C: A high G+C content is essential to protect a CGI from DNA methylation. A 
sequence that contains as many CpGs as an average CGI but has a C+G content like the 
bulk genome becomes heavily methylated, indicating that CpGs are not enough to protect 
against DNA methylation, which is detrimental to the establishment of both, H3K4me3 and 
H3K27me3. Complexes drawn in opaque have not been investigated in this study but might 
play a role.   
 
6.1.1. A high G+C content in GGIs is required for maintaining their 
unmethylated state 
In this thesis it was shown that a CGI-like sequence with a high CpG frequency and a high 
G+C content in a gene desert is sufficient to maintain an unmethylated state in mouse ES 
cells (see Figure 4.2.2-1). This result indicates that, at least in ES cells, transcriptional 
activity is not required for a CGI-like sequence to remain unmethylated, as no form of RNA 
polymerase II was detected at the inserted region. Moreover, it was demonstrated that a high 
G+C content is necessary to keep a sequence free of DNA methylation and that a high CpG 
content is not sufficient to prevent de novo DNA methylation (see Figure 5.2.3-1).  
 
Interestingly, in the original study of Thomson and colleagues, where the promoterless CGI-
like sequences eGFP and PuroGFP were introduced into the 3’end of the Mecp2 and Nanog 
gene, respectively, eGFP became methylated whereas PuroGFP remained free of DNA 
methylation (Lienert et al, 2011; Thomson et al, 2010). Both CGI-like sequences display 
sequence properties that lie above the threshold that is usually applied for CGIs. It has been 
suggested that the locus of insertion might play a role. The eGFP sequence was integrated 
into the 3’ UTR of Mecp2, a gene that is only lowly expressed in ES cells, whereas the 
PuroGFP was inserted into the 3’UTR of the highly expressed Nanog gene. However, it 
seems unlikely that the integration site is a factor influencing DNA methylation, as the same 
PuroGFP sequence remained unmethylated when integrated into a transcriptionally inert 
gene desert. When comparing the two CGI-like sequences differences become apparent; the 
eGFP sequence is shorter than the PuroGFP sequence (726 bp vs. 1287 bp). Moreover, both 
CpG frequency and C+G content are lower in the eGFP sequence than in the PuroGFP 
sequence (8 CpGs/100 bp and 61.6% G+C content vs. 11 CpGs/100 bp and 66.5% G+C 
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content). Together this indicates that eGFP is a “weaker” CGI and therefore might be more 
susceptible to DNA methylation.  
 
A recent study by Lienert and colleagues, where around 50 different sequences were inserted 
into a transcriptionally inert locus, showed that these sequences autonomously recapitulated 
correct DNA methylation in absence of transcription (Lienert et al, 2011). However in this 
study they found that 7 out of 10 sequences from the E.coli genome that had an average 
length of 780 bp and varied in CpG density from 4.4 to 6.8 CpGs per 100 bp, became 
methylated. This CpG frequency is on the lower end of what normally constitutes a CGI but 
still well above the bulk genome. The 3 fragments that did not become methylated were 
among those with the higher frequency of CpGs, although some other fragments with the 
same CpG density did become methylated. On the first sight this observation might seem 
contradictory to the results obtained in this thesis that showed that a high CpG density and a 
high G+C content is enough to protect a sequence from becoming methylated. In order to 
investigate this issue further we analysed the exact sequence composition of the E.coli 
sequences used in the study by Lienert and colleagues. It became apparent that the G+C 
content of these sequences was considerably lower than that of average CGIs. The E.coli 
sequences displayed a G+C content between 40-55%, whereas usually CGIs have a G+C 
content of around 60%. The three fragments that did not become methylated showed the 
highest G+C content. This is in agreement with the finding presented here, which 
demonstrated that a high G+C content of 40% together with normal, high density of CpGs is 
not sufficient to protect against de novo DNA methylation. In order to further investigate the 
influence of G+C content on prevention of DNA methylation, a further construct will be 
created that displays the normal CpG density of a typical CGI but contains an intermediate 
G+C content of 51%.   
 
In summary, CGIs are important features that are able to influence local chromatin to form a 
permissive structure that is per default characterized by absence of DNA methylation, 
presence of H3K4me3 and H3K27me3. DNA methylation was shown to be dominant over 
the formation of bivalent domains, presumably because recruitment of histone modifying 
enzymes is impaired by methylated Cs. Whereas CpGs are important for the recruitment of 
histone-modifying enzymes, a high G+C content is required to prevent DNA methylation 
(for a model see Figure 6.1.1-1). This shows how two common features of CGIs, CpG 
frequency and G+C content, act together in order to ensure an open chromatin structure that 
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